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1
Introduction and aims of this thesis
One out ten couples with the wish to conceive will face infertility. Infertility is a disease 
of the reproductive system defined by the failure to achieve a clinical pregnancy after 
12 months or more of regular unprotected sexual intercourse (Zegers-Hochschild, et al., 
2009). These couples are then referred by their general practitioner to the fertility clinic 
to seek help. 
In approximately 40% of infertile couples a male factor is involved (Hull, et al., 1985). Male 
infertility presents mostly with decreased sperm quality. 
Spermatogenesis & Azoospermia
Spermatogenesis takes places in the testes, which contain two anatomical units: first a 
network of seminiferous tubules containing Sertoli cells and second the interstitium 
containing Leydig cells as presented in Figure 1 (Page, et al., 2008). 
Figure 1  Endocrinology of spermatogenesis
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Chapter 1
Spermatogenesis is regulated by a hormonal axis comprising three anatomical 
components: hypothalamus (located in the brain), pituitary gland (located in the brain) 
and the testicles. The hypothalamic-pituitary-testicular axis, regulates an endocrine loop 
with negative feedback of downstream hormonal products. Testicular production of 
testosterone and inhibin B is carefully regulated by gonadotropins produced by the 
pituitary gland. Gonadotropin production is under the direct control of pulsatile 
gonadotropin releasing hormone (GnRH) secretion from the hypothalamus. The main 
hormones that actually control spermatogenesis are follicle stimulating hormone (FSH) 
and testosterone. FSH receptors are present in Sertoli cells and spermatogonia, and 
androgen receptors are present in Sertoli cells, Leydig cells, and peritubular myoid cells. 
After spermatogenesis takes place in the testis (Page, et al., 2008), mature sperm cells are 
stored in the epididymis (Figure 2). During ejaculation, sperm cells from the epididymis 
accompanied with prostate fluid and secrete of the seminal vesicle form the ejaculate 
(Nap, 2013). Sometimes there are no spermatozoa present in the ejaculate at all, a condition 
called azoospermia. Azoospermia is diagnosed as the cause of the infertility in 5-10% of 
infertile couples, and also found in one percent of the general population (De Croo, et al., 
2000, Jarow, et al., 1989).
Figure 2  Anatomy of the male reproductive tract
Source: Open Stax College Download for free at http://cnx.org/contents/48d9cf34-dcfd-4dd3-a196-eec3eea6f408@1.7. 
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The most used classification of azoospermia is based on its aetiology: a transport problem 
of sperm cells after they leave the testes (obstruction) or a disturbed spermatogenesis (no 
obstruction). Obstructive azoospermia (OA) is diagnosed in 30-40% of the cases while 
non-obstructive azoospermia (NOA) is found in 60-70% of the azoospermic males (Ezeh, 
2000, Matsumiya, et al., 1994). 
Obstructive azoospermia
In OA, normal spermatogenesis is assumed, but due to an obstruction of the spermatic 
chords (vas deferens) in the more distal parts of the epididymis, sperm cells are not found 
in the ejaculate. Causes of OA are among others: epididymitis (inflammation of the 
epididymis); testicular trauma resulting in damage; status after vasectomy and absence of 
spermatic cords (congenital bilateral absence of vas deferens). This last condition is found 
in males suffering from cystic fibrosis or in males who are carrier of this gene defect. 
Histological normal or mild hypospermatogenesis is often found in these men with OA. 
Therefore, sperm cells can be retrieved by puncturing the epididymis with a needle, called 
percutaneous epididymal sperm aspiration (PESA), for use in fertility treatment, see next 
paragraphs.
Non-obstructive azoospermia
In NOA, the lack of sperm cells in the ejaculate is due to a qualitative and/or quantitative 
extremely disturbed spermatogenesis. Generally, these men present with low testicular 
volume and high levels of FSH, see Box 1 for the definition of NOA (Adamopoulos and 
Koukkou, 2010, Jungwirth, et al., 2012). 
Known causes of NOA are iatrogenic damage (radiation or chemotherapy); testicular 
torsion; orchitis (inflammation of the testes); cryptorchidism (a condition in which one or 
both of the testes fail to descend from the abdomen into the scrotum) or genetic 
abnormalities (Y-chromosomal AZF-deletions or Klinefelter syndrome). Y-chromosomal 
deletions are observed in about three percent of males diagnosed with NOA (Johnson, 
1998, Pryor, et al., 1997, Skaletsky, et al., 2003). Unfortunately, in most men with NOA the 
cause of disturbed spermatogenesis remains unexplained. 
Box 1 Definition non-obstructive azoospermia
Azoospermia without evidence of obstruction with either:
- Small testes (volume per testis <15 ml)
and / or
- Elevated FSH level ( >10 IU/L)
and / or
- Decreased Inhibin B (<150 ng/L)
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Chapter 1
In order to obtain sperm cells for fertility treatment in NOA men, a testicular biopsy (TESE, 
testicular sperm extraction) can be performed. Several histological stages can be observed 
when taking a testicular biopsy. In case of Sertoli-Cell-Only syndrome sperma togonial 
stem cells are absent (germinal cell aplasia) which will lead to an unsuccessful sperm 
retrieval when TESE is performed (Levin, 1979). When spermatogonia are present but sper-
matogenesis development stops at some point during maturation, we call this maturation 
arrest. This happens most often at first meiotic prophase and no sperm or scarcely sperm 
cells, not appropriate for fertility treatment, can be found (Levin, 1979). In other cases there 
is focal spermatogenesis, which is a mixture of tubules with Sertoli- Cell-Only and tubules 
with active spermatogenesis (Levin, 1979).
Azoospermia: Treatment and health of offspring
Sperm cells obtained by PESA or TESE can be used for intracytoplasmic sperm injection 
(ICSI) treatment in order to conceive a genetically own child. From the moment PESA-ICSI 
and TESE-ICSI were introduced into daily practice in the early nineties (Devroey, et al., 1994, 
Nagy, et al., 1995, Tournaye, et al., 1994), the Dutch board of gynaecologists (NVOG) and 
embryologists (KLEM) expressed their concerns about the possible short and long term 
effects on the health of children conceived by surgical retrieved sperm. Hence, in 1996 a 
moratorium was set on the use of surgical retrieved sperm for ICSI treatment. For couples 
facing azoospermia it was not possible to receive fertility treatment in the Netherlands. 
This resulted in couples seeking fertility treatment abroad. The first international follow up 
report of ICSI children born from OA and NOA fathers, indicated that there were no 
increased health risks in terms of major birth defects compared with ICSI children 
conceived with ejaculated sperm (Bonduelle, et al., 1998). Therefore, after approval of the 
Central Committee on Research Involving Human Subjects (CCMO) in 2001, ICSI using 
epipidymal sperm was restarted but under strict regulations. Research into the quality of 
epididymal sperm and prospective follow up of children born after these procedures 
were performed in order to evaluate health effects. At the Radboud university medical 
center, a study of quality of epididymal sperm in azoospermia, reported highly elevated 
rates of sperm DNA damage and chromatin condensation defects in epididymal sperm 
(PhD thesis L. Ramos). However, sperm selection based on motility showed similar quality 
to ejaculated sperm (Ramos, 2004). In a follow up study of Woldringh et al. the prevalence 
of birth defects and development of children born after PESA-ICSI were studied. The 
group reported that ICSI with epididymal sperm did not lead to more still births or 
congenital malformations in comparison to children born after IVF. Moreover, ICSI with 
ejaculated sperm did not lead to poor development of children compared with a Dutch 
reference group of children born after IVF or ICSI with ejaculated sperm (Woldringh, 2011). 
In 2007, besides PESA-ICSI also TESE-ICSI was allowed in research settings in Radboud 
university medical center (Nijmegen) and Academic Medical Center (Amsterdam). The 
CCMO protocol focussed on the safety aspect of TESE and the health of the children born 
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from NOA men. At that time insufficient data about late developmental effects in children 
born after TESE-ICSI were available. Two studies described pregnancy and neonatal 
outcome of children born after TESE-ICSI short after birth, either by data analysis (Vernaeve, 
et al., 2003) as well as by physical examination (Ludwig and Katalinic, 2003).  No prospective 
studies had been performed regarding behavioural, cognitive, motor and physical 
performance of children born after TESE-ICSI older than two years of age. The Central 
Committee on Research Involving Human Subjects (CCMO, The Hague, the Netherlands) 
approved a study protocol studying the behavioural, cognitive, motor and physical 
performance of children born after TESE-ICSI, at the age of five. After a preliminary report 
of this study (May 2014) regarding the prevalence of birth defects in these children, and a 
Quality Standard regarding ART with surgical retrieved sperm developed by the Dutch 
board of gynaecologists (NVOG) , urologists (NVU) and embryologists (KLEM), in June 2014 
the moratorium on TESE-ICSI was lifted by Mrs. E.I. Schippers, Minister of Health, Welfare 
and Sport (NVOG, 2013, Staatscourant, 2014). Figure 3 presents an overview of the 
availability (introduction and re-introduction) of assisted reproductive techniques in the 
Netherlands. 
The azoospermic couple: Counselling 
Only in about half of TESE procedures, sperm retrieval is successful in men with NOA (Chan 
and Schlegel, 2000, Colpi, et al., 2005, Tournaye, 2010). In men with OA who had a failed 
PESA, TESE is more successful (Omurtag, et al., 2013) than in men with NOA.  Preference for 
epididymal sperm upon testicular biopsy is based on the quality of sperm and risks of the 
surgical procedure. Taking a testicular biopsy carries a small risk of complications, including 
loss of significant amount of testicular tissue, haematoma, inflammatory changes and 
permanent devascularisation (Schlegel and Su, 1997). Even though the pregnancy rate 
after TESE-ICSI is encouragingly high, it is lower than in men with normal spermatogenesis 
Figure 3   Timeline of availability and introduction of assisted reproductive techniques  
in The Netherlands
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Chapter 1
(Nicopoullos, et al., 2004, Tournaye, 2010). Figure 4 presents the steps an azoospermic 
couple has to undergo during the fertility treatment.
For those couples with failed testicular sperm retrieval or those who failed to conceive 
after TESE-ICSI, insemination using donor sperm, adoption or becoming foster parents are 
other options to fulfil their child wish. In order to involve couples in their treatment and 
help them making their own choices by shared decision making, the fertility professional 
should present the treatment options and expected outcome clearly (Legare, et al., 2014). 
Nowadays, counselling couples about their chances of successful sperm retrieval by TESE 
and a successful TESE-ICSI outcome, in terms of treatment resulting in a live born child, is 
mandatory. Couples have to consider whether it is worth for them to start the intensive 
treatment burden that means a TESE procedure, ovarian stimulation, oocyte retrieval and 
embryo transfer before starting with the procedures. In addition, they have to consider 
the emotional impact of a negative result of the TESE procedure, but also the psychological 
impact of the ICSI treatment if sperm retrieval is successful (Rockliff, et al., 2014, Verhaak, et 
al., 2007). For counselling we need clinical prediction models which can foresee the 
chance of successful sperm retrieval in TESE and predict the chance of a live birth adjusted 
for couple’s characteristics. A number of prediction models for successful sperm retrieval 
in TESE have been developed already but none of them have been externally validated 
(Boitrelle, et al., 2011, Ramasamy, et al., 2013, Samli and Dogan, 2004, Tsujimura, et al., 2004). 
In reproductive medicine several prediction models have been developed, but none has 
been developed and validated for couples requiring TESE-ICSI. It is unknown whether 
parameters known to be predictive for IVF or ICSI outcome with ejaculated sperm play the 
same predictive role for these specific couples, as azoospermic couples have no natural 
chances for pregnancy. It can be imagined that in these couples, different clinical or 
laboratory parameters will have impact on the probability of getting pregnant and having 
a live born child.
Paternal ageing and assisted reproductive techniques
In the Netherlands, about ten percent of the couples who are trying to get pregnant are 
referred to the fertility clinic because of failure to conceive (Nap, 2013). This percentage has 
increased during time because couples seek for help after a shorter period of exposure 
but also due to delayed parenthood, second marriages and therefore more infertility 
cases are found (Nap, 2013). In western society and developed countries, there is a 
tendency for delayed parenthood as a consequence of social economical welfare, 
personal education development and increased life expectancy. Not only females are 
delaying parenthood; male age for parenthood has also increased in the last decade: in 
the year 2001 in the Netherlands 11.1% (n=22981) of the children born had a father over 40 
years old; in 2012 this percentage increased to 16.4% (n=28 888) (CBS, 2011). 
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Figure 4   Steps in fertility treatment for couples facing azoospermia
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While for female age a biological clock will determine the declining of their fecundity, male’s 
biological clock does not play such a prominent role, as men can produce sperm even at 
a very advanced age. Assisted reproductive techniques (ART) are commonly used to treat 
infertile couples. While a maximum access age to ART has been legally determined for 
women because of the low pregnancy changes and increased genetic risks, such a 
maximum age not has been considered for men. However, male ageing can compromise 
spermatogenesis (Plas, et al., 2000), increase DNA methylation (Jenkins, et al., 2013), and 
increased production of reactive oxygen species can induce DNA damage (Cocuzza, et al., 
2008). Moreover, recent epidemiological literature demonstrates an association between 
paternal age and the prevalence of autism spectrum disorders, schizophrenia and low 
educational attainment in offspring (D’Onofrio, et al., 2014, Humm and Sakkas, 2013). In 
addition, Pfeiffer syndrome, Crouzon syndrome, Achondroplasia, Apert syndrome, MEN2A 
and MEN2B are examples of genetic disorders associated with an advanced paternal age 
(Goriely and Wilkie, 2012). These disorders have their origin in mutations of paternal 
imprinted genes FGFR 2, FGFR 3 and/or RET (Crow, 2000) and occur more frequently than 
expected because of a selective advantage of these mutated cells in spermatogenesis.
Limited or but also controversial results about the influence of paternal age on the 
reproductive outcome after ART have been published. Previous studies show discordant 
findings in terms of effects on embryo quality, pregnancy rate and live born delivery (de 
La Rochebrochard, et al., 2006, Ferreira, et al., 2010, Klonoff-Cohen and Natarajan, 2004). In 
these studies the use of non-ejaculated sperm (epididymal or testicular origin) was not 
included. However, particularly elderly males who had a vasectomy are candidates for in-
tracytoplasmic sperm injection (ICSI) with non-ejaculated sperm for ART treatment. 
Therefore, this subject should be studied more extensively.
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Aims and outline of the thesis
This thesis focuses on the safety and efficacy of ART in male infertility and aims to provide 
tools and information for the physician to give a better counselling to couples facing 
azoospermia. The following research questions are being studied in this thesis:
•	 What factors pertain to the prediction of obtaining spermatozoa with TESE in men with 
NOA and how well does the resulting prognostic model perform using data from 
another centre? (Chapter 2) 
•	 Which parameters have a predictive value for live birth in couples undergoing TESE-ICSI 
and how well does the resulting prognostic model perform using data from another 
centre? (Chapter 3)
•	 What is the prevalence of birth defects in newborns born after PESA-ICSI and TESE-ICSI, 
and is there an effect of maternal and treatment-related factors (lab factors) on ART 
outcome? (Chapter 4)
•	 Are children born after TESE-ICSI at risk for behavioural, cognitive, motor or physical 
problems at the age of five? (Chapter 5)
•	 Does paternal age influence the reproductive outcome in ART in terms of the availability 
of a top quality embryo for transfer, biochemical pregnancy, ongoing pregnancy and 
miscarriage? (Chapter 6)
Chapter 7 provides a general discussion on the findings reported in this thesis, with rec-
ommendations for further research.
Chapter 8 is a summary of the thesis.
Processed on: 21-9-2016
505365-L-bw-Meijerink
18
Chapter 1
References
Adamopoulos, D. A. and Koukkou, E. G. ‘Value of FSH and inhibin-B measurements in the diagnosis of azoosper-
mia’--a clinician’s overview. International journal of andrology 2010, 33, e109-113.
Boitrelle, F., Robin, G., Marcelli, F., Albert, M., Leroy-Martin, B., Dewailly, D., Rigot, J. M. and Mitchell, V. A predictive score 
for testicular sperm extraction quality and surgical ICSI outcome in non-obstructive azoospermia: a retrospective 
study. Human reproduction 2011, 26, 3215-3221.
Bonduelle, M., Wilikens, A., Buysse, A., Van Assche, E., Devroey, P., Van Steirteghem, A. C. and Liebaers, I. A follow-up 
study of children born after intracytoplasmic sperm injection (ICSI) with epididymal and testicular spermatozoa and 
after replacement of cryopreserved embryos obtained after ICSI. Human reproduction 1998, 13 Suppl 1, 196-207.
CBS (2011) One out of six fathers is over 40 at birth of their child.
Chan, P. T. and Schlegel, P. N. Nonobstructive azoospermia. Current opinion in urology 2000, 10, 617-624.
Cocuzza, M., Athayde, K. S., Agarwal, A., Sharma, R., Pagani, R., Lucon, A. M., Srougi, M. and Hallak, J. Age-related 
increase of reactive oxygen species in neat semen in healthy fertile men. Urology 2008, 71, 490-494.
Colpi, G. M., Piediferro, G., Nerva, F., Giacchetta, D., Colpi, E. M. and Piatti, E. Sperm retrieval for intra-cytoplasmic 
sperm injection in non-obstructive azoospermia. Minerva urologica e nefrologica = The Italian journal of urology and 
nephrology 2005, 57, 99-107.
Crow, J. F. The origins, patterns and implications of human spontaneous mutation. Nature reviews Genetics 2000, 1, 40-47.
D’Onofrio, B. M., Rickert, M. E., Frans, E., Kuja-Halkola, R., Almqvist, C., Sjolander, A., Larsson, H. and Lichtenstein, 
P. Paternal age at childbearing and offspring psychiatric and academic morbidity. JAMA psychiatry 2014, 71, 432-438.
De Croo, I., Van der Elst, J., Everaert, K., De Sutter, P. and Dhont, M. Fertilization, pregnancy and embryo implantation 
rates after ICSI in cases of obstructive and non-obstructive azoospermia. Human reproduction 2000, 15, 1383-1388.
de La Rochebrochard, E., de Mouzon, J., Thepot, F., Thonneau, P. and French National, I. V. F. R. A. Fathers over 40 and 
increased failure to conceive: the lessons of in vitro fertilization in France. Fertility and sterility 2006, 85, 1420-1424.
Devroey, P., Liu, J., Nagy, Z., Tournaye, H., Silber, S. J. and Van Steirteghem, A. C. Normal fertilization of human oocytes 
after testicular sperm extraction and intracytoplasmic sperm injection. Fertility and sterility 1994, 62, 639-641.
Ezeh, U. I. Beyond the clinical classification of azoospermia: opinion. Human reproduction 2000, 15, 2356-2359.
Ferreira, R. C., Braga, D. P., Bonetti, T. C., Pasqualotto, F. F., Iaconelli, A., Jr. and Borges, E., Jr. Negative influence of 
paternal age on clinical intracytoplasmic sperm injection cycle outcomes in oligozoospermic patients. Fertility and 
sterility 2010, 93, 1870-1874.
Goriely, A. and Wilkie, A. O. Paternal age effect mutations and selfish spermatogonial selection: causes and 
consequences for human disease. American journal of human genetics 2012, 90, 175-200.
Hull, M. G., Glazener, C. M., Kelly, N. J., Conway, D. I., Foster, P. A., Hinton, R. A., Coulson, C., Lambert, P. A., Watt, E. M. and 
Desai, K. M. Population study of causes, treatment, and outcome of infertility. British medical journal 1985, 291, 
1693-1697.
Humm, K. C. and Sakkas, D. Role of increased male age in IVF and egg donation: is sperm DNA fragmentation 
responsible? Fertility and sterility 2013, 99, 30-36.
Jarow, J. P., Espeland, M. A. and Lipshultz, L. I. Evaluation of the azoospermic patient. The Journal of urology 1989, 142, 
62-65.
Jenkins, T. G., Aston, K. I., Cairns, B. R. and Carrell, D. T. Paternal aging and associated intraindividual alterations of 
global sperm 5-methylcytosine and 5-hydroxymethylcytosine levels. Fertility and sterility 2013, 100, 945-951.
Processed on: 21-9-2016
505365-L-bw-Meijerink
19
1
Introduction and aims of this thesis
Johnson, M. D. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommenda-
tions for genetic counseling and screening. Fertility and sterility 1998, 70, 397-411.
Jungwirth, A., Giwercman, A., Tournaye, H., Diemer, T., Kopa, Z., Dohle, G., Krausz, C. and European Association of 
Urology Working Group on Male, I. European Association of Urology guidelines on Male Infertility: the 2012 update. 
European urology 2012, 62, 324-332.
Klonoff-Cohen, H. S. and Natarajan, L. The effect of advancing paternal age on pregnancy and live birth rates in 
couples undergoing in vitro fertilization or gamete intrafallopian transfer. American journal of obstetrics and 
gynecology 2004, 191, 507-514.
Legare, F., Stacey, D., Turcotte, S., Cossi, M. J., Kryworuchko, J., Graham, I. D., Lyddiatt, A., Politi, M. C., Thomson, R., 
Elwyn, G. et al. Interventions for improving the adoption of shared decision making by healthcare professionals. The 
Cochrane database of systematic reviews 2014, 9, CD006732.
Levin, H. S. Testicular biopsy in the study of male infertility: its current usefulness, histologic techniques, and 
prospects for the future. Human pathology 1979, 10, 569-584.
Ludwig, M. and Katalinic, A. Pregnancy course and health of children born after ICSI depending on parameters of 
male factor infertility. Human reproduction 2003, 18, 351-357.
Matsumiya, K., Namiki, M., Takahara, S., Kondoh, N., Takada, S., Kiyohara, H. and Okuyama, A. Clinical study of 
azoospermia. International journal of andrology 1994, 17, 140-142.
Nagy, Z., Liu, J., Cecile, J., Silber, S., Devroey, P. and Van Steirteghem, A. Using ejaculated, fresh, and frozen-thawed 
epididymal and testicular spermatozoa gives rise to comparable results after intracytoplasmic sperm injection. 
Fertility and sterility 1995, 63, 808-815.
Nap, A. d. H., T.; Kremer, J. (2013) Handboek Voortplantingsgeneeskunde, De Tijdstroom uitgeverij.
Nicopoullos, J. D., Gilling-Smith, C., Almeida, P. A., Norman-Taylor, J., Grace, I. and Ramsay, J. W. Use of surgical sperm 
retrieval in azoospermic men: a meta-analysis. Fertility and sterility 2004, 82, 691-701.
NVOG Kwaliteitsnorm: Geassisteerde voortplanting met chirurgisch verkregen zaadcellen. 2013, 1.0.
Omurtag, K., Cooper, A., Bullock, A., Naughton, C., Ratts, V., Odem, R. and Lanzendorf, S. E. Sperm recovery and IVF 
after testicular sperm extraction (TESE): effect of male diagnosis and use of off-site surgical centers on sperm 
recovery and IVF. PloS one 2013, 8, e69838.
Page, S. T., Amory, J. K. and Bremner, W. J. Advances in male contraception. Endocrine reviews 2008, 29, 465-493.
Plas, E., Berger, P., Hermann, M. and Pfluger, H. Effects of aging on male fertility? Experimental gerontology 2000, 35, 
543-551.
Pryor, J. L., Kent-First, M., Muallem, A., Van Bergen, A. H., Nolten, W. E., Meisner, L. and Roberts, K. P. Microdeletions in 
the Y chromosome of infertile men. The New England journal of medicine 1997, 336, 534-539.
Ramasamy, R., Padilla, W. O., Osterberg, E. C., Srivastava, A., Reifsnyder, J. E., Niederberger, C. and Schlegel, P. N. A 
comparison of models for predicting sperm retrieval before microdissection testicular sperm extraction in men 
with nonobstructive azoospermia. The Journal of urology 2013, 189, 638-642.
Ramos, L. (2004) The quality of epididymal sperm in azoospermia. Radboud university medical center, Nijmegen.
Rockliff, H. E., Lightman, S. L., Rhidian, E., Buchanan, H., Gordon, U. and Vedhara, K. A systematic review of psychosocial 
factors associated with emotional adjustment in in vitro fertilization patients. Human reproduction update 2014, 20, 
594-613.
Samli, M. M. and Dogan, I. An artificial neural network for predicting the presence of spermatozoa in the testes of 
men with nonobstructive azoospermia. The Journal of urology 2004, 171, 2354-2357.
Processed on: 21-9-2016
505365-L-bw-Meijerink
20
Chapter 1
Schlegel, P. N. and Su, L. M. Physiological consequences of testicular sperm extraction. Human reproduction 1997, 12, 
1688-1692.
Skaletsky, H., Kuroda-Kawaguchi, T., Minx, P. J., Cordum, H. S., Hillier, L., Brown, L. G., Repping, S., Pyntikova, T., Ali, J., 
Bieri, T. et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 
2003, 423, 825-837.
Staatscourant Regeling van de Minister van Volksgezondheid, Welzijn en Sport van 3 september 2014, kenmerk 
654779-124939-CZ, houdende wijziging van het Planningsbesluit in-vitrofertilisatie in verband met het opheffen 
van het moratorium op PESA en TESE. 2014.
Tournaye, H. Update on surgical sperm recovery--the European view. Human fertility 2010, 13, 242-246.
Tournaye, H., Devroey, P., Liu, J., Nagy, Z., Lissens, W. and Van Steirteghem, A. Microsurgical epididymal sperm 
aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital 
bilateral absence of the vas deferens. Fertility and sterility 1994, 61, 1045-1051.
Tsujimura, A., Matsumiya, K., Miyagawa, Y., Takao, T., Fujita, K., Koga, M., Takeyama, M., Fujioka, H. and Okuyama, A. 
Prediction of successful outcome of microdissection testicular sperm extraction in men with idiopathic 
nonobstructive azoospermia. The Journal of urology 2004, 172, 1944-1947.
Verhaak, C. M., Smeenk, J. M., Evers, A. W., Kremer, J. A., Kraaimaat, F. W. and Braat, D. D. Women’s emotional adjustment 
to IVF: a systematic review of 25 years of research. Human reproduction update 2007, 13, 27-36.
Vernaeve, V., Bonduelle, M., Tournaye, H., Camus, M., Van Steirteghem, A. and Devroey, P. Pregnancy outcome and 
neonatal data of children born after ICSI using testicular sperm in obstructive and non-obstructive azoospermia. 
Human reproduction 2003, 18, 2093-2097.
Woldringh, G. H. (2011) ICSI Children. Radboud university medical center, Nijmegen.
Zegers-Hochschild, F., Adamson, G. D., de Mouzon, J., Ishihara, O., Mansour, R., Nygren, K., Sullivan, E., van der Poel, S., 
International Committee for Monitoring Assisted Reproductive, T. and World Health, O. The International Committee 
for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised 
Glossary on ART Terminology, 2009. Human reproduction 2009, 24, 2683-2687.
Processed on: 21-9-2016
505365-L-bw-Meijerink
21
1
Introduction and aims of this thesis
Processed on: 21-9-2016
505365-L-bw-Meijerink
Processed on: 21-9-2016
505365-L-bw-Meijerink
Prediction model for obtaining 
spermatozoa with TESE in men with 
 non-obstructive azoospermia
A.M. Meijerink*, M. Cissen*, K. d’Hauwers, A. Meissner, N. van der Weide, M.H. Mochtar, 
A.A. de Melker, L. Ramos, S. Repping, D.D.M Braat, K. Fleischer, M. van Wely
* The first two authors should be regarded as joint first authors
 
Human Reproduction. 2016 Sep;31(9):1934-41
2
Processed on: 21-9-2016
505365-L-bw-Meijerink
24
Chapter 2
Abstract
Study question: Can an externally validated model, based on biological variables, be 
developed to predict successful sperm retrieval with testicular sperm extraction (TESE) in 
men with non-obstructive azoospermia (NOA) using a large nationwide cohort?
Summary answer: Our prediction model including six variables was able to make a good 
distinction between men with a good chance and men with a poor chance of obtaining 
spermatozoa with TESE.
What is known already: Using ICSI in combination with TESE even men suffering from 
NOA are able to father their own biological child. Only in approximately half of the patients 
with NOA can testicular sperm be retrieved successfully. The few models that have been 
developed to predict the chance of obtaining spermatozoa with TESE were based on 
small datasets and none of them have been validated externally.
Study design, size, duration: We performed a retrospective nationwide cohort study. 
Data from 1371 TESE procedures were collected between June 2007 and June 2015 in the 
two fertility centres.
Participants/materials, setting, methods: All men with NOA undergoing their first 
TESE procedure as part of a fertility treatment were included. The primary end-point was 
the presence of one or more spermatozoa (regardless of their motility) in the testicular 
biopsies. We constructed a model for the prediction of successful sperm retrieval, using 
univariable and multivariable binary logistic regression analysis and the dataset from one 
centre. This model was then validated using the dataset from the other centre. The area 
under the receiver-operating characteristic curve (AUC) was calculated and model 
calibration was assessed.
Main results and the role of chance: There were 599 (43.7%) successful sperm retrievals 
after a first TESE procedure. The prediction model, built after multivariable logistic 
regression analysis, demonstrated that higher male age, higher levels of serum testosterone 
and lower levels of FSH and LH were predictive for successful sperm retrieval. Diagnosis of 
idiopathic NOA and the presence of an azoospermia factor c gene deletion were predictive 
for unsuccessful sperm retrieval. The AUC was 0.69 (95%confidence interval (CI): 0.66–0.72).
The difference between the mean observed chance and the mean predicted chance was, 
<2.0% in all groups, indicating good calibration. In validation, the model had moderate 
discriminative capacity (AUC 0.65, 95% CI: 0.62–0.72) and moderate calibration: the 
predicted probability never differed by more than 9.2% of the mean observed probability.
Limitations, reasons for caution: The percentage of men with Klinefelter syndrome 
among men diagnosed with NOA is expected to be higher than in our study population, 
which is a potential selection bias. The ability of the sperm retrieved to fertilize an oocyte 
and produce a live birth was not tested.
Wider implications of the findings: This model can help in clinical decision-making in 
men with NOA by reliably predicting the chance of obtaining spermatozoa with TESE.
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Introduction
Azoospermia is defined by the complete absence of spermatozoa in the ejaculate (WHO, 
2009). It affects ~ 1% of the male population (Jarow, et al., 1989) and can be divided into 
two main categories; mechanical obstruction along the seminal tract (obstructive 
azoospermia (OA)) and an intrinsic testicular impairment of sperm production (non- 
obstructive azoospermia (NOA)). NOA is diagnosed in 60% of azoospermic men (Jarow, et 
al., 1989, Matsumiya, et al., 1994). Using ICSI in combination with testicular sperm extraction 
(TESE) even men suffering from NOA are able to father their own biological child.
TESE is an invasive procedure with an, albeit small, risk of complications, including 
haematoma, inflammation and permanent devascularization, all possibly resulting in the 
loss of a significant amount of testicular tissue (Donoso, et al., 2007, Schlegel and Su, 1997). 
Only in approximately half of the patients with NOA can testicular sperm be retrieved 
successfully (Chan and Schlegel, 2000, Colpi, et al., 2005, Tournaye, 2010).
A number of factors have been suggested to be of predictive value to distinguish patients 
with a good chance to retrieve sperm cells from patients who have a poor chance. Factors 
such as testicular volume, serum FSH levels and serum inhibin B levels (Bryson, et al., 2014, 
Chen, et al., 2010, Toulis, et al., 2010, Yang, et al., 2015, Yildirim, et al., 2014) have been used 
as variables in several prediction models (Boitrelle, et al., 2011, Ramasamy, et al., 2013, Samli 
and Dogan, 2004, Tsujimura, et al., 2004). Unfortunately, all these models are of limited 
value. Most included only a limited number of patients and the models were not validated 
externally. Since a model tends to perform better in the population in which it has been 
constructed, external validation is a crucial step before the model can be used in daily 
practice across different centres (Bleeker, et al., 2003).
It is evident that patients should be well informed about their chances of a successful TESE 
procedure and their likelihood to retrieve sperm cells before consenting to the procedure. 
It would therefore be of great value to be able to estimate an individual’s chance of sperm 
retrieval to empower patients in their decision-making. The aim of this study is to develop 
an externally validated model to predict successful sperm retrieval with TESE in men with 
NOA in a large nationwide cohort.
Materials and Methods
Study design
We performed a nationwide retrospective cohort study among all men diagnosed with 
NOA undergoing a first TESE as part of a fertility treatment in the Radboud University 
Medical Center, Nijmegen (Radboudumc—development set) and the Academic Medical 
Center, Amsterdam (AMC—validation set), The Netherlands. Data were collected between 
1 June 2007 and 1 June 2015. These two centres were the only centres offering TESE–ICSI 
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during the study period until 1 October 2014, as legal restrictions in the Netherlands 
limited TESE–ICSI to be conducted only in research settings.
Ethical approval
The protocol for this multicentre study was approved by the Dutch Central Committee on 
Research involving Human Subjects (NL12408.000.06 CCMO, The Hague, The Netherlands). 
All couples signed informed consent for treatment and follow-up before participating in 
this study.
Study population
We included all men diagnosed with NOA and undergoing their first TESE as a part of 
fertility treatment. NOA was defined as azoospermia without evidence of obstruction and 
with an elevated level of FSH (>10 UI/l), decreased level of inhibin B (<150 ng/l) and/or 
small testicular volume (<15 cc per testis) (Adamopoulos and Koukkou, 2010, Jungwirth, et 
al., 2015). Before surgical sperm extraction, each male underwent a complete andrological 
evaluation by an urologist. We defined idiopathic NOA when there was no abnormality 
found in diagnostics such as Klinefelter syndrome, azoospermia factor (AZF)-deletions, 
cryptorchidism, infection and malignancy. Men with deletions of the AZF-a or AZF-b 
region of the Y chromosome were excluded for TESE in the Radboudumc. Until September 
2010, men diagnosed with Klinefelter syndrome (47XXY) were excluded in both centres 
due to restrictions in government policies.
TESE procedure
A TESE procedure was performed under local anaesthesia or occasionally under general 
anaesthesia. A scrotal skin incision was made over the largest testicle or, in case of equal 
volume, the testicle with the better consistency. Thereafter, the tunica vaginalis was 
opened and, if necessary, the testis luxated outside the scrotum. The tunica albuginea was 
longitudinally incised. Either a longitudinal biopsy over the whole length (in case of 
uniform morphology of the seminiferous tubules) or targeted biopsies of the thicker 
tubules (in case of differences in quality of the tubules) were taken and immediately 
transported to the fertility laboratory. The biopsy was then subjected to mechanical 
dissection and cells present in the lumen of the tubules were extracted (Silber, 2000). 
The obtained cell suspension was directly examined for the presence of spermatozoa. 
If no spermatozoa were present in the initial biopsy, then a subsequent biopsy was taken 
from the contralateral testis. If spermatozoa were present, their number and motility were 
noted, and the cell suspension was cryopreserved, as described previously (Hessel, et al., 
2013).
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Outcome
The presence of one or more spermatozoa (regardless of their motility) in the testicular 
biopsy was considered as successful sperm retrieval and was used as the primary 
end-point of the study.
Model building
A model was developed to calculate the probability of obtaining sperm with a TESE 
procedure. Data from Radboudumc were used for building this model (development set). 
Only the first performed TESE procedure for each couple was included for the analysis. 
Candidate prognostic parameters or covariates were male age (years), BMI (kg/m2), smoking 
behaviour (self-reported; yes/no), alcohol consumption (self-reported; yes/no), duration 
of infertility (months), serum testosterone (nmol/l), inhibin B (ng/l), FSH (IU/l) and LH (IU/l) 
levels, total testicular volume (cc) (measured by physical examination) and aetiology of 
NOA (Klinefelter syndrome/AZF-c deletion/cryptorchidism and/or orchidopexy/idiopathic/ 
others).
For each candidate prognosticator, the association with successful sperm retrieval was 
assessed using thex2 test in a logistic regression model. Collinearity between variables was 
assessed to prevent the inclusion of redundant variables in the model. All cases were 
included in the final model, and cases with missing covariate values were imputed using 
multiple imputation. Missing data varied from 0% to _6% for the potential predictor 
variables and these values were interpreted as missing at random. We checked the 
linearity of the association between the continuous variables and a successful sperm 
retrieval using cubic spline analyses and used transformation in case of non-linearity.
Statistical analysis
Covariates were selected using forward selection (P<0.15 for entry). Backward elimination 
(P >0.15 for removal) confirmed the covariate selection for the final model. First-order 
interaction terms and quadratic terms were tested, but not found to be significant. 
For the final logistic regression model, we used the Akaike Information Criterion for each 
imputation set separately to account for differences between sets. Predictors for the final 
multivariable model were selected using the majority method. The receiver-operating 
characteristic (ROC) curve was plotted, and the area under the curve (AUC, or c-statistic) 
was calculated. These characteristics are data driven and presumably too optimistic, 
therefore the calculated values were denoted as ‘apparent’ AUC. Optimism corrected 
values were calculated using leave-one-out cross-validation, i.e. regression coefficients 
associated with the ‘final model’ were re-estimated with each case left out in turn. We 
then combined the ‘leave-one-out’ regression coefficient with the case’s covariate values 
in order to mimic the prediction of the outcome for each case. Finally, a logistic regression 
model was fitted with the resulting ‘leave-one-out’ prognostic index (PI) as the only 
covariate in order to obtain the optimism-corrected AUC. A histogram displaying the 
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distribution of the predicted probabilities was plotted. A score chart (Hunault, et al., 2004) 
was constructed for easier application of the model.
Model validation
External model validation was based on the TESE data from the AMC in Amsterdam 
(validation set) and focused on two aspects: discrimination and calibration (Leushuis, et al., 
2009).
Discrimination is the ability of the model to distinguish between cases with and without 
the event of interest, in this case between men with successful sperm retrieval with TESE 
and men where no spermatozoa could be found. Discrimination was measured by the 
area under the ROC curve, i.e. c-statistic. This statistic ranges from 0.5 (no discrimination) 
 to 1 (perfect discrimination). Calibration refers to correspondence between the predicted 
probabilities and the observed probabilities. Calibration was assessed visually by 
comparing predicted probabilities and observed probabilities after dividing men into four 
groups based on their predicted probability and, more formally, by fitting a logistic 
regression model with a single covariate for the so-called PI, a linear combination of the 
case’s covariate values and the associated regression coefficients.
For all analyses, we used IBM SPSS Statistics 22 (Chicago, IL, USA) and STATA 14 (Stata-Corp, 
College Station, TX, USA).
Results
A total of 1371 first TESE procedures were included: 918 in the development set and 453 in 
the validation set. Baseline characteristics are shown in Table 1. The sperm retrieval rate 
was 45.6% (419/918) in the development set and was 39.7% (180/453) in the validation set.
Model building
The spline function demonstrated a non-linear association between the continuous 
variable LH and successful sperm retrieval. We therefore transformed LH to better fit the 
data using a polynominal: LH + LH².
Univariable analysis confirmed that older men, men with higher testosterone and high 
inhibin B levels, men with a history of cryptorchidism and/or orchidopexy and men with a 
larger testicular volume had significantly higher chances of successful sperm retrieval. 
Diagnosis of idiopathic NOA, Klinefelter syndrome, detection of an AZF-c deletion and 
high levels of FSH and LH were significantly associated with lower chances of successful 
sperm retrieval.
The multivariable logistic regression model (Table 2) included male age, levels of 
testosterone, LH and FSH, diagnosis of idiopathic NOA and the presence of an AZF-c 
deletion as independent predictors.
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Cases with missing values for the covariates selected in the final model were evaluated 
separately. In these 81 cases (FSH (n = 8), LH (n = 46), testosterone (n = 43), AZF deletion 
(n = 10), idiopathic NOA (n = 10)) the fact of whether data were missing or was not 
associated with a successful sperm retrieval.
The calculated probability of sperm retrieval in the development set had a range from 6 
to 93%, with a mean of 44% (Fig. 1A). 
The model had moderate discriminative capacity in the development set. The c-statistic 
was 0.70 (95% confidence interval (CI): 0.66–0.73) and 0.69 (95% CI: 0.66–0.72) in the 
optimism- corrected model (Fig. 2A). In the calibration model in the development set, the 
estimated intercept was 20.01 (95% CI: 20.10 to 0.08) and the slope 1.03 (95% CI: 0.84–1.22). 
The intercept approached zero and the slope unity. The predicted probability of successful 
Table 1   Baseline characteristics of men with NOA who underwent a first TESE
Total
(n=1,371)
Development set
(n=918)
Validation set
(n=453)
Clinical characteristics
Age (years, SD) 34.29 (6.3) 34.05 (6.02) 34.78 (6.83)
Duration infertility (months, SD) - 33.36 (25.24) -
Male BMI (kg/m2, SD) - 26.04 (4.13) -
Smoke n (%) Yes - 224 (24.6) -
No - 688 (75.4) -
Alcohol n (%) Yes - 705 (77.5) -
No - 205 (22.5) -
Testosterone (nmol/L, SD) 13.97 (5.46) 13.43 (5.33) 15.00 (5.55)
LH (IU/L,SD) 8.97 (4.99) 8.57 (4.67) 9.85 (5.53)
FSH (IU/L, SD) 22.13 (12.22) 21.57 (11.83) 23.27 (12.91)
Inhibin B (ng/L, SD) 39.04 (38.85) 40.09 (38.70) 35.89 (39.21)
Total testicular volume (cc, SD) - 24.94 (9.16) -
Diagnosis n (%)
Idiopathic 531 (38.7) 341 (37.1) 190 (41.9)
Klinefelter 85 (6.2) 42 (4.6) 43 (9.5)
AFZ-c deletion 63 (4.6) 35 (3.8) 28 (6.2)
Genetic (others) 12 (0.9) 8 (0.9) 4 (0.9)
Cryptorchidism and/or orchidopexy 450 (32.8) 340 (37.0) 110 (24.3)
Others 209 (15.2) 142 (15.5) 67 (14.8)
Missing 21 (1.5) 10 (1.1) 11 (2.4)
NOA: non-obstructive azoospermia; SD: standard deviation; TESE: testicular sperm extraction, AFZ: azoospermia 
factor
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sperm retrieval was compared with the observed sperm retrieval rate in that category. The 
difference between the mean observed chance and the mean predicted chance was 
<2.0% in all groups, which indicates a good calibration of the prediction model in the 
development set (Table 3 and Fig. 3A).
Table 2   Multivariable logistic regression model for successful sperm retrieval with TESE: 
stepwise-built logistic model, each row depicting the cumulative contribution 
of a variable to a model including all variables from previous rows
Covariate OR 95% CI p-value AUC AUC corrected
Male age 1.06 1.03-1.09 <0.001 0.56 0.56
LH 0.91 0.88-0.93 <0.001 0.63 0.62
LH2 1.002 1.000-1.003 0.05 0.64 0.63
FSH 0.98 0.96-0.99 0.003 0.65 0.64
Testosterone 1.03 1.01-1.06 0.023 0.65 0.64
AZF-c deletion 0.24 0.11-0.52 <0.001 0.66 0.65
Idiopathic NOA 0.44 0.32-0.59 <0.001 0.69 0.67
AUC: area under the curve; CI: confidence interval; OR: odds ratio.
Figure 1   Distribution of the men according to their calculated probabilities of s 
perm retrieval
A: Development set (n = 918)
B: Validation set (n = 453)
A B
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Table 3   Mean predicted probability of successful sperm retrieval versus the mean 
observed successful sperm retrievals
Internal validation 
Predicted chance No. of patients  
in group
Mean predicted 
chance (%)
No. of successful 
sperm retrievals
Mean observed 
chance( %)
< 35% 301 25.4 81 26.9
35%-50% 264 42.1 112 42.4
50%-65% 228 57.0 134 58.8
> 65% 115 72.9 86 74.8
External validation
Predicted chance No. of patients  
in group
Mean predicted 
chance (%)
No. of successful 
sperm retrievals
Mean observed 
chance (%)
< 35% 171 23.2 48 28.1
35%-50% 134 42.2 53 39.6
50%-65% 86 57.1 41 47.7
> 65% 51 72.8 36 70.6
Figure 2   Area under the receiver-operating curve for prediction of sperm retrieval
A: Development set
B: Validation set
A B
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Figure 3   Relationship between calculated and observed sperm retrieval rates.  
The four groups represent the quintiles of the calculated probabilities. Data on 
sperm retrieval rate are reported as percentage and 95% confidence interval
A: Development set
B: Validation set
A
B
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The mathematical formulation for predicting the probability of sperm retrieval for an 
individual man is as follows: probability = 1 / [1 + exp (-β)], where β = -1.009 + (male age × 
0.058) + (LH ×-0.115) + (LH2 × 0.001) + (FSH - 0.019) + (testosterone × 0.034) + (AZF-c 
deletion - 1.480) + (idiopathic NOA - 0.855). Table 4 shows an example of calculated 
probabilities of successful sperm retrieval with TESE for five hypothetical men based on 
our prediction model.
External validation
The calculated probabilities of successful sperm retrieval in the validation set ranged from 
4 to 92%, with a mean of 41%, indicative of a population with comparable probabilities to 
the men in the development set (Fig. 1B). The discriminative capacity was in the same 
range as that in the development set, with a c-statistic of 0.65 (95% CI: 0.59–0.70) (Fig. 2B). 
The predicted probability of successful sperm retrieval was compared with the observed 
sperm retrieval rate in that category. The difference between the mean observed chance 
and the mean predicted chance was 2.2–9.4%, which indicates a moderate calibration of 
the prediction model (Table 3). Calibration is shown in Fig. 3B. The model showed good 
calibration below 50% and above 65%. For the predicted sperm retrieval rate between 50 
and 65%, a slight overestimation was seen. However, the CIs of the group with a poor 
predicted chance (<35%) and the group with a moderate predicted change (50–65%) did 
not overlap, indicating a reliable distinction between these prognostic groups.
Table 4   Five hypothetical men with the calculated probability for obtaining 
spermatozoa with TESE
Man A Man B Man C Man D Man E
Age (years) 24 30 34 38 42
LH (IU/L) 6 12 8 6 10
FSH (IU/L) 22 26 20 16 20
Testosterone (nmol/L) 20 10 14 18 12
Aetiology Klinefelter 
syndrome
AZF-c 
deletion
Idiopathic 
NOA
Cryptorchidism Idiopathic 
NOA
Calculated probability for 
obtaining spermatozoa
50% 11% 34% 70% 39%
Probability = 1/[1+ exp(−β)] where β= -1.009 + (male age x 0.058) + (LH x -0.115) + (LH2 x 0.001) + (FSH x -0.019) 
+ (testosterone x 0.034) + (AZF-c deletion x -1.480) + (idiopathic NOA x -0.855)
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Discussion
This study was designed to develop and validate a model to predict successful testicular 
sperm retrieval in men with NOA. Our prediction model, built after multivariable logistic 
regression analysis, demonstrated that higher male age, higher values for serum testosterone 
and lower values for serum FSH and LH were predictive for successful sperm retrieval. 
Diagnosis of idiopathic NOA and the detection of an AZF-c deletion were predictive for 
unsuccessful sperm retrieval. The predictive capacity was moderate with an AUC of 0.69 
in the development set and 0.65 in the external validation set. The calibration indicated 
that our model could distinguish men with a poor prognosis from men with a good 
prognosis, in terms of sperm retrieval.
A number of prediction models have been developed previously to predict successful 
sperm retrieval with TESE in men with NOA (Boitrelle, et al., 2011, Ramasamy, et al., 2013, 
Samli and Dogan, 2004, Tsujimura, et al., 2004). The efficacy of these models was moderate. 
One study reported a sensitivity of 71.0% and a specificity of 71.4% (Tsujimura, et al., 2004), 
while another reported a sensitivity of 68.0% and a specificity of 87.5% (Samli and Dogan, 
2004). Two studies performed AUC analysis and found an AUC of 0.64 (Ramasamy, et al., 
2013) and an AUC of 0.66 (Boitrelle, et al., 2011). None of the developed models was 
externally validated. For prediction models in the field of infertility, external validation has 
a demonstrated lower predictive capacity when evaluated in a different population 
(Altman and Royston, 2000). Thus, these models need external validation before they can 
be used in clinical practice.
Four of the independent predictors that we included in our final model were also found 
previously, i.e. male age, and serum FSH, LH and testosterone levels. Furthermore, 
previously developed prediction models found that testicular volume, duration of 
infertility, inhibin B, prolactin, Klinefelter syndrome and history of cryptorchidism were 
independently correlated with TESE outcome. Most of these variables (not prolactin) were 
included in our univariable analysis and appeared to have no significant correlation with 
TESE outcome (duration of infertility) or did not retain their significance after multivariable 
analysis (testicular volume, inhibin B, Klinefelter syndrome and history of cryptorchidism).
This study has some limitations that need to be addressed. First, there is a potential 
selection bias, due to the restrictions in government policies on men diagnosed with 
Klinefelter syndrome. Until September 2010, these men were excluded from undergoing 
TESE in the Netherlands. The percentage of men with Klinefelter syndrome among men 
diagnosed with NOA is expected to be higher (11%; (Aksglaede and Juul, 2013)) than in our 
study population (4.6% in the development set and 9.5% in the validation set). Secondly, 
there may be some confounders that affect the chances of finding spermatozoa, such as 
patient selection, and clinical and laboratory techniques (Vloeberghs, et al., 2015). There 
are no rigorously designed randomized studies that compare the various surgical 
techniques for effectiveness and safety. A recent meta-analysis, which found that the 
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sperm retrieval rate is higher for micro-TESE compared with conventional TESE and for 
conventional TESE compared with testicular sperm aspiration (Bernie, et al., 2015), also had 
some serious limitations. The heterogeneity of the population of men diagnosed with 
NOA was high and consideration of other variables, such as tissue processing techniques, 
was lacking. Moreover, the factors that we have identified as predictors in sperm retrieval 
by TESE are likely to be predictive for any of the techniques used to retrieve spermatozoa 
from the testis. Finally, we did not measure prolactin levels in our study population on a 
routine basis although it has been mentioned as a possible prognosticator. Of note, 
previous studies found no differences between prolactin levels in men with a successful 
sperm retrieval compared with men with unsuccessful sperm retrieval, rendering it 
unlikely that prolactin is a main predictor for testicular sperm retrieval (Samli and Dogan, 
2004, Tsujimura, et al., 2004).
A strength of our nationwide cohort is the large number of men that we studied. With a 
total of 1371 first TESE procedures, it is to our knowledge the largest study on this subject 
reported thus far. The performance of the external validation of our model further 
strengthens our study. This study shows that our prediction model can be applied in a 
general population of men with NOA, without losing its accuracy, regardless of the setting 
of the hospital. 
Once TESE is successful, the second step in achieving a pregnancy is ICSI with the surgically 
retrieved spermatozoa. Again, predicting the chance of success (in this case live birth) is 
then important to allow informed decisions to be made. Two studies have attempted to 
find predictive factors for pregnancy outcome after TESE (Silber, et al., 1997, Vernaeve, et 
al., 2004). We recently developed a prediction model where we address the clinical 
decision to start or continue with ICSI using TESE derived spermatozoa before treatment 
or after one or more unsuccessful ICSI treatments (Meijerink, et al., 2016). This model is built 
using the same cohort of patients as this study, with the obvious exception that only 
those couples that initially underwent a successful sperm recovery with TESE are included 
in the prediction model for live birth. The model has a moderate discriminative capacity 
(AUC of 0.62 in the development set; AUC of 0.67 in the validation set) and calibrates well.
Appropriate counselling of men undergoing TESE is an important issue from a 
psychological viewpoint. Using this model it is possible to counsel men individually about 
their chance of successfully obtaining spermatozoa with TESE. Considering their individual 
chance to obtain spermatozoa together with their personal options and preferences will 
help men and their partners to decide whether to undergo a TESE procedure or not. Men 
with a poor prognosis might decide to refrain from this treatment option and reconsider 
artificial insemination of their partner with donor sperm, adoption and/or becoming 
foster parents to fulfil the child wish. Future studies should clarify patients’ preferences 
and allow clinicians to provide shared decision-making (den Breejen, et al., 2013).
In conclusion, this study demonstrates that in the prediction of successful testicular sperm 
retrieval a distinction can be made between men with a good prognosis and men with a 
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poor prognosis. The success of sperm retrieval was found to depend on male age, FSH, LH, 
and testosterone levels, diagnosis of idiopathic NOA and detection of an AZF-c deletion. 
After external validation, the model proved to be accurate in predicting chances of 
success with TESE. We propose that our model should be used for counselling men with 
NOA.
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Abstract
Study question: Which parameters have a predictive value for live birth in couples 
undergoing ICSI after successful testicular sperm extraction (TESE-ICSI)?
Summary answer: Female age, a first or subsequent started TESE-ICSI cycle, male LH, 
male testosterone, motility of the spermatozoa during the ICSI procedure and the initial 
male diagnosis before performing TESE were identified as relevant and independent 
parameters for live birth after TESE-ICSI.
What is known already: In reproductive medicine prediction models are used frequently 
to predict treatment success, but no prediction model currently exists for live birth after 
TESE-ICSI.
Study design, size, duration: A retrospective cohort study between 2007 and 2015 in 
two academic hospitals including 1559 TESE-ICSI cycles. The prediction model was 
developed using data from one centre and validation was performed with data from the 
second centre.
Participants/materials, setting, methods: We included couples undergoing ICSI 
treatment with surgically retrieved sperm from the testis for the first time. In the 
development set we included 526 couples undergoing 1006 TESE-ICSI cycles. In the 
validation set we included 289 couples undergoing 553 TESE-ICSI cycles. Multivariable 
logistic regression models were constructed in a stepwise fashion
(P < 0.2 for entry). The external validation was based on discrimination and calibration.
Main results and the role of chance: We included 224 couples (22.3%) with a live birth 
in the development set. The occurrence of a live birth was associated with lower female 
age, first TESE-ICSI cycle, lower male LH, higher male testosterone, the use of motile 
spermatozoa for ICSI and having obstructive azoospermia as an initial suspected diagnosis. 
The area under the receiver operating characteristic (ROC) curve was 0.62. From validation 
data, the model had moderate discriminative capacity (c-statistic 0.67, 95% confidence 
interval: 0.62–0.72) but calibrated well, with a range from 0.06 to 0.56 in calculated 
probabilities.
Limitations, reasons for caution: We had a lack of data about the motility of spermatozoa 
during TESE, therefore, we used motility of the spermatozoa used for ICSI after freeze-
thawing, information which is only available during treatment. We had to exclude data on 
paternal BMI in the model because too many missing values in the validation data 
hindered testing. We did not include a histologic diagnosis, which would have made our 
data set less heterogeneous and, finally, our model may not be applicable in centres 
which have a different policy for the indication for performing sperm extraction. The 
prognostic value of the model is limited because of a low ‘area under the curve’.
Wider implications of the findings: This model enables the differentiation between 
couples with a low or high chance to reach a live birth using TESE-ICSI. As such it can aid 
in the counselling of patients and in clinical decision-making.
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Introduction
One revolutionary achievement in assisted reproductive techniques (ART) has been the 
introduction of ICSI in 1992 (Palermo, et al., 1992). ICSI allowed couples with severe oligo-
zoospermia to father their genetically own offspring. Subsequently, ICSI was used in 
conjunction with testicular sperm extraction (TESE) in men with azoospermia (Devroey, 
et al., 1995).
Spermatozoa are found in _50% of the men with non-obstructive azoospermia (NOA) 
who undergo TESE (Chan and Schlegel, 2000, Tournaye, et al., 1995). Surgical sperm 
retrieval carries a small but existing complication risk, such as loss of significant amounts 
of testicular tissue, haematoma, inflammatory changes and permanent devascularisation 
(Schlegel and Su, 1997). Only one out of seven men undergoing TESE eventually fathers a 
genetically own child (Vloeberghs, et al., 2015). We recently developed and externally 
validated a prediction model for obtaining spermatozoa with TESE in men with NOA 
(Cissen, et al., 2016). 
Once spermatozoa are successfully retrieved, it is possible to start ICSI treatment. Although 
TESE-ICSI is a blessing for the NOA couple, it is in our opinion still important to inform 
patients of their realistic chances to conceive. Couples should have the possibility to 
consider whether it is worth the intense treatment burden that entails ovarian stimulation, 
oocyte retrieval, and not to forget the emotional impact of a failed treatment (Rockliff, et 
al., 2014, Verhaak, et al., 2007). For this we need a clinical prediction model which can 
predict the chance of a live birth adjusted for couple’s characteristics.
In reproductive medicine several prediction models have been developed for spontaneous 
pregnancy, pregnancy after intrauterine insemination and pregnancy after IVF/ICSI 
(Leushuis, et al., 2009). In studies that predict the outcome of ICSI, it was demonstrated 
that maternal age is the most important predictive parameter next to the duration of 
infertility and obstetric history (Lintsen, et al., 2007, Stolwijk, et al., 2000). Nevertheless, it is 
unknown if these parameters play the same predictive role for couples who require 
TESE-ICSI, as these couples have no natural chances for pregnancy. It is possible that in 
these specific couples, other parameters will have an impact on the probability of getting 
pregnant.
The aim of this study was to develop and validate a model for couples who had a successful 
TESE, to predict their chance of having a live birth with TESE-ICSI.
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Materials and Methods
Study design
Between 1 September 2007 and 1 May 2014 we performed a retrospective cohort study, 
among couples undergoing TESE-ICSI at the Radboud university medical center, The 
Netherlands (Radboudumc). The data we collected from Radboudumc were used to 
develop a model to predict live birth after a TESE-ICSI cycle (development set). An ICSI 
cycle was defined as a fresh cycle and the corresponding cryo embryo cycle(s) derived 
from it; each cycle was considered as a separate unit of analysis. Between 1 August 2007 
and 1 September 2015, we collected data for validation of the model in couples undergoing 
TESE-ICSI in the Academic Medical Center (AMC), The Netherlands (validation set).
Ethical approval
Until 2014 in the Netherlands, a TESE procedure was allowed only in research settings. 
The protocol for this study was approved by the Dutch Central Committee on Research 
involving Human Subjects (NL12408.000.06CCMO, The Hague, The Netherlands). 
All couples signed an informed consent for treatment and follow-up before participating 
in this study.
Study population
The study population contained couples eligible for ICSI treatment. We included men 
with azoospermia—defined as no spermatozoa found in the sediment of a centrifuged 
sample, confirmed in at least two semen analyses (WHO, 2009)—who, after a complete 
andrologic evaluation by an urologist, were diagnosed with NOA and subsequently 
underwent a successful TESE procedure or men who were initially suspected for obstructive 
azoospermia (OA), underwent an unsuccessful percutaneous epididymal sperm aspiration 
(PESA) procedure, but a successful TESE procedure, i.e. viable spermatozoa were found. 
The TESE procedure was performed in both clinics. We excluded men with deletions in 
the AZF-a or AZF-b region of the Y chromosome and Klinefelter syndrome.
TESE procedure
All TESE procedures were performed by a trained urologist. The description of the local 
clinical protocol has been published (Hessel, et al., 2013). In summary, a conventional 
longitudinal testicular biopsy according to the method described by Silber was performed 
in all men (Silber, 2010) before the start of female hormonal stimulation, to make sure that 
viable sperm were available at oocyte retrieval. If spermatozoa were found in the testicular 
biopsy, aliquots of sperm cell suspensions were cryopreserved and female hormonal 
stimulation was started and the sperm cell suspension was thawed at oocyte retrieval. In 
case no viable sperm was found, a second TESE was performed with the agreement of the 
patient, and in the absence of physical or medical contraindication, and fresh sperm cells 
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were used at oocyte retrieval. Surplus aliquots of spermatozoa cell suspensions of the 
second TESE were cryopreserved as well.
ICSI cycles
All couples underwent at least one ICSI cycles. Controlled ovarian hyperstimulation was 
performed with recombinant FSH (Puregon or Gonal-F) or human urinary FSH (Menopur 
or Fostimon) after pituitary down-regulation with a GnRH agonist or antagonist. Oocyte 
retrieval took place by ultrasound-guided needle aspiration, 34–36 h after hCG (5000 or 10 
000 IU) administration. Only metaphase II, morphologically normal oocytes were injected 
with frozen–thawed or fresh spermatozoa. In case of immotile spermatozoa, viable 
spermatozoa were selected using the tail touch procedure (de Oliveira, et al., 2004, Hessel, 
et al., 2015). The tail touch procedure involves the recording of sperm tail flexibility after 2 
h of incubation. The tail of the spermatozoon is gently touched with an ICSI micropipette, 
and when the tail is flexible the spermatozoon is considered viable.
Embryo scoring and evaluation for transfer was based on fragmentation and the number 
of blastomeres, assessed by a qualified embryologist or laboratory technician using a light 
inverted microscope, at standard set points: fertilization, early cleavage stage, Day 2 and 
Day 3 of development (ESHRE, 2000).
Intrauterine embryo transfer was performed at the third, fourth or fifth day after oocyte retrieval. 
Single embryo transfer (SET) or double embryo transfer (DET) was performed depending 
on female age, female medical history, the couple’s preference and national policy. 
National embryo transfer policy changed over time, which brought about compulsory 
SET in women <38 years in the first two cycles for the last 3 years of the study period. No 
embryo transfer was performed in case of absence of fertilization, abnormal embryos or 
in case of (risk for) ovarian hyperstimulation syndrome (OHSS).
Luteal phase was supported by vaginal administration of 600 mg progesterone per day. 
An ongoing pregnancy was defined as the appearance of a foetal heartbeat examined by 
ultrasound after 12 weeks of gestational age. Live birth was defined as the complete 
expulsion or extraction from its mother of a product of fertilization, irrespective of the 
duration of the pregnancy, which, after such separation, breathes or shows any other 
evidence of life such as heart beat, umbilical cord pulsation, or definite movement of 
voluntary muscles, irrespective of whether the umbilical cord has been cut or the placenta 
is attached (Zegers-Hochschild, et al., 2009).
Building the predictive model
We used live birth as the primary end-point of the study. We defined one delivery as the 
birth of one singleton baby or multiples. We developed a model by calculating the 
probability of live birth after a TESE-ICSI cycle. We considered each started cycle including 
corresponding cryo embryo cycle(s) as a separate unit of analysis. Model building was 
based on TESE-ICSI data from the development set (Radboudumc).
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Based on the current literature, previous prediction models and our own expectations, we 
identified a number of candidate predictors (Boitrelle, et al., 2011, Friedler, et al., 2002, 
Leushuis, et al., 2009, Ramasamy, et al., 2013, Tehraninejad, et al., 2012, van Loendersloot, et 
al., 2013). The candidate baseline parameters/covariates were as follows:
Type of infertility (primary/secondary);
Duration of infertility (months);
Female age (years);
Parity (n);
Average menstrual cycle length (days);
Uterine abnormalities (yes/no);
Antral follicle count before stimulation (number of follicles <11 mm);
Alcohol use (self-reported; yes/no) for male and female;
Smoking status (self-reported; yes/no) for male and female;
BMI at baseline (kg/m²) for male and female;
Male age (years);
Male testosterone (nmol/l);
Male inhibin B (ng/l);
Male FSH (IU/l);
Male LH (IU/l);
Total testicular volume (cc);
Suspected primarily diagnosis of azoospermia (OA/NOA) before sperm retrieval.
NOA was defined as azoospermia, in combination with either small testes (volume per 
testis <15 ml), elevated level of FSH (>10 IU/l) and/or decreased level of inhibin B (<150 
ng/l) (Adamopoulos and Koukkou, 2010, Jungwirth, et al., 2012) and without evidence of 
obstruction. In men with evidence of obstruction and with normal testes volume, FSH and 
inhibin B levels, the initial suspected diagnosis was OA.
The candidate cycle parameters/covariates were:
Number of TESE-ICSI cycles;
Spermatozoa (fresh or frozen–thawed);
Motility of spermatozoa (oocytes injected with motile spermatozoa/immotile spermatozoa 
or a combination of both for each individual cycle);
Number of oocytes retrieved.
Ideally, all parameters in a prognostic model are available before start of the treatment. In 
this case it would be preferable to include the motility of spermatozoa found at the TESE 
procedure. However, due to a lack of these data we decided to use the motility of the 
spermatozoa used for ICSI (in most cases after freeze-thawing). Besides motility, three 
other cycle depended parameters were also analysed as described above.
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Statistical analysis
For each candidate prognostic variable, the association with occurrence of an ongoing 
pregnancy leading to a live birth was assessed using the χ score test in a logistic regression 
model. Colinearity between variables was assessed to prevent the inclusion of redundant 
variables in the model. After the inclusion of female age, covariates were selected using 
forward selection (P < 0.20 for entry). Backward elimination (P > 0.20 for removal) 
confirmed the covariate selection for the final model. All subjects were included in the 
final models with missing covariate values imputed using linear regression. First-order 
interaction terms and quadratic terms were tested, but not found to be statistically 
significant.
We first analysed our data with generalized estimating equations (GEE) and afterwards 
with logistic regression. The point estimates and confidence intervals (CI) after analysis 
with GEE were almost identical to those of logistic regression. As logistic models are easier 
to interpret and the point estimates did not differ, we decide to use multivariable logistic 
regression to develop a model.
For the final logistic regression model the receiver operating characteristic (ROC) curve 
was plotted and the area under the curve (AUC, or c-statistic) was calculated.
As the capacity of a variable to predict live birth may vary in a series of ICSI cycles, we 
explicitly tested statistically for interactions between included predictors and ICSI cycle 
number. In deciding between competing expressions of related parameters, we used 
Akaike’s information criterion in variable selection.
These characteristics are data driven and presumably too optimistic. Optimism- corrected 
values were calculated using leave-one-out crossvalidation, i.e. the regression coefficients 
associated with the ‘final model’ were re-estimated with each subject left out in turn. We 
then combined the ‘leave-one-out’ regression coefficient with the subject’s covariate 
values in order to mimic the prediction of the outcome for each subject. Finally, a logistic 
regression model was fitted with the resulting ‘leave-one-out’ prognostic index as the 
only covariate in order to obtain the optimism-corrected AUC. A histogram (not shown) 
displaying the distribution of the predicted probabilities was plotted.
Model validation
A crucial aspect of a prediction model derived from one data set is the wider applicability 
to a data set from another centre or from a different time period. The idea of validating a 
prognostic model is generally taken to mean establishing that it works satisfactorily for 
patients other than those from whose data the model was derived (Altman and Royston, 
2000). External model validation was based on the TESE-ICSI data from the validation set 
(at AMC) and focused on two aspects: discrimination and calibration (Leushuis, et al., 
2009).
Discrimination was measured by the area under the ROC curve, the c-statistic. This statistic 
ranges from 0.5 (no discrimination) to 1 (perfect discrimination). Calibration refers to 
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correspondence between the predicted probabilities and the observed proportions. 
Calibration was assessed visually by comparing predicted probabilities and observed 
proportions after dividing patients in six groups based on their predicted probability and, 
more formally, by fitting a logistic regression model. All analyses were performed using 
IBM SPSS Statistics 22 (Chicago, IL, USA) and STATA 14 (Texas, USA).
Results
In this study we included in total 815 couples who had undergone 1559 TESE-ICSI cycles 
for the development and validation set. Figure 1 shows the steps to take for a couple 
undergoing TESE-ICSI treatment and Table 1 shows the baseline characteristics. For the 
development set, we included 526 couples who had undergone 1006 TESE-ICSI cycles of 
which 379 men (72.1%) were diagnosed with NOA and 147 men (27.9%) with suspected OA 
but with no sperm retrieval after PESA or microsurgical epididymal sperm aspiration 
(MESA) and successful testicular sperm retrieval (OA.NOA diagnosis group). In 73 couples 
(80 cycles) there was no embryo transfer: 66 cycles resulted in a total failure of fertilization, 
in 10 cycles there was no suitable embryo for transfer present and in 4 cycles a fresh 
embryo transfer was withheld because of imminent OHSS. The cumulative ongoing 
pregnancy rate per cyclewas 229 (22.8%) of which 224 (22.3%) resulted in a live birth of 1 
or more children: 196 singletons, 27 twins and 1 triplet. Three pregnancies were terminated 
because of congenital anomalies: 1 with both a hygroma colli and an omphalocele, 1 with 
trisomy 18 and 1 because of craniocephalic malformation. Two pregnancies involved a 
stillbirth at 20 and 41 weeks of gestational age, respectively.
For the external validation set, we included 289 couples who had undergone 553 TESE-ICSI 
cycles of which 169 men (58.4%) were diagnosed with NOA and 105 men (36.3%) were in 
the OA>NOA diagnosis group. In 15 men (5.2%) the initial diagnosis was unclear due to 
missing hormonal values. There were 119 ongoing pregnancies (21.5%) of which 113 
(20.4%) resulted in a live birth of 1 or more children. Univariable analysis showed that 
younger women, younger men, men with lower LH, lower FSH and higher testosterone 
levels, and those with motile spermatozoa used for ICSI and having an OA as initial 
diagnosis and those undergoing the first ICSI cycle, had significantly higher chances of a 
live birth. None of the hormone values were below the limit of detection.
We included six predictors in the final multivariable logistic regression model: female age, 
cycle number, male LH level, male testosterone level, sperm motility and suspected 
diagnosis before sperm retrieval (OA versus NOA). When we added a square term for 
female age, we did not find interactions, nor did interaction terms improve the model.
In the development set three variables we had selected for the final model, were 
incomplete, i.e. male LH (9%), male testosterone (9%) and sperm motility (1%) had missing 
values. In the validation set four variables we had selected were incomplete, i.e. male LH 
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Figure 1   Steps in TESE-ICSI treatment
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Table 1   Baseline characteristics of testicular sperm extraction (TESE)-ICSI cycles included 
in this study
  Total
n=1559
Development 
set 
n=1006
Validation  
set 
n=553
No. of couples (n) 815 526 289
Clinical characteristics mean (±SD)
Female age years 32.8 (4.5) 32.4 (4.4) 33.7 (4.5)
Male age years 38.5 (8.5) 38.2 (8.1) 39.1 (9.0)
Type of infertility per cycle
Primary infertility n (%) 830 (82.5)
Secondary infertility n (%) 176 (17.5)
Duration of infertility months mean (±SD) 41.5 (25.2)
Female parameters per cycle n (%)
Endometriosis 18 (1.8)
Polycystic ovary syndrome 50 (5.0)
Congenital uterine anomaly 4 (4.0)
Acquired uterine anomaly 13 (12.9)
Male hormones at baseline mean (±SD)
Male testosterone  nmol/l 15.2 (5.8) 14.8 (6.0) 16.0 (5.4)
Male inhibin B ng/l 92.2 (79)
Male FSH IU/l 13.9 (11.6) 13.6 (11.3) 15.0 (12.8)
Male LH IU/l 6.4 (4.1) 6.0 (3.6) 7.5 (5.0)
No. ICSI cycles n (%)
1st  cycle 815 (52.3) 526 (52.3) 289 (52.3)
2nd  cycle 466 (29.9) 306 (30.4) 160 (28.9)
3th  cycle 222 (14.2) 137 (13.6) 85 (15.4)
≥4th  cycle 56 (3.6) 37 (3.7) 19 (3.4)
Sperm characteristics
Sperm condition used in ICSI cycle n (%)
Fresh 239 (15.3) 200 (19.9) 39 (7.1)
Frozen thawed 1317 (84.5) 806 (80.1) 511 (92.4)
Unknown 3 (0.2) 0 3 (0.5)
Sperm motility used in ICSI cycle n (%)
Motile 773 (49.6) 641 (63.7) 132 (15.7)
Immotile 180 (11.5) 138 (13.7) 42 (7.6)
Both motile & immotile 305 (19.6) 218 (21.7) 87 (23.9)
Motility unknown 301 (19.3) 9  (0.9) 292 (52.8)
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(9%), male testosterone (3%), sperm motility (53%) and initial diagnosis (4%) had missing 
values. Whether or not data were missing was not associated with the occurrence of an 
ongoing pregnancy leading to a live birth and were not significant in the analysis 
described above.
The multivariable analysis is presented in Table 2. We did not find a significant additional 
effect of ICSI cycle number, nor did we find any significant interactions between the 
identified predictors and cycle number. For this reason, we used the same point estimates 
for all predictors and we included cycle number as a predictor.
Table 1   Continued
  Total
n=1559
Development 
set 
n=1006
Validation  
set 
n=553
Laboratory data per cycle mean (±SD)
No. oocytes 10.5 (5.6) 10.3 (5.2) 10.9 (6.2)
No. oocytes fertilized 4.4 (3.1)
No. 2pn embryos 4.1 (3.2) 4.3 (3.0) 3.8 (3.4)
No. frozen embryos 0.6 (1.3)
No. embryos transferred 1.3 (0.7) 1.4 (0.6) 1.2 (0.8)
Pregnancies n (%)
No. ongoing pregnancies 348 (22.3) 229 (22.8) 119 (21.5)
No. live births 337 (21.6) 224 (22.3) 113 (20.4)
No.: number; Acquired uterine anomaly: uterus myomatosus or endometrial polyp; PN: pronuclei
Table 2   Multivariable analysis for predicting live birth after a TESE-ICSI cycle
Predictors OR 95% CI p-value AUC AUC corrected
Female age2 0.99 0.98-0.99 0.02 0.56 0.56
No. of ICSI cycles 0.76 0.56-1.04 0.07 0.58 0.58
Male LH 0.94 0.98-0.99 0.02 0.62 0.62
Male testosterone 1.03 1.00-1.05 0.06 0.61 0.61
Sperm motility 1.82 1.09-3.04 0.02 0.60 0.60
NOA vs. OA>NOA 1.31 0.90-1.97 0.09 0.63 0.63
Suspected diagnosis before sperm retrieval based on medical history, physical examination and hormonal values.
OA>NOA: suspected OA but with no sperm retrieval after epididymal sperm aspiration.
OR: Odds ratio; CI: confidence interval; AUC: area under the curve; Female age2: age square; NOA: non-obstructive 
azoospermia; OA: obstructive azoospermia.
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The calculated probabilities of a live birth for the 526 couples in the development set 
ranged from 0.03 to 0.47, with a mean of 0.19. Twenty-five per cent of the TESE-ICSI cycles 
had a probability of a pregnancy less than 0.14, 25% had a probability between 0.14 and 
0.19, 25% a probability between 0.19 and 0.24, and 25% had a probability exceeding 0.24.
In the development set the model had moderate discriminative capacity with a c-statistic 
of 0.63 (95% CI: 0.59–0.67) and in the over optimism corrected model 0.62 (95% CI: 
0.58–0.68) (Fig. 2). The model calibrated well; the goodness-of-fit test (Hosmer–Lemeshow) 
showed no significant miscalibration (P= 0.79). Figure 3A shows the calibration plot in the 
development set. In the case of perfect calibration, all points would be on the diagonal, 
the line of equality and average probabilities correspond perfectly to the observed live 
birth rates. Our calibration plot showed that the model calibrated well. In the calibration 
model in the development set, the estimated intercept was 0.02 (95% CI: 20.05 to 0.09) and 
the slope 1.07 (95% CI: 0.89–1.25). The intercept approached zero and the slope unity.
External validation
External model validation was based on the TESE data from the AMC in Amsterdam 
(validation set) and focused on two aspects: discrimination and calibration (Leushuis, et al., 
2009).
Figure 2   Receiver operating characteristic curve (ROC) of the multivariable  
logistic regression model for the prediction of live birth after TESE-ICSI  
(model development)
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Discrimination is the ability of the model to distinguish between cases with and without 
the event of interest, in this case between men with successful sperm retrieval with TESE 
and men where no spermatozoa could be found. Discrimination was measured by the 
area under the ROC curve, i.e. c-statistic. This statistic ranges from 0.5 (no discrimination) 
to 1 (perfect discrimination). Calibration refers to correspondence between the predicted 
probabilities and the observed probabilities. In the external validation set the model had 
slightly better discriminative capacity. The c-statistic was 0.67 (95% CI: 0.62–0.72) (Fig. 4). 
The model calibrated well; the goodness-of-fit test (Hosmer–Lemeshow) showed no 
significant miscalibration (P = 0.73). The calibration plot visually resembles the calibration 
Figure 3   Calibration plots with calculated probability on the X-axis and observed 
proportion on Y-axis, development set (A) & validation set (B)
A
B
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of the development set though with larger 95% boundaries and a range from 0.06 to 0.56 
in calculated probabilities (Fig. 3B).
Table 3 presents the prediction model and shows an example of calculated probabilities 
of a live birth in a TESE-ICSI cycle for five hypothetical couples based on our prediction 
model. It should be taken into account whether or not the spermatozoa used for ICSI are 
motile. For example couple C of which the female age is 34 years, who will have their first 
ICSI cycle, with a male LH of 4 IU/l and a male testosterone of 20 nmol/l in a man diagnosed 
with NOA, the chance of a live birth in the first ICSI cycle is 22% when there are enough 
motile spermatozoa for the injection of all oocytes and 13% when there are not.
Validation of the model without sperm motility
The sperm motility was only known for 261 (47%) cycles of the external validation set 
therefore we also made a model without sperm motility. This model, including all 
previously selected variables while excluding sperm motility, had a c-statistic of 0.61 (95% 
CI: 0.57–0.65) in the development set and 0.62 (95% CI: 0.55–0.69) in the validation set. 
However this model did not calibrate well and therefore this model is not discussed 
further.
Figure 4   Receiver operating characteristic curve of the multivariable logistic regression 
model for the prediction of live birth after TESE-ICSI (model validation)
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Discussion
In our analysis of 526 infertile couples suffering from azoospermia who had 1006 TESE-ICSI 
cycles, we found that a live birth was associated with a lower female age, the first versus 
subsequent TESE-ICSI cycles, lower male LH, higher male testosterone, availability of 
motile spermatozoa for ICSI and having OA as an initial diagnosis. After model development 
using multivariable logistic regression analysis, we found an AUC of 0.62, and good 
calibration. We validated our model externally with 553 cycles in 289 infertile couples in a 
second academic hospital performing TESE-ICSI during the same study period. In the 
external validation set the model had a slightly better discriminative capacity (AUC 0.67) 
and calibrated well.
We found similar predictors, such as female age and the number of started cycles (first 
versus subsequent), as previous studies on IVF/ ICSI had found (Lintsen, et al., 2007, van 
Loendersloot, et al., 2013). These models are however not applicable to our couples since 
the females are not per se infertile and the azoospermic men carry specific predictors, not 
to be found in men with oligo or normospermia.
Table 3   Five hypothetical couples with the calculated probability of a live birth in  
a TESE-ICSI cycle
Couple A Couple B Couple C Couple D Couple E
Female age (years) 24 30 34 38 40
ICSI cycle 1 2 1 2 1
Male LH (E/L) 4 8 4 10 6
Male Testosterone 
(nmol/L)
20 14 20 10 14
NOA(=0) or OA>NOA 
(=1)
OA>NOA NOA NOA NOA OA>NOA
Motile spermatozoa  
for ICSI Yes (=1) or  
No (=0)
Yes No Yes No Yes No Yes No Yes No
Calculated probability 
of a live birth per cycle
0.31 0.20 0.16 0.09 0.22 0.13 0.06 0.04 0.10 0.06
Probability of live birth after a TESE-ICSI cycle= EXP (-7.659 + 0.442*Female age - 0.008*Female age2 - 0.278 *No. 
ICSI cycle + 0.608*Sperm motility + 0.026*Testosterone - 0.06*LH + 0.269*(N)OA ) / (1 + EXP (-7.659 + 0.442*Fe-
male age - 0.008*Female age2 - 0.278*No. ICSI cycle + 0.608*Sperm motility + 0.026*Testosterone -0.06*LH + 
0.269*(N)OA )).
Suspected diagnosis before sperm retrieval based on medical history, physical examination and hormonal values.
OA>NOA: suspected OA but with no sperm retrieval after epididymal sperm aspiration.
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We found that a lower male LH and a higher male testosterone level are of predictive 
value for live birth after TESE-ICSI in our study group. Since the production of testosterone 
in the Leydig cells is regulated by LH, a lower male LH will indicate a (relative) normal 
testicular function because of negative feedback by testosterone on LH. In men with NOA 
the hypothalamic-pituitary axis is often already deregulated leading to low testosterone 
levels, but obesity might also contribute to low testosterone. Unfortunately, we could not 
include paternal BMI as a predictor in our model, because of too many missing values. 
Perhaps, if we had complete data, paternal BMI might play a minor predictive role. One 
previous study found that sperm retrieval rates were similar in normal weight and obese 
men, but a lower male BMI predicted a higher chance of clinical pregnancy after TESE-ICSI 
(Ramasamy, et al., 2013). This study however did not report on LH and testosterone. Our 
findings support the hypothesis that deregulation of the hypothalamic–pituitary–gonadal 
axis may influence the quality of sperm in terms of the ability to conceive. Future research 
should explore whether or not paternal obesity and perhaps coinciding low testosterone 
levels effects live birth rates. Since in the majority of the cases the genetic cause of the 
azoospermia is still unknown (Ezeh, 2000), it is possible that genetic effects may also 
influence the live birth rate.
In our study sperm motility was found as an independent predictor for live birth. In 
ejaculated sperm, motility is a marker for sperm integrity and is associated with better 
chromatin condensation and less DNA-damage (Moskovtsev, et al., 2009, Ortega, et al., 
2011, Ramos and Wetzels, 2001). It is unknown whether motility is also a marker for integrity 
of testicular sperm, since testicular sperm is not meant to be motile and chromatin 
condensation is incomplete.
The strength of our study is that we used data from the only two centres in the Netherlands 
who were allowed to perform TESE-ICSI until May 2014. Before the study period TESE-ICSI 
was not allowed due to restrictions in government policies based on concerns about the 
safety of the procedure for the men and health of the children born from the use of 
testicular sperm. It enabled us to develop and also externally validate a prediction model 
with live birth as primary outcome.
The applicability of our results in different clinical settings is subject to certain limitations. 
For instance, in this study we included all couples with azoospermic men, in which TESE 
was the only suitable method for sperm retrieval and who underwent TESE-ICSI, i.e. we 
did not differentiate between patients diagnosed with NOA and patients who were 
suspected of OA but with a previous failed PESA/MESA. We did not include a histologic 
diagnosis, which would have made our data set less heterogeneous. For those couples 
with an OA.NOA diagnosis (suspected OA but with no sperm retrieval after epididymal 
sperm aspiration), the sperm retrieval rate after TESE is higher. Our model may not be 
applicable in centres which have a different policy for the indication of performing PESA 
and TESE. Moreover, in these cycles the chance to find enough motile spermatozoa for 
injection of all oocytes, which we found as an independent predictive factor for live birth, 
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is also higher. Finally, the prognostic value of the model is limited because of a low ‘area 
under the curve’.
In fertility treatment for couples with men diagnosed with azoospermia there are several 
steps to take, e.g. TESE, oocyte retrieval, successful thawing of TESE spermatozoa, injection 
of oocytes, fertilization, embryo transfer, pregnancy and finally giving birth. A clear starting 
point should be determined for developing a prediction model for these couples. In this 
study we choose this point after successful TESE; we included couples when the oocyte 
retrieval resulted in the injection of oocytes with testicular extracted spermatozoa. We 
have also developed a model which predicts the chance of finding spermatozoa in men 
with NOA (Cissen, et al., 2016). The predictive capacity our model was fair with an AUC of 
0.69 in the development set and 0.65 in the validation set. The calibration indicated that 
our model could distinguish men with a poor prognosis from men with a good prognosis. 
Ideally, all parameters in a prognostic model are known before start of the treatment. 
However, we had a lack of data of the motility of spermatozoa at TESE. Therefore, we 
decided to use the motility of the spermatozoa used for ICSI. In the counselling of couples 
one should discuss both options, i.e. with or without motile spermatozoa used for ICSI. 
The motility of spermatozoa at TESE (before freeze thawing) may give an indication for the 
chance of having motile spermatozoa for ICSI. Sperm cells extracted after a first TESE, and 
remaining after a first use for TESE-ICSI, could be used in a second TESE-ICSI treatment. Our 
model provides some insight and may help in the counselling of couples about their 
chances of success during the fertility treatment and might help them in their decision 
whether or not to continue treatment after a failed cycle.
Without TESE-ICSI NOA couples do not have a chance to conceive. Physicians can involve 
patients in the process of making decisions about their health so that patients receive care 
that meets their needs and wishes. This is called ‘shared decision-making’ (Legare, et al., 
2010). Using shared decisions, the physician and the couple can assess the burden of the 
treatment and the chance of a live birth (Baysal, et al., 2015). Several studies found that 
patients who are involved in decisionmaking are less prone to experience decisional 
conflict and regret (Bastings, et al., 2014, Legare, et al., 2010). Using our model a physician 
is better able to inform the couple about their actual chances.
In conclusion, in this study we developed and externally validated a prediction model 
which is able for the first time to predict the chance of live birth after TESE-ICSI. Using this 
model it is possible to counsel couples individually about their chances to conceive and 
becoming parents. Considering their individual chance to conceive and weighing their 
personal options will help couples in deciding to start or continue treatment or not. Our 
study revealed that besides the known factors, such as female age and the number of 
started cycles, a number of male-related factors (i.e. male LH, male testosterone, motility 
of spermatozoa used for ICSI and the initial male diagnosis) were also predictors for live 
birth after TESE-ICSI.
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Abstract
Introduction 
We performed a retrospective cohort study with the aim to evaluate the effect of maternal 
and treatment-related factors on the prevalence of birth defects after intracytoplasmic 
sperm injection (ICSI) using percutaneous epididymal sperm aspiration (PESA) and 
testicular sperm extraction (TESE).
Material and methods
643 newborns born after PESA-ICSI (n = 406) and TESE-ICSI (n = 237) in Radboud University 
Medical Center, after a gestational age of 12 weeks, 1 January 2002–1 January 2011 and 1 
March–1 November 2014, respectively, were included in this study. Three sources of data 
were used for analysis: questionnaires, national obstetrics registration forms, and a lab 
database of all ICSI treatments. Data were analyzed using generalized estimating equations 
and logistic regression analysis. 
Results
The prevalence of major birth defects in newborns born after PESA-ICSI was 6.9% and 
after TESE-ICSI was 5.9% (odds ratio 0.89, 95% confidence interval 0.46–1.75). No significant 
association was found between maternal or treatment-related factors and the prevalence 
of birth defects. 
Conclusions
We found a similar overall prevalence of birth defects in newborns born after PESA-ICSI 
and TESE-ICSI. The maternal and treatment-related factors investigated did not show a 
significantly increased cumulative risk of birth defects.
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Introduction
Since 1992, intracytoplasmic sperm injection (ICSI) has become the preferred method of 
treatment in severe male infertility. In 10% of the male infertility cases, the male suffers 
from azoospermia. In these cases, it is only possible for couples to conceive by ICSI using 
either percutaneous epididymal sperm aspiration (PESA) for males suffering from 
obstructive azoospermia or testicular sperm extraction (TESE) for males suffering from 
non-obstructive azoospermia (Devroey, et al., 1994). 
Generally, a slightly higher rate of birth defects is found in children born after assisted 
reproductive techniques (ART) than those conceived naturally (Pandey, et al., 2012). Recent 
studies regarding children born after PESA-ICSI or TESE-ICSI appear reassuring but they 
mainly focus on pregnancy and neonatal outcome (Fedder, et al., 2013, Tsai, et al., 2011, 
Woldringh, et al., 2010). However, not only infertility, and therefore ART, is associated with 
birth defects. Several studies show other influencing factors (de la Rochebrochard and 
Thonneau, 2002, Hackshaw, et al., 2011, Karacan, et al., 2013, Maheshwari, et al., 2012, Tsai, et 
al., 2013). 
First, a higher risk of miscarriage and chromosomal defects in the offspring of women over 
35 has been established (de la Rochebrochard and Thonneau, 2002). However, it remains 
unknown whether this risk of birth defects is more strongly influenced by maternal age 
after PESA-ICSI or TESE-ICSI.
Secondly, evidence confirms that congenital birth defects are associated with maternal 
smoking during pregnancy (Hackshaw, et al., 2011, Salmasi, et al., 2010).
A third factor may be the use of fresh or cryopreserved sperm. Studies investigated the 
differences between the use of fresh and cryopreserved non-ejaculated sperm on 
fertilization rates and perinatal outcome (Karacan, et al., 2013, Tsai, et al., 2013). None of 
these studies investigated the influence of using fresh or cryopreserved non-ejaculated 
sperm on birth defects. 
Fourthly, the prevalence of birth defects might be influenced by embryo transfer 
(ET)-related factors such as the transfer of fresh or frozen-thawed embryos and the quality 
of the embryos. A meta-analysis showed a better perinatal outcome in singleton in vitro 
fertilization (IVF) and ICSI pregnancies after the transfer of frozen-thawed embryos, but 
these results were not specified for PESA or TESE groups (Maheshwari, et al., 2012). 
There have been several studies on birth defects in children born after ICSI with 
non-ejaculated sperm; however, too little attention has been paid to other possible factors 
influencing the risk of birth defects. We expect that there may be worse outcomes for 
TESE children since immature sperm cells are used in TESE-ICSI. Therefore, we performed 
a cohort study with the following aims: to evaluate the prevalence of birth defects in 
newborns born after PESA-ICSI and TESE-ICSI, and to investigate the effect of maternal 
and treatment-related factors, i.e. maternal age, maternal smoking behaviour, fresh or 
frozen- thawed sperm, fresh or frozen-thawed embryos, and embryo quality.
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Material and methods
Study design
A retrospective cohort study was performed. Newborns born between 1 January 2002 
and 1 January 2011 (PESA-ICSI) and between 1 March 2008 and 1 November 2014 
(TESE-ICSI) were included. During the study period in the Netherlands, PESA and TESE 
procedures were allowed only in research settings. Therefore, PESA-ICSI and TESE-ICSI 
study protocols were approved by the Dutch Central Committee on Research Involving 
Human Subjects (CCMO, The Hague, the Netherlands P99.000.1A & NL12408.000.06) and 
followed the Helsinki Declaration.
Study population
All newborns born after an ongoing pregnancy beyond 12 weeks’ gestational age after 
PESA-ICSI (n = 421) or TESE-ICSI (n = 259) procedures in the Radboud University Medical 
Center were eligible for inclusion. All pregnancies occurred without interference of 
pre-implantation genetic diagnosis. In this study, both foetuses and children were 
analyzed collectively; we called this group ‘newborns’ unless stated otherwise. We 
subdivided foetuses born before and foetuses born after 24 weeks of gestational age 
because of viability after 24 weeks. All parents gave their written informed consent for 
treatment and follow up of newborns before participating in this study. 
Before entering the fertility treatment procedure, each male underwent a complete 
andrologic evaluation by an urologist. Males with deletions in the AZF-a or AZF-b region 
of the Y-chromosome or chromosomal abnormalities were excluded for TESE. In the case 
of obstructive azoospermia, PESA was the primary choice of treatment. In the case of 
non-obstructive azoospermia or where no viable sperm was found after PESA, a TESE 
procedure was performed. Generally, in both obstructive and non-obstructive 
azoospermia patients, diagnostic sperm retrieval was performed in advance, to make sure 
that viable sperm were available. Retrieved sperm were cryopreserved. If sperm could not 
be cryopreserved in the diagnostic setting or no viable sperm were found after thawing, 
the procedure was repeated at the day of ovum pick up. 
Women were admitted for an IVF/ICSI treatment at the fertility department. Exclusion and 
inclusion criteria were according to the local clinical protocol. Women were down 
regulated with a GnRH agonist following the standard long agonist protocol as described 
previously by Dam et al. (Dam, et al., 2012). The ovum pick up was performed 36 h after 
hCG injection when ≥three follicles with a diameter of >17 mm were observed using 
ultrasound examination. ICSI was performed as described previously by DeVroey et al. 
(Devroey, et al., 1994). Transfer policy has changed over time, in the last 3 years towards 
compulsory single ET in women <38 years. Frozen embryos were mainly transferred in 
hormonally substituted cycles. In the case of pregnancy, presence of foetal cardiac activity 
was examined at a gestational age of 7–8 weeks.
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Data collection
Three sources of data were used for the follow up of all newborns. First, data was obtained 
from the ART treatment lab-database at the Radboud University Medical Center with 
regard to embryos (fresh or frozen-thawed, number of embryos transferred, embryo 
quality) and sperm (PESA/TESE, fresh or frozen-thawed). Secondly, parents were asked to 
fill in questionnaires after birth and after 1 year. These questionnaires collected parental 
data (maternal age, maternal and paternal smoking behaviour), on pregnancy (such as 
hypertension, preeclampsia, gestational diabetes), labour (such as complications, position, 
assisted delivery) and child-related data (such as birth defects). Questions regarding 
smoking behaviour were specified by asking whether the mother smoked before or 
during pregnancy, and whether the father smoked at all (passive smoking). Only mothers 
who smoked during pregnancy were assigned to the smoking group. If parents did not 
respond to the questionnaire, they received a reminder 3 months later. A third additional 
data source was collected via an obstetric registration form provided by hospitals and 
midwifes after delivery to collect extra medical information. This form gathered 
information about medical problems in pregnancy, APGAR scores and reported 
information about the presence of birth defects. However, no additional birth defects 
were mentioned in the obstetric registration form. 
If a questionnaire was not returned, the children were considered lost to follow up and 
were excluded from analysis.
Definitions
Embryo scoring and evaluation was based on fragmentation and the number of 
blastomeres using a light inverted microscope determined by a qualified embryologist or 
lab technician on day 3. The quality of each embryo was categorized from best to lowest 
as follows: A-quality: embryos with 0–20% fragmentation and containing 7, 8 or 9 
blastomeres; B-quality: embryos with 20–50% fragmentation containing 7 or 8 
blastomeres, or embryos with 0–20% fragmentation containing 4, 5, 6 or 10, 11, 12 
blastomeres; C-quality: all remaining embryos. After scoring, one or two of the best 
embryo(s) available were selected for ET. In the case of double ET, only the best available 
embryo quality was taken into account in our analyses. Birth defects were defined as all 
congenital abnormalities that are present in less than 4% of the general population of the 
same racial group (Smith, 1975). 
Birth defects were classified according to the International Classification of Disease (ICD-10) 
and were also classified according to the severity of major and minor birth defects 
(Bonduelle, et al., 2002). 
Major birth defects were defined as those birth defects that generally cause functional 
impairment or require surgical correction, with the following exceptions: pyloric stenosis 
was considered major; inguinal hernia was considered major for a child born at term (≥37 
weeks) but minor for a child born preterm; ductus arteriosus was considered major if still 
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present after 3 months for a child born at term or still present after 6 months for a child 
born preterm. The remaining birth defects were considered to be minor (Smith, 1975). 
Infant death was subdivided into three groups: early neonatal death for children who died 
within 7 days; late neonatal death for children who died within 7–28 days; post neonatal 
death for children who died between 28 days and 1 year (Barfield, et al., 2011).
Statistics
First, birth characteristics were described, separately for singletons and multiples. 
Continuous data were compared using Student’s t-test if the distribution was considered 
sufficiently normal or Mann–Whitney U-test if not. Fisher’s exact test was used for nominal 
outcome data. The association between the presence of major birth defects and maternal 
and treatment-related factors was evaluated by means of a generalized estimating 
equations approach for binomial data using a logit link, resulting in odds ratios (OR) and 
95% confidence intervals (CI). Two-sided p-values < 0.05 were considered significant. To 
correct the models for a possible correlation in the outcomes due to the fact that a mother 
could have multiple children, an exchangeable working correlation matrix was used. If 
there were no birth defects in one of the groups, a continuity correction was applied by 
allocating 0.1 to one of the subjects of that group in order to be able to estimate an OR. All 
factors were analyzed separately for the PESA and TESE groups. To evaluate the effect of 
the combined factors, we performed first an univariate analysis in the total groups of 
newborns followed by an explorative multivariable analysis starting with all factors and 
PESA/TESE. Backward selection was applied manually. At all times, PESA/TESE, the main 
factor for analysis, was kept in the selection. With the quasi-likelihood under the 
independence model criterion it was decided whether maternal age should be added as 
a continuous or a dichotomized variable. Statistical analysis was performed using IBM SPSS 
Statistics 20 (IBM Corp., Armonk, NY, USA).
Results
In total, 680 newborns were born after PESA-ICSI and TESE-ICSI, at a gestational age of at 
least 12 weeks, between 1 January 2002 and 1 January 2011 and between 1 March and 1 
November 2014, respectively. Of these, 37 children were lost to follow up. As result, 643 
newborns, PESA (n = 406) and TESE (n = 237), from 546 pregnancies of 465 mothers were 
included for analysis in this study. In all, 161 newborns were born from 80 mothers with 
two or more consecutive pregnancies. 
Figure 1 shows a flow chart with the included newborns. In the TESE group, the group of 
multiples includes only twins, with the exception of one triplet. In the PESA group, three 
pregnancies were terminated, two because of trisomy 21 (maternal ages 32 and 39 years) 
and one because of trisomy 18. One pregnancy was terminated because of anencephaly 
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Figure 1   Flowchart of included newborns
Included
PESA TESE
406 237
Excluded:
lost to follow up
PESA TESE
15 22
Death
PESA TESE
3 3
Live Births
PESA TESE
395 232
Termination of 
pregnancy
PESA TESE
3 1
Major birth defect
PESA TESE
15 11
Minor birth defect
PESA TESE
8 7
Major birth defect
PESA TESE
1 2
Major birth defect
PESA TESE
3 1
Singletons
PESA TESE
261 179
Multiples
PESA TESE
134 53
Major birth defect
PESA TESE
9 0
Minor birth defect
PESA TESE
11 3
Early neonatal death
PESA TESE
0 1
No birth defect
PESA TESE
237 161
No birth defect
PESA TESE
114 50
Late neonatal death
PESA TESE
1 0
Early neonatal death
PESA TESE
1 0
Post neonatal death
PESA TESE
1 0
Eligible for inclusion
PESA TESE
421 259
Foetuses < 24 weeks
PESA TESE
6 4
Foetuses ≥ 24 weeks
PESA TESE
400 233
Stillbirth
PESA TESE
5 1
No birth defect
PESA TESE
5 1
Processed on: 21-9-2016
505365-L-bw-Meijerink
72
Chapter 4
in the TESE group. One twin pregnancy in the PESA group was reduced to a singleton 
pregnancy because of a child with a partial trisomy 9. In the group of foetuses <24 weeks’ 
gestational age there were two miscarriages (<20 weeks). In both, a major birth defect was 
observed: a trisomy 18 (TESE) and the presence of an omphalocele (TESE). In the PESA 
group, one foetus was live born but died after an hour and a half. Infant death occurred in 
four cases. No major birth defects were found in these children. In two cases, the children 
suffered from necrotizing enterocolitis. All of these children were born preterm – one 
extremely preterm and three very preterm. 
Table 1 shows the birth characteristics of all newborns. The prevalence of newborns with 
a major birth defect was 6.9% (28/406) in the PESA group and 5.9% (14/237) in the TESE 
group. The effect of the ART procedure was not significant (OR TESE vs. PESA 0.89, CI 
0.46–1.75). No significant differences were found in birth weight, gender, APGAR score or 
gestational age between the PESA and TESE group for singletons and multiples, 
respectively. 
Table 2 presents an overview of major and minor birth defects specified per tract for both 
treatments. If a newborn had multiple birth defects, the defects are mentioned separately 
to provide insight into the prevalence of birth defects in each tract. In the PESA group, one 
child was born at term and was diagnosed with an inguinal hernia (K40.3); this child also 
suffered from microcephaly, dysmorphic features and psychomotor retardation e causa 
ignota (F79.0). Another child in this group was born preterm and had an inguinal hernia 
(K40.9) and also was diagnosed with macrocephaly-capillary malformation syndrome 
(Q87.3). The TESE group also contained a child with two major birth defects. In this child, 
an anus atresia (Q42.2) and a bicuspid aortic valve (Q23.8) were observed. The musculo-
skeletal tract was the most affected tract in both groups, with hip dysplasia (Q65.x) 
providing the largest share: PESA, n = 5 (17%) and TESE, n = 5 (33%). In each group, two 
children with hip dysplasia had a breech position during delivery. 
Table 3 presents the ORs for the association of various maternal and treatment- related 
factors in relation to birth defects in the separate PESA and TESE groups and in the whole 
group. There was no significant effect of maternal age. Maternal smoking behaviour, such 
as maternal smoking during pregnancy, did not notably influence the prevalence of birth 
defects. Of the non-smoking group, 105 mothers had a partner who smoked, of which 
four newborns (3.8%) suffered from a major birth defect. Sperm- and embryo-related 
factors did not show a significant influence on the prevalence of birth defects. 
After analyzing all factors separately in the PESA/TESE groups and in the whole group, an 
explorative multivariable model was built starting with all factors, PESA/TESE, and 
maternal age as continuous variables. Using backward selection, all factors were eliminated 
from the model except the PESA/TESE group, which was kept on purpose. None of the 
factors had a significant association with birth defects in PESA and TESE groups.
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Table 2   Major birth defects specified per tract and treatment
PESA TESE
Total n 
(%)
Major n 
(%)
Total n 
(%)
Major n 
(%)
Total number of newborns 47 28 24 14
Circulatory tract 6 (13) 3 (11) 3 (13) 2 (14)
PESA: Q21.3;Q25.1
TESE: Q21.0; Q23.8
Respiratory tract 3 (6) 2 (7) 0 0 
PESA: Q32.1
Gastrointestinal tract 9 (19) 2 (7) 1 (4) 1 (7)
PESA: K40.3; Q40.0
TESE: Q42.2
Urogenital tract 4 (9) 1 (4) 4 (17) 1 (7)
PESA: Q60.0
TESE: Q60.4
Musculoskeletal tract 11 (23) 9 (32) 8 (33) 7 (50)
PESA: Q65.2; Q65.5; Q66.0; Q70.4
TESE: Q65.2; Q65.6; Q66.0; Q79.2
Nervous system 2 (4) 1 (4) 1 (4) 1 (7)
PESA: Q03.9
TESE: Q00.0
Skin 4 (9) 1 (4) 5 (21) 2 (14)
PESA: Q38.6
TESE: D22.9; Q82.0; 
Chromosomal 4 (9) 4 (14) 1 (4) 1 (7)
PESA: Q90.9; Q91.3; Q92.9
TESE: Q91.3
Other 5 (11) 5 (18) 2 (8) 0 
PESA: E03.1; E71.3; E88.9; Q77.3; 
Q87.3
ICD-10: Major birth defects were classified according to ICD-10, codes are corresponding with disease (appendix). 
If a newborn had multiple birth defects, the defects are mentioned separately
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Table 2a   Minor birth defects specified per tract and treatment
PESA TESE
Total n (%) Minor n (%) Total n (%) Minor n (%)
Total number of newborns 47 19 24 10
Circulatory tract 6 (13) 3 (16) 3 (13) 1 (10)
PESA: Q21.0; Q25.0
TESE: Q25.0
Respiratory tract 3 (6) 1 (5) 0 0 
PESA: Q30.0
Gastrointestinal tract 9 (19) 7 (37) 1 (4) 0 
PESA: K40.2; K40.9; K42.9
Urogenital tract 4 (9) 3 (16) 4 (17) 3 (30)
PESA: P83.5; Q62.5; Q63.9
TESE: Q52.4; Q53.1; Q53.2
Musculoskeletal tract 11 (23) 2 (11) 8 (33) 1 (10)
PESA: Q66.0; Q69.0
TESE: Q69.0
Nervous system 2 (4) 1 (5) 1 (4) 0 
PESA: Q13.1
Skin 4 (9) 3 (16) 5 (21) 3 (30)
PESA: Q82.5
TESE: Q82.5; Q82.9
Chromosomal 4 (9) 0 1 (4) 0 
Other 5 (11) 0 2 (8) 2 (20)
TESE: Q17.0
ICD-10: Minor birth defects were classified according to ICD-10, codes are corresponding with disease (appendix) 
If a newborn had multiple birth defects, the defects are mentioned separately.
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Discussion
The aim of this study was to evaluate the effect of maternal and treatment-related factors 
on the prevalence of birth defects after PESA-ICSI and TESE-ICSI. We found no significant 
difference in the prevalence of major birth defects between the TESE group (5.9%) and 
the PESA group (6.9%). None of the factors – maternal age, maternal smoking behaviour, 
fresh or frozen-thawed sperm, fresh or frozen-thawed embryos and embryo quality – had 
a significant effect on the prevalence of birth defects. 
The main result of this study, regarding the similar prevalence of birth defects between 
PESA-ICSI and TESE-ICSI, is consistent with previous studies (Belva, et al., 2011, Woldringh, 
et al., 2010). Others found a prevalence of 6.2% major birth defects in 1462 children born 
after IVF and 4.4% in 8422 children born after spontaneous conception (Olson, et al., 2005). 
The prevalence of birth defects in our study is in line with that in the IVF children, and 
slightly higher than in children born after spontaneous conception. 
In ART using non-ejaculated sperm, some steps have to be taken before an ET can take 
place. These steps, i.e. PESA or TESE, cryopreserving sperm, ICSI, embryo quality selection 
and cryopreserving embryos, separately are found to be related to an increase in 
prevalence of birth defects (Karacan, et al., 2013, Maheshwari, et al., 2012, Pandey, et al., 
2012). In addition, external factors, such as maternal age and maternal smoking behaviour, 
are often investigated in relation to the risk of birth defects (de la Rochebrochard and 
Thonneau, 2002, Hackshaw, et al., 2011). However, little is known about the cumulative 
effect of these maternal and treatment-related factors in combination with this multiplicity 
of procedures. 
First, advanced maternal age is recognized as a risk factor for birth defects above the age 
of 40 (Vaughan, et al., 2014). In our analyses, the group of women above 40 years was small 
due to the maternal age-related exclusion criterion for ICSI. Therefore, the cut-off point for 
advanced maternal age was set at 35 years based on the literature, which states that the 
risk of both chromosomal and non-chromosomal birth defect rises substantially with 
advanced maternal age, i.e. >35 years (Reefhuis and Honein, 2004, Yoon, et al., 1996). We 
did not observe an increase in birth defects in this group. 
Another known factor of influence is maternal smoking behaviour. A recent systematic 
review showed a significant increase in birth defects in the musculoskeletal tract, the gas-
trointestinal tract and birth defects involving the eyes and the oral cleft, in children of 
mothers who smoked during pregnancy (Hackshaw, et al., 2011). This finding could not be 
reproduced in our study. However, maternal smoking during pregnancy was reported by 
only 4.8% of women in our study population. This is substantially lower than the Dutch 
average of 7% (van Gelder, et al., 2008) and the average of 17% in the systematic review 
(Hackshaw, et al., 2011). This could be due to the wish to conceive and preconception or 
prenatal counselling women received. However, bias due to data collection by 
self-reported questionnaires cannot be ruled out. Salmasi et al. found an increased risk of 
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birth defects in children born from passive smoking mothers (Salmasi, et al., 2010). 
Nevertheless, in the passive smoking group in our study, the prevalence of birth defects 
was only 3.8%. 
The freeze-thawing process is known to have a major impact on viability of sperm. 
However, this effect seems to apply mostly to the quantity of sperm cells. There is no 
indication of a negative effect on the quality of the sperm cells surviving the freeze-thawing 
process (Tsai, et al., 2013, Wald, et al., 2006). Previous research did not find negative effects 
on fertilization rates or pregnancy rates when using frozen-thawed sperm (Friedler, et al., 
1997, Habermann, et al., 2000). We found no significant increase of birth defects observed 
after using cryopreserved sperm. We hypothesize that these reassuring findings might be 
the consequence of the semi-natural selection through the freeze-thawing procedure, 
leaving a lower quantity of sperm cells capable of generating similar results as a full 
number of fresh sperm (Karacan, et al., 2013, Tsai, et al., 2013). This could imply that the 
highest quality sperm cells survive the freeze-thawing process. 
We found no difference in birth defects between newborns conceived with fresh and 
frozen-thawed embryos. A meta-analysis found the same results in the IVF population 
(Maheshwari, et al., 2012). The reason for similar or even better outcomes of frozen-thawed 
embryos than fresh embryos remains unknown. Better outcomes were judged mainly on 
birth weight, gestation and the occurrence of antepartum haemorrhage and mortality in 
IVF/ICSI studies (Maheshwari, et al., 2012). As we suggested for freeze-thawing of sperm, 
the physical effects of the freeze-thawing procedure may be a way of selecting embryos 
of the best quality (Maheshwari, et al., 2012). In addition, there is no ovarian hyperstimula-
tion needed immediately prior to an ET with a frozen-thawed embryo. Therefore, the 
better outcome after cryo ET might suggest that the more natural endometrial 
angiogenesis favours the implantation and development of embryos. 
The last factor of interest was embryo quality. Fauque et al. showed a significant influence 
of embryo quality on pregnancy and live birth rates in IVF and ICSI (Fauque, et al., 2007), 
but does not discuss the influence of embryo quality on the prevalence of birth defects. 
Our study showed no significant effect on the occurrence of birth defects. The majority of 
newborns were born after an ET with an A or B-quality embryo; only 3.4% of the newborns 
included were born after an ET of a C-quality embryo. Although not significant, a slightly 
higher prevalence of birth defects was found in the B-quality group than in the A-quality 
group. 
The distribution of birth defects over various tracts was comparable to that in previous 
studies (Bonduelle, et al., 2002, Fedder, et al., 2013). We found most birth defects originated 
from the musculoskeletal tract. In particular, hip dysplasia was the largest contributor 
within the group of newborns with a birth defect [PESA, n = 5 (17%) and TESE, n = 5 (33%)]. 
Although this was the largest share of all birth defects, the prevalence (PESA 1.2% and 
TESE 2.1%) seems similar to the prevalence in spontaneous conceived children (1.4–3.5%) 
(Lambeek, et al., 2013, Lehmann, et al., 2000, Witt, 2003). Regarding the distribution of birth 
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defects, an increased prevalence of hypospadias, as found by Fedder et al., could not be 
confirmed (Fedder, et al., 2007). However, in that study only three cases of hypospadia 
were found, of which two were from dizygotic twins. 
Our study has some limitations. A major limitation is the rather low power of the study 
due to a low prevalence of birth defects. We performed a post-hoc power calculation, 
based on the actual group sizes of PESA and TESE and the actual birth defect rate of 6.9% 
in the PESA group. This showed that a difference of approximately 7% in birth defect 
prevalence could have been detected with 80% power and a significance level of 5%. 
Another limitation is that data were collected by parent reported questionnaires. This 
questionnaire was used in another study (Woldringh, et al., 2011). In that study, the same 
questionnaires were sent after birth and after 1 year, and physical examination was 
performed at 2 years. The authors found that after 1 year, parents reported additional 
birth defects. However, at 2 years of age, physical examination revealed no birth defects 
other than those already reported in the questionnaires. Therefore, it seems that the 
parents reliably reported birth defects correctly. Furthermore, the conclusions involving 
the embryo quality may have been influenced by cases with double ET in which two 
embryos with different embryo quality were used. Newborns could not be linked to the 
original embryo with 100% certainty. 
The strength of this study lies in the included maternal and treatment-related factors. We 
studied the influence of each factor separately, with the consideration of other possible 
confounding factors. Based on our results, our study rejects the hypothesis that TESE-ICSI 
increases the prevalence of major birth defects, in comparison with PESA-ICSI, in terms of 
maternal and treatment-related factors. However, the number of newborns included was 
small to draw statistically significant conclusions about the influence of these factors. In 
conclusion, we found a similar overall prevalence of birth defects in newborns born after 
PESA-ICSI and TESE-ICSI. Additionally, the maternal and treatment-related factors 
investigated did not show a significantly increased cumulative risk of birth defects.
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Appendix   ICD-10 codes
Circulatory tract
Q21.0 Ventricular septal defect
Q23.1 Congenital insufficiency of aortic valve
Q23.8 Other congenital malformations of aortic and mitral valves
Q25.0 Patent ductus arteriosus
Q25.1 Coarctation of aorta
Respiratory tract
Q30.0 Choanal atresia
Q32.1 Other congenital malformations of trachea
Gastointestinal tract
Q40.0 Congenital hypertrophic pyloric stenosis
Q42.2 Congenital absence, atresia and stenosis of anus with fistula
K40.2 Bilateral inguinal hernia, without obstruction or gangrene
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene
K42.9 Umbilical hernia without obstruction or gangrene
Urogenital tract
P83.5 Congenital hydrocele
Q52.4 Other congenital malformations of vagina
Q53.1 Undescended testicle, unilateral
Q53.2 Undescended testicle, bilateral
Q60.0 Renal agenesis, unilateral
Q60.4 Renal hypoplasia, bilateral
Q62.5 Duplication of ureter
Q63.9 Congenital malformation of kidney, unspecified
Musculoskeletal tract
Q65.2 Congenital dislocation of hip, unspecified
Q65.5 Congenital subluxation of hip, unspecified
Q65.6 Unstable hip
Q66.0 Talipes equinovarus
Q69.0 Accessory finger(s)
Q70.4 Polysyndactyly
Q79.2 Reduction defect of lower limb, unspecified
Nervous system
Q00.0 Anencephaly
Q03.9 Congenital hydrocephalus, unspecified
Q13.1 Absence of iris
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Appendix   Continued
Skin
D22.9 Melanocytic naevi, unspecified
Q38.6 Other congenital malformations of mouth
Q82.0 Hereditary lymphoedema
Q82.5 Congenital non-neoplastic naevus
Q82.9 Congenital malformation of skin, unspecified
Chromosomal
Q90.9 Down syndrome, unspecified
Q91.3 Edwards syndrome, unspecified
Q92.9 Trisomy and partial trisomy of autosomes, unspecified
Other
E03.1 Congenital hypothyroidism without goitre
E71.3 Disorders of fatty-acid metabolism
E88.9 Metabolic disorder, unspecified
F79.0 Unspecified intellectual disabilities
Q17.0 Accessory auricle
Q77.3 Chondrodysplasia punctata
Q87.3 Congenital malformation syndromes involving early overgrowth
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Chapter 5
Abstract
Objective: To evaluate behavioural, cognitive and motor performance, and physical 
development of children born after TESE-ICSI at the age of five.
Design: A prospective longitudinal cohort study. 
Setting: Two university medical centres. 
Patients: A total of 103 five-year-olds born after TESE-ICSI.
Intervention(s): The follow-up of the children was performed by questionnaires at birth 
and again at one year old and at four years old. Five-year-old children were invited for 
individual assessment. Behavioural performance was assessed using the Child Behaviour 
Checklist for parents and teachers. Cognitive performance was assessed using the Dutch 
Wechsler Preschool and Primary Scale of Intelligence test, third version. Motor performance 
was assessed using the Dutch Movement Assessment Battery for Children, second version. 
Physical development was assessed by physical examination and medical history.
Main Outcome Measure(s): Behavioural, cognitive and motor performance, and physical 
development.
Results: Eighty-nine children were completely assessed and fourteen were partially 
assessed at the age of five. Our ‘five-years-old cohort’ assessed significantly better on 
behavioural and cognitive performance and significantly worse on motor performance—
but still in the normal range—compared to the theoretical distribution in the general 
population. Four children (3.8%) of the ‘five-years-old cohort’ had developmental 
problems/delays. Two of them were previously diagnosed with a form of autism (Pervasive 
Developmental Disorder-Not Otherwise Specified). Two children had developmental 
problems based on our behavioural, cognitive and/or motor assessments.
Conclusion: The long-term effects on development and health in children born after 
TESE-ICSI procedures seem reassuring.
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Introduction
For severe male factor infertility, intracytoplasmic sperm injection (ICSI) has become the 
method of treatment. Azoospermia, the most severe form of spermatogenesis abnormality, 
is found in about ten percent of all male infertility cases (De Croo, et al., 2000). When 
testicular sperm extraction (TESE) is successful, it is possible for those couples to conceive 
after TESE-ICSI. Since 1995 that method has been used worldwide. However, the presumed 
abnormal maturation of sperm retrieved from the testicles may have consequences for 
the development or health of the offspring born after TESE-ICSI. 
A number of studies described pregnancy and neonatal outcomes of children born after 
TESE-ICSI shortly after birth. Those descriptions used data analysis (Fedder, et al., 2013, 
Oldereid, et al., 2014, Vernaeve, et al., 2003) as well as physical examination (Ludwig and 
Katalinic, 2003) by reporting on congenital abnormalities (Belva, et al., 2011, Fedder, et al., 
2007). Fedder et al. reported an increased frequency of hypospadia but overall these 
studies were reassuring (Fedder, et al., 2007). 
Long-term effects on development and health of children born from TESE-ICSI is a subject 
less studied. Many diseases or developmental problems manifest themselves later and are 
not visible or measurable at birth or shortly thereafter. Only two studies have focused on 
development of children during childhood (Bonduelle, et al., 2002, Tsai, et al., 2011). 
Bonduelle et al. examined physical, neurological and psychomotor development in a 
group of 206 children born after TESE-ICSI until the age of two, but the researchers did not 
report that data, focusing instead on congenital abnormalities (Bonduelle, et al., 2002). Tsai 
et al. used a preschool developmental screening table in a group of 60 children but 
mentioned only that no psychomotor or intellectual development retardations were 
noted. Moreover, the researchers used a retrospective cross-sectional design (Tsai, et al., 
2011) and did not report on psychomotor and intellectual performance. A Dutch national 
cohort study regarding the development of very preterm of very low birth weight infants 
until the age of 19, reported that problems with behaviour and school performance were 
often noticed in the first years at school (van der Pal-de Bruin, et al., 2015). 
Early childhood is a period of major neurocognitive development, Mous et al. found that 
intelligence quotient is positively associated with neuropsychological functioning in 
children aged 6 to 10 years (Mous, et al., 2016).  Another study found that in term-born 
children, a low stability of motor development from birth until school age (Roze, et al., 
2010). A Dutch national cohort study including 1338 very preterm of very low birth weight 
infants with a follow up until the age of 19, reported that problems with behavior and 
school performance were often noticed in the first years at school. Special education after 
the age of five was associated with mild problems with cognition, behavior and learning 
(van der Pal-de Bruin, et al., 2015). To our knowledge no prospective studies have been 
performed regarding behavioural, cognitive and motor performance, and physical 
development of children born after TESE-ICSI above two years of age. 
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Our aim of this study was to evaluate behavioural, cognitive and motor performance and 
physical development of children born after TESE-ICSI at the age of five. To that end we 
performed a nationwide, prospective longitudinal cohort study in the Netherlands during 
an eight year period.
Material and methods
Study design
A prospective longitudinal cohort study was performed on the development of children 
born after TESE-ICSI in the Radboud university medical center (Radboudumc) and the 
Academic Medical Center (AMC) between March 1, 2008, and May 1, 2016. 
Ethical approval
The Dutch Central Committee on Research Involving Human Subjects (NL12408.000.06 
CCMO, The Hague, the Netherlands) approved the protocol for this multicentre study. 
TESE
Each male with azoospermia underwent a complete workup by an andrology-specialized 
urologist. In case of non obstructive azoospermia (NOA) or no viable spermatozoa were 
found after percutaneous epididymal sperm aspiration (PESA) or microsurgical epididymal 
sperm aspiration (MESA), a TESE procedure was performed, and the testicular sperm 
obtained was cryopreserved for further use with ICSI (Meijerink, et al., 2016). 
TESE-ICSI
Each female partner was assessed for suitability for treatment before undergoing ICSI. 
Female patients were, in general, downregulated with a gonadotropin-releasing hormone 
agonist following the standard long agonist protocol as described previously by Dam et 
al. (Dam, et al., 2012). ICSI was performed as previously described by Palermo et al. 
(Palermo, et al., 1992). Three days after ovum pick up one or two embryos were transferred. 
The remaining high-quality embryos were frozen with a slow controlled-rate freezing 
procedure. Frozen embryos were mainly transferred in E2/progesterone substituted 
cycles. The presence of foetal cardiac activity was examined by ultrasound at a gestational 
age of seven to eight weeks. 
Study procedures
All live born children after TESE-ICSI procedures in Radboudumc between March 1, 2008, 
and May 1, 2016, and live born children after TESE-ICSI procedures in AMC between March 
1, 2008, and October 1, 2012, were eligible for inclusion. Participants signed informed 
consent forms before the TESE procedure was started. The follow-up of the children born 
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after TESE-ICSI treatment was performed by questionnaires at birth and at one year and 
four years of age. The questionnaire after birth collected data on parental (age, smoking 
behaviour, educational level), pregnancy (e.g., hypertension, preeclampsia, gestational 
diabetes), and labour and child factors (including gestational age, mode of delivery, birth 
weight, presence or absence of malformations, and neonatal problems). The questionnaire 
at one and four years of age collected data regarding growth parameters and medical and 
paramedical history. If parents did not respond to the questionnaire they received a 
reminder letter three months later.
Assessment of the ‘five-years-old cohort’ children
In addition to the questionnaires, the five-year-old children were invited for complete 
behavioural, cognitive, motor and physical assessments. In the general population these 
assessments are only performed when indicated, in this study we used them to evaluate 
development in our ‘five-years-old cohort’. The children’s assessments took place in a 
single visit and were administered by a paediatric psychologist, a paediatric physiothera-
pist and a physician in Radboudumc. If the parents refused to come to the hospital for the 
assessments, they were asked if they would agree to partial assessments by completing 
questionnaires about medical condition and behaviour or by providing information from 
a general practitioner or paediatrician. Together, this complete and partially assessed 
group we named ‘five-years-old cohort’.
Assessment of behavioural performance
Behavioural performance was assessed by using the Dutch version of the Child Behaviour 
Checklist (CBCL) for children aged 1.5–5 years as reported by both parents, and the Teacher 
Report Form (TRF) as reported by the teacher (Achenbach, 2000). The CBCL and the TRF 
are validated questionnaires and both rate problem behaviour items on a 3-point scale 
based on the behaviour of the child during the preceding 2 months. Scores of the 
questionnaires were recalculated into age-corrected T-scores.  The T-scores of our study 
cohort were compared with the theoretical distribution of the CBCL en TRF based on a 
normative value of 50 and a standard deviation of 10. T-scores were categorised from best 
to worst as follows: normal range, <60; borderline range, 60–63; and clinical range, ≥63. 
The scales of the CBCL and the TRF distinguish internalizing and externalizing problems 
(Piek, et al., 2010). The total test score includes all problem scales.
Assessment of cognitive performance
Cognitive performance was assessed by using the Wechsler Preschool and Primary Scale 
of Intelligence-III-NL test (WPPSI-III-NL) for children aged 4.0–7.1 years old and was 
administered by a paediatric psychologist. The WPPSI-III-NL is a validated test which 
distinguishes total intelligence quotient (IQ), verbal IQ, performal IQ and processing speed 
(Hurks, et al., 2013). The age-corrected scores of our study cohort were compared with the 
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theoretical distribution of the WPPSI-III-NL test scores based on a normative value of 100 
and a standard deviation of 15. 
Assessment of motor performance
Motor performance was assessed using the Movement Assessment Battery for Children, 
second Dutch version (MABC-2-NL) (Henderson, et al., 2010). This test assesses manual 
dexterity, aiming and catching and balance motor tasks. The scores of those three 
components were converted to a standard total test score. Children with a standard total 
test score of >7 were considered to have a normal motor performance. Children with a 
score of 6 or 7 were considered to be at risk of having a movement difficulty. Children with 
a score of ≤5 were considered to be at risk of a significant movement difficulty. The 
age-corrected standard scores of our study cohort were compared with the theoretical 
distribution of the MABC-2 NL standard scores based on a normative value of 10 and a 
standard deviation of 3.
Assessment of physical development
Physical development was assessed by medical physical examination (i.e., inspection of 
birth defects, inspection of the skin, auscultation, basic neurologic examination, length 
and weight) and asking parents questions about the medical history of their child during 
the past year. Standard deviations for length, weight and weight for length were calculated 
with the growth curves of boys and girls of the same age and racial group. 
Definitions
A birth defect was defined as a certain congenital abnormality that is present in less than 
four percent of the general population of the same racial group (Holmes, 1976, Smith, 
1975). Birth defects were classified according to the International Classification of Disease 
(ICD-10). Major birth defects were defined as those birth defects that generally cause 
functional impairment or require surgical correction, with the following exceptions: 
Pyloric stenosis was considered major; inguinal hernia was considered major for a child 
born at term but minor for a child born preterm; and ductus arteriosus was considered 
major if it was still present after three months for a child born at term or still present after 
six months for a child born preterm. The remaining birth defects were considered minor 
(Bonduelle, et al., 2002).
Gestational age was subdivided into groups following the accepted definition: preterm for 
children born before 37 weeks gestational age, at term for children born between 37+0 
and 41+6 weeks, and postterm for children born equal to or later than 42 weeks gestational 
age (WHO, 2012).
We defined a developmental problem/delay as (1) one behavioural, cognitive or motor 
test score in the severe range, or (2) two scores in the moderate range or (3) three scores 
in the mild range or based on a previous psychiatric diagnosis (i.e., autism spectrum 
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disorder) or a motor disability confirmed by a specialized health care professional. Classifi-
cations of severe, moderate or mild range were as follows: behaviour (severe, ≥70; 
moderate, 63–69; and mild, 60–62), IQ (severe, <55; moderate, 55–69; and mild, 70–84) 
and motor performance (severe, <1—cerebral palsy or not able to assess; moderate, ≤5; 
and mild, 6–7).
Statistics
Characteristics at birth and at one year and four years were described separately for the 
‘five-years-old cohort’, subdivided for singletons and multiples. Fisher’s exact test was 
used for nominal outcome data. A one-sample Kolmogorov–Smirov test was used to 
determine whether the distribution of the study group’s data corresponded with the 
theoretical distribution in the general Dutch population based on test characteristics, after 
normal distribution of the study group’s data was confirmed by a Q-Q plot. Continuous 
data were compared using Student’s t-test. Statistical analysis was performed using IBM 
SPSS Statistics 20 (Chicago, IL, USA). A p value of <0.05 was considered significant. Test 
results of subgroups with children having major birth defects and children having a 
developmental problem were described separately. We were unable to perform a power 
analysis on developmental outcomes because of the nature of our study The power 
analysis was performed soley based on major birth defects reported by questionnaires; 
we estimated that 190 children were necessary to include in order to detect an increase of 
five percent of major birth defects compared to a prevalence of four percent in IVF/ICSI 
(Pinborg, et al., 2004). 
Results
Between March 1, 2008, and May 1, 2016, 411 children were live born after TESE-ICSI 
treatment in Radboudumc (n = 354) and AMC (n = 57), all parents initially consented for 
follow up of their child before start of the treatment. Four hundred four children entered 
the follow-up program by returning a questionnaire at birth. We received 319/347 
questionnaires from children that has reached the age of one and 146/180 questionnaires 
from children that has reached the age of four. During our study period 125 children 
reached the age of five and were invited for assessment.
We completely assessed 89 (71%) children aged between 5 years and 0 months and 5 
years and 11 months. Fourteen children (11%) (i.e., their parents) refused to come to the 
hospital but agreed to fill out questionnaires and provide medical reports from their 
paediatricians/family doctors. Those 103 completely or partially assessed children formed 
the ‘five-years-old cohort’. Reasons for no follow-up were mainly the burden (n = 7) of the 
assessment and no response (n = 6). 
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Table 1   Follow up of live born children after TESE-ICSI 
Total cohort ‘Five-years-old cohort’
Singletons Multiples Singletons Multiples
Birth n=321 n=83 n=72/321 n=31/83
Gender
Boy n (%) 159 (49.5) 43 (51.8) 37 (51.4) 15 (48.4)
Girl n (%) 162 (50.5) 40 (48.2) 35 (48.6) 16 (51.6)
Gestational age mean weeks (SD) 39.5 (2.0) 36.2 (3.0) 39.8 (1.5) 36.0 (3.3)
Preterm n (%) 16 (5.0) 37 (44.6) 4 (5.6) 15 (48.4)
At term n (%) 295 (91.9) 46 (55.4) 63 (87.5) 16 (51.6)
Post term n (%) 10 (3.1) 0 5 (6.9) 0
Birth weight mean gr (SD) 3436 (570) 2403 (608) 3516 (454) 2298 (552)
Major birth defect n (%) 23 (7.2) 1 (1.2) 9 (12.5) 0
Infant death n (%) 2 (0.6) 1 (1.2) 0 0
1 year n=247 n=72
Growth parameters
Weight mean kg (SD) 9.7 (1.2) 9.1 (1.1) 9.8 (1.1) 9.3 (1.1)
Length mean cm  (SD) 75.7 (3.1) 74.6 (2.7) 76.1 (3.0) 74.7 (2.2)
Medical & Paramedical history in first year
Seen by a medical specialist n (%) 85 (34.4) 23 (31.9) 22 (30.6) 13 (41.9)
Underwent surgery n (%) 8 (3.2) 4 (5.6) 4 (5.6) 1 (3.2)
Referral because of developmental issues n (%) 2 (0.8) 0 1 (1.4) 0 
Seen by a physiotherapist n (%) 45 (18.2) 20 (27.8) 13 (18.1) 12(40.0)
Hearing problems diagnosed n (%) 1 (0.4) 1 (1.4) 1 (1.4) 0
4 year n=106 n=38
Growth parameters
Weight mean kg (SD) 17.0 (2.1) 16.5 (2.3) 17.1 (2.1) 17.1 (2.0)
Length mean cm (SD) 105 (4.7) 104 (4.5) 105 (4.8) 105 (4.4)
Medical & Paramedical history since 1 years of age
Seen by a medical specialist n (%) 36 (34.0) 19 (47.5) 27 (37.5) 14 (45.2)
Underwent surgery n (%) 22 (20.8) 9 (23.7) 18 (25.0) 5 (16.1)
Referral because of developmental issues n (%) 5 (4.7) 1 (2.6) 4 (5.6) 0
Seen by a speech therapist n (%) 19 (17.9) 9 (23.7) 13 (18.1) 6 (19.4)
Seen by a physiotherapist n (%) 11 (10.4) 3 (7.9) 8 (11.1) 2  (6.5)
Hearing problems diagnosed n (%) 6 (5.7) 2 (5.3) 5 (7.1) 0
Specialized elementary school needed n (%) 2 (1.9) 1 (2.6) 2 (2.8) 0
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Table 1 shows the baseline characteristics and results of the questionnaires of the total 
group and of the ‘five-years-old cohort’. The mean maternal age at delivery was 32.4±3.8 
(range: 23–43) and paternal age 36.8±7.5 (range: 25–64) years. Three infants died in the 
first week after birth, two singletons were born at 23+1 and 26+1 weeks and one 
second-born twin was born at 25+1 weeks. There was no significant difference in the 
prevalence of birth defects (p = 0.23) and percentage of referral because of developmental 
reasons in ‘five-years-old cohort’ and the group of children who did not reach the age of 
five during the study period (p = 1.00).
Results of the behavioural assessment are presented in Figure 1. Parents and teachers of 
the ‘five-years-old cohort’ reported significantly less behavioural problems in this group 
compared with the theoretical distribution in general Dutch children. The total test scores 
of parents about the behaviour of their children were significantly lower than the scores 
of the teachers (p = 0.02). While teachers reported significantly more behavioural problems 
(p = 0.05), mothers reported more externalising problems (p = 0.02) in boys compared 
with girls. There was no difference in behavioural problems in boys compared with girls 
reported by questionnaires filled out by fathers. No differences in behavioural performance 
were found between children born preterm and at term. 
Results of the cognitive assessment in terms of total IQ are presented in Figure 2. The ‘five-
years-old cohort’ had a significantly higher IQ compared with the theoretical distribution 
general Dutch children. Forty-four percent of the mothers and 35% of the fathers reported 
higher professional education or university levels on the questionnaire at birth of their 
children. Girls had a significantly higher total IQ (p = 0.04) and processing speed (p = 0.002) 
Table 1   Continued 
Total cohort ‘Five-years-old cohort’
Singletons Multiples Singletons Multiples
5 year n=72 n= 31
Growth parameters
Weight mean kg (SD) 20.8 (2.9) 20.8 (2.8) 20.8 (2.9) 20.8 (2.8)
Length mean cm (SD) 115.3 (4.5) 114.7 (4.7) 115.3 (4.5) 114.7 (4.7)
Medical & Paramedical history last year
Seen by a medical specialist n (%) 26 (36.1) 7 (22.6) 26 (36.1) 7 (22.6)
Underwent surgery n (%) 9 (12.5) 2 (6.5) 9 (12.5) 2 (6.5)
Referral because of developmental issues n (%) 1 (1.4) 0 1 (1.4) 0
Seen by a speech therapist n (%) 14 (19.4) 9 (29.0) 14 (19.4) 9 (29.0)
Seen by a physiotherapist n (%) 8 (11.1) 3 (9.7) 8 (11.1) 3 (9.7)
Seen by a psychologist n (%) 6 (8.3) 1 (3.2) 6 (8.3) 1 (3.2)
Specialized elementary school needed n (%) 2 (2.8) 0 2 (2.8) 0
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Figure 1   Behavioural performance in ‘five-years-old cohort’ reported by the mother, 
father and teacher
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compared to boys. Children born at term scored significantly higher for both total (p = 0.002) 
and performal IQ (p = 0.000) than children born preterm. 
Results of the motor assessment are presented in Figure 3. The children in the ‘five-years-
old cohort’ had significantly poorer motor performances compared with the theoretical 
distribution in general Dutch children. We found 21 (23%) children with a delayed motor 
performance, 12 of which were at risk of a movement difficulty and 9 had a significant 
movement difficulty. Nine children already had the support of a paediatric physiotherapist. 
Total scores (p = 0.006), manual dexterity (p = 0.006) and balance (0.02) were significantly 
better in girls compared with boys. The scores for children born preterm and at term did 
not differ statistically with the exception of the component score for balance that showed 
children born at term had a higher score (p = 0.001). 
The results of the assessment of physical development are presented in Table 1. Nine 
children had a major birth defect: hip dysplasia (ICD-10 Q65.2 and Q65.6), ventricular 
septal defect (ICD-10 Q21.0), patent ductus arteriosus (ICD-10 Q25.0), galactosemia 
(ICD-10 E74.2), XYY karyotype (ICD-10 Q98.5), hemivertebra (ICD-10 Q76.4), posterior 
urethral valves (ICD-10 Q60.4) and inguinal hernia (ICD-10 K40.9). Ninety-six percent of the 
children had a standard deviation between –2.0 and 2.0 for length and 93% and 95% 
percent for weight and weight for length, respectively (general population covering 95%) 
corrected for age and race. 
Figure 1   Continued
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Children with major birth defects
The mean test scores for a subgroup of children with a major birth defect were as follows: 
behavioural assessment total problem score: 43.0 (mother), 41.4 (father) and 46.5 (teacher); 
cognitive assessment total IQ, 120.8; and motor assessment standard total test score, 9.6. 
The scores of this subgroup were in the same range as those of the total ‘five-years-old 
cohort’. 
Children with developmental problems
Four children of the ‘five-years-old cohort’ had developmental problems/delays: Two had 
a previous psychiatric diagnosis and two presented with two scores in the moderate 
range. A brief description of those four children follows: 
Child 1 was diagnosed with a form of autism (Pervasive Developmental Disorder-Not 
Otherwise Specified, PDD-NOS). This child was born at term and was diagnosed with 
posterior urethral valves. After one year he had undergone a renal transplantation because 
of renal failure, and there was a delay in the developmental milestones. At four years he 
had deprived language and motor development and pubertas praecox; he attended a 
specialized primary school.
Figure 2   Cognitive performance in ‘five-years-old cohort’
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5Child 2 was also diagnosed with PDD-NOS. He was born at term. At one year he visited a 
paediatrician because of reflux. At four years he had deprived language and motor 
development, and he had undergone surgery (placing tympanostomy tubes and a 
tonsillectomy).
Child 3 was diagnosed with XYY syndrome during pregnancy by a chorionic villus 
sampling. He was born at term. At one year he had developed normally, but at four years 
he had deprived language and motor development and attended a specialized primary 
school. At five years this boy had developmental problems suspicious for autism spectrum 
disorder, but he had not been finally diagnosed. The teacher reported behavioural 
problems in the clinical range (total problem score of 65). Moreover, this child had 
deprived language development. For this reason we were unable to assess cognitive 
performance. This child also had a significant movement difficulty (standard total test 
score: 1). 
Child 4 was born at term. At one year and four years his weight was above average (+2.2 
SD and +2.1 SD) with no other remarks. At five years the teacher reported his behaviour in 
the borderline range (total problem score of 60), whereas the parents did not. This child 
had an IQ of 72 and was at risk for a movement difficulty (standard total test score of 7). 
Figure 3   Motor performance in ‘five-years-old cohort’
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In addition to those four children with developmental problems/delays, two other 
children did not meet our definition of having a developmental problem. A brief 
description of those two children follows: 
Child 1 had internalizing behavioural problems within the clinical range, according to the 
mother, and total behavioural problems in the clinical range, according to the teacher, but 
the father reported none. The IQ was 139, and he had a normal motor performance. The 
parents suspected an autism spectrum disorder, but this child has not yet been diagnosed. 
Child 2 had behavioural problems in the clinical range, according to the parents; the 
teacher did not fill out the questionnaire. The child had a short stature (length SD 2.5; 
weight SD 2.4). His IQ was 129, and he had a normal motor performance.
Discussion
In this prospective study we examined the development of children born after TESE-ICSI. 
We evaluated the development of 404 children born after TESE-ICSI at birth and at one 
year and four years of age, and we evaluated the development of 103 five-year-old children 
with behavioural, cognitive and motor performance tests and growth parameters.
Our ‘five-years-old cohort’ scored significantly better on behavioural and cognitive 
performance but significantly worse on motor performance than the general population. 
We found four children (3.8%) of the ‘five-years-old cohort who presented with developmental 
problems. Our results concerning the safety of TESE-ICSI regarding its long-term effects on 
development and health in children born after these procedures seem reassuring.
In this study we found two children with a form of autism, which is a relatively high 
prevalence in this small sample. In the general population the prevalence of autism is 
about one percent in the age group between four and seven year old (CBS, 2014). 
Although it is known that autism is more common in children of older fathers (D’Onofrio, 
et al., 2014), the fathers of the two children were 28 and 33 years at child birth. 
Our findings of the cognitive performance in our ‘five-years-old cohort’ of boys and girls 
and pre- or at-term-born children were in accordance with the literature (Hoff Esbjorn, et 
al., 2006, Strauss, et al., 2006). Moreover, our results are in line with a systematic review 
regarding IVF children, which concludes that, in general, long-term mental and emotional 
health outcomes from IVF treatment are reassuring (Hart and Norman, 2013). Punamäki et 
al. recently studied the mental health and developmental outcomes of 225 children, 7–8 
years old, born after IVF/ICSI and compared the outcomes with 278 naturally conceived 
controls (Punamaki, et al., 2016). They found that children born after IVF/ICSI did not differ 
with regard to mental health or social and cognitive developmental problems. They did 
not specify whether they included children born after TESE-ICSI, and their results were 
based only on parental reports. In literature, generally CBCL scores are higher than TRF 
scores on most scales, this is in discordance with our study (Rescorla, et al., 2014).
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In our study we found a better behavioural and cognitive performance of children born 
after TESE-ICSI compared with the general Dutch population. However, this may be related 
to a high education level of the children’s parents. A prospective follow-up study of 
four-year-olds born to infertile couples (including 63 IVF, 53 natural cycle IVF, and 79 
natural conception children) found no causal effect between ovarian stimulation or in 
vitro procedures and cognitive and behavioural outcomes. But the authors concluded, 
based on the results of IQ tests and CBCL questionnaires, that infertility per se, and 
especially more severe infertility, negatively affects children’s cognitive and behavioural 
outcomes (Schendelaar, et al., submitted - 2015). They expressed the severity of infertility 
in terms of time to pregnancy rather than by specific underlying causes. However, in 
couples with males suffering from azoospermia, time to pregnancy may not be a good 
parameter because their failure to conceive is not dependent on time of exposure. 
We found that motor performance in our ‘five-years-old cohort’ was significantly worse 
compared with the general Dutch population. That might be due to a higher proportion 
of multiples and preterm births in our cohort compared with the general population. 
However, in our cohort we found no difference in total scores in children born preterm or 
at term, maybe because moderately preterm infants born between 32 and 37 weeks were 
included. Although there is a significant difference compared with the general Dutch 
population, the mean total test score of our cohort is still within the normal range and less 
clinically relevant. However, it is striking that we referred four children for physical therapy. 
One child’s parents were advised to stop physical therapy, and another child’s parents to 
restart physical therapy. In our study children born at term had a better score for balance 
compared with children born preterm, which is in line with what is known from the 
general population (de Kieviet, et al., 2009).
A major birth defect was observed in 5.9% of the children in the total cohort and 8.7% of the 
children in our ‘five-years-old cohort’, this percentage is in line with previous studies (Belva, 
et al., 2011, Woldringh, et al., 2010) regarding ICSI outcomes with non-ejaculated sperm. The 
prevalence of major birth defects in the general population in the Netherlands in 2010-2012 
was estimated between 3.6-3.7% (TNO, 2014). It is known that the prevalence of major birth 
defect after IVF/ICSI is elevated compared with general population. A systematic review 
showed that the use of testicular sperm doesn’t contribute to an increased risk compared 
with ejaculated sperm (Woldringh, et al., 2010) . We previously studied the probability of 
achieving a live birth in TESE-ICSI in a cohort of azoospermic males and their female partners 
(Meijerink, et al., 2016), the parents of the children in our current study were part of that 
cohort. In this cohort, the majority (85%) of the TESE-ICSI cycles were performed with frozen 
thawed testicular sperm. ICSI results were as follows: mean number of oocytes retrieved 10.5; 
mean number of fertilized 2pn embryos 4.1; mean number of transferred embryos per cycle 
1.3. In this cohort 22% of the cycles resulted in a live birth.
The strength of our study is its prospective longitudinal design with limited bias. In the 
Netherlands, because of a moratorium effective until 2014, ICSI with testicular retrieved 
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spermatozoa was allowed only in research settings. For that reason all children born from 
couples who underwent TESE-ICSI treatment in the Netherlands were included in this 
study, which limited bias. Furthermore, our lost to follow-up during our study was limited 
to 18%. 
Despite the prospective nature and the nationwide character of our study, there are some 
limitations. First, we were unable to compare our cohort with naturally conceived controls. 
To compare our 5-years-old cohort with the naturally conceived children we used standard 
deviations and the range of test scores. Second, we were unable to perform a power 
analysis on developmental outcomes because of the nature of our study. Moreover, there 
were some children lost to follow up which may attrition bias our study. However, we did 
not find any underlying reasons for non-participation potentially related to the health of 
the children. Finally, data may be influenced by interobserver variations. The cognitive 
assessment was administered by five paediatric psychologists; the motor assessment by 
three paediatric physical therapists (two of the three therapists assessed about half of the 
children and both therapists were trained by the third therapist); and the physical 
examination by one physician.
In conclusion, we found that the behavioural and cognitive performance scored better 
but the motor performance was poorer in five-year olds born after TESE-ICSI compared 
with the general population.  Despite statistical significance, differences in outcomes 
compared with the general population were small and of questionable or clinical 
importance, being small in magnitude, subject to influence of small numbers of measures 
at the extremes of rang, and loss of follow up of some subjects. Therefore, the long-term 
effects on development and health in children born after TESE-ICSI seem reassuring. Our 
findings could empower health-care providers to comprehensively counsel couples who 
consider TESE-ICSI treatment and help them in their concern about their children’s 
development. We want to emphasize that follow-up of these children should continue 
because knowledge of their long-term health is scarce.
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Supplemental Table 1   Classification of developmental subtests 
Severe Moderate Mild Normal
Behavioural performance  
(total problem score)
≥70 63-69 60-62 <60
Cognitive performance 
(total intelligence quotient)
<55 55-69 70-84 ≥85
Motor performance 
(total test score)
<1/not possible 
to assess/CP
≤5 6-7 >7
A developmental problem/delay was defined by us as [1] one behavioural; cognitive or motor test score in severe 
range, or [2] two scores in moderate range or [3] three in mild range, or based on previous psychiatric diagnosis 
(i.e. autism spectrum disorder) or motor disability confirmed by a specialized health care professional. CP= cerebral 
palsy.
Supplemental Table 2   Assessment of behavioural performance ‘five-years-old cohort’ 
Child behaviour1 Mother 
n=96
p-value Father 
n=95
p-value Teacher 
n=85
p-value
Total score mean (SD) 44.3 (9.7) 0.00 43.2 (9.4) 0.00 46.7 (9.8) 0.006
Normal range (<60) n (%) 89 (92.7) 90 (94.7) 75 (88.2)
Borderline range (60-62) n (%) 2 (2.1) 3 (3.2) 6 (7.1)
Clinical range (≥63) n (%) 5 (5.2) 2 (2.1) 4 (4.7)
Internalizing problems  
score mean (SD)
45.5 (10.4) 0.00 45.0 (9.9) 0.00 46.3 (10.4) 0.001
Normal range (<60) n (%) 87 (90.6) 84 (88.4) 77 (90.6)
Borderline range (60-62) n (%) 3 (3.1) 8 (8.4) 3 (3.5)
Clinical range (≥63) n (%) 6 (6.3) 3 (3.2) 5 (5.9)
Externalizing problems  
score mean (SD)
45.3 (10.4) 0.00 44.9 (9.2) 0.00 47.9 (8.4) 0.024
Normal range (<60) n (%) 86 (89.6) 90 (94.7) 76 (89.4)
Borderline range (60-62) n (%) 4 (4.2) 1 (1.1) 5 (5.9)
Clinical range (≥63) n (%) 6 (6.3) 4 (4.2) 4 (4.7)
1. Child Behaviour Checklist (CBCL) reported by parents, and Teacher Report Form (TRF) reported by the teacher
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Supplemental Table 3   Assessment of cognitive performance ‘five-years-old cohort’ 
Child cognitive performance1 n=89 p-value
Total Intelligence Quotient mean (SD) 111.8 (14.2) 0.000
Very superior (≥130) n (%) 9 (10.1)
Superior (120-129) n (%) 18 (20.2)
High average (110-119) n (%) 24 (27.0)
Average (90-109) n (%) 33 (37.1)
Low average (80-89) n (%) 4 (4.5)
Borderline (70-79) n (%) 1 (1.1)
Verbal Intelligence Quotient mean (SD) 111.6 (14.2) 0.000
Very superior (≥130) n (%) 10 (11.2)
Superior (120-129) n (%) 15 (16.9)
High average (110-119) n (%) 23 (25.8)
Average (90-109) n (%) 36 (40.4)
Low average (80-89) n (%) 2 (2.2)
Borderline (70-79) n (%) 2 (2.2)
Missing 1 (1.1)
Performal Intelligence Quotient mean (SD) 110.3 (11.9) 0.000
Very superior (≥130) n (%) 5 (5.6)
Superior (120-129) n (%) 15 (16.9)
High average (110-119) n (%) 27 (30.3)
Average (90-109) n (%) 37 (41.6)
Low average (80-89) n (%) 5 (5.6)
Borderline (70-79) n (%) 0
Processing speed mean (SD) 100.5 (14.4) 0.576
1. Wechsler Preschool and Primary Scale of Intelligence – III NL (WPSSI-III-NL) assessed by a paediatric psychologist
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Supplemental Table 4   Assessment of motor performance ‘five-years-old cohort’ 
Child motor performance 1 Preterm n= 16 At term n= 74 p-value  
for total group 
n=90
Standard total test score mean (SD) 9.5 (3.1) 9.3 (3.0) 0.001
Normal range (>7) n (%) 12 (75) 57 (77)
At risk (6-7) n (%) 1 (6) 11 (15)
Movement difficulty (≤5) n (%) 3 (19) 6 (8)
Manual dexterity mean (SD) 9.5 (2.5) 9.9 (2.8) 0.013
Normal range (>7) n (%) 13 (82) 61 (82)
At risk (6-7) n (%) 2 (13) 9 (12)
Movement difficulty (≤5) n (%) 1 (6) 4 (5)
Aiming & catching mean (SD) 8.7 (3.6) 9.4 (2.6) 0.000
Normal range (>7) n (%) 10 (63) 54 (73)
At risk (6-7) n (%) 2 (13) 15 (20)
Movement difficulty (≤5) n (%) 4 (25) 5 (7)
Balance mean (SD) 10.3 (2.8) 8.9 (2.8) 0.000
Normal range (>7) n (%) 13 (82) 50 (68)
At risk (6-7) n (%) 3 (19) 17 (23)
Movement difficulty (≤5) n (%) 0 7 (9)
1. Movement Assessment Battery for Children 2 –NL (MABC-2-NL) assessed by a paediatrics physiotherapist, 
results sub dived for children born preterm (i.e. <37 weeks of gestation) and children born at term (i.e. ≥37 weeks 
of gestation including post term).
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Supplementary figure   Flowchart of the included live born children after TESE-ICSI
2008-2016 longitudinal cohort
Questionnaire completed at birth 404
Reached ve years of age
before May 2016
Invited for assessment 125
Five-years-old cohort 103
Complete assessment 89
Partial assessment 14
Lost to follow up 22
- Burden – Impact 7
- Untraceable – Noresponse 6
- Living abroad 3
- No show 3
- Planning 2
- Refusal to participate 1
‘Five-years-old cohort’: all children born after TESE-ICSI procedures in Rumc and AMC, who were completely assessed for 
behavioural, cognitive, motor and/or physical performance or partially assessed by questionaires for medical condition and 
behaviour, or providing information from a general practioner or pediatrian, at the age of five.
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Abstract 
A retrospective cohort study was performed with the followings aims: to evaluate the 
influence of paternal age on best embryo quality available for embryo transfer on the 
third day; biochemical pregnancy rate; miscarriage rate and ongoing pregnancy rate at 8 
weeks’ gestational age, after IVF or intracytoplasmic sperm injection (ICSI) treatment, 
respectively, including treatment with non-ejaculated spermatozoa. In total, 7051 first IVF/
ICSI cycles in Radboud university medical center, between 1 January 2001 and 1 June 2013 
were included in this study. A statistical model was used to analyse the effect of paternal 
age and maternal age. No statistically significant differences between the paternal age 
groups were found with respect to the probability of an ongoing pregnancy after the first 
cycle (35–44 years: odds ratio [OR] = 0.97 [95% confidence interval [CI]: 0.86 to 1.10] and 
≥45 years: OR = 1.01 [95% CI: 0.82 to 1.26]), respectively, compared with <35 years of age 
(control). Similar results were found with respect to paternal age and the availability of a 
top quality embryo for transfer, biochemical pregnancy and miscarriage. However, live 
birth was not taken into account. In conclusion, paternal age did not affect ongoing 
pregnancy rates in first IVF/ICSI cycles.
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Introduction
In Western society and developed countries, there is a tendency for delayed parenthood 
as a consequence of social economical welfare, personal education development, 
increased life expectancy, divorce and restarting new families. Nowadays, not only women 
are delaying parenthood; men’s ages for parenthood have also increased in the last 
decade. In the Netherlands in 2000, 11.1% (n = 22,981) of the children born had a father 
over 40 years old; in 2012 this percentage was 16.4% (n = 28,888) (CBS, 2011). 
While for women their biological clock will determine the end of their fecundity, men’s 
biological clocks do not play such a prominent role, as men can produce spermatozoa 
until a very advanced age. Currently, there are no legal or biological restrictions given to 
participation of elderly men in assisted reproductive programmes. The focus on factors 
affecting the outcome of assisted reproductive techniques is mainly related to the 
influence of female factors, including age, diagnosis, co-morbidity and ovarian stimulation. 
It is well known that women older than 35 years have a higher risk of spontaneous 
abortion, pregnancy complications and chromosomal abnormalities, but couples with 
men over 40 years of age also seem to have a higher risk for miscarriage (de la 
Rochebrochard and Thonneau, 2002). Another study found a 4.5-fold higher risk of having 
a child with trisomy 21 in men over 45 years of age compared with men younger than 30 
years (Zhu, et al., 2005). They suggest that this could be induced by biological or 
environmental factors causing gamete mutations in men. It seems that reproductive 
function in both women and men declines with age (Wiener-Megnazi, et al., 2012). 
Fathers in couples undergoing assisted reproductive techniques are older than their fertile 
counterparts (Stern, et al., 2014), but only limited or controversial results about the 
influence of paternal age on reproductive outcome after assisted reproductive techniques 
have been published. Previous studies show discordant findings in terms of effects on 
embryo quality, pregnancy rate and live born delivery (de La Rochebrochard, et al., 2006, 
Ferreira, et al., 2010, Klonoff-Cohen and Natarajan, 2004). In these studies the use of 
non-ejaculated spermatozoa (of epididymal or testicular origin) was not included. 
However, older men who had a previous vasectomy, in particular, are candidates for intra-
cytoplasmic sperm injection (ICSI) with non-ejaculated spermatozoa for assisted 
reproductive treatment. Studies using an ovum donation model reveal that embryo 
implantation rates decline with increasing paternal age, but show no agreement regarding 
pregnancy outcome and have not been adjusted for recipient age (Humm and Sakkas, 
2013, Robertshaw, et al., 2014). The aim of this study is to look at the influence of paternal 
age on best embryo quality available for embryo transfer (ET), biochemical pregnancy 
rate (BPR), miscarriage rate and ongoing pregnancy rate (OPR) up to 8 weeks’ gestational 
age, after IVF or ICSI treatment, respectively, including treatment with non-ejaculated 
spermatozoa. To this end, a large retrospective cohort study of first assisted reproductive 
treatment cycles was performed.
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Materials and methods
Study population
A retrospective cohort study was performed to investigate the influence of paternal age 
on reproductive outcome when using assisted reproductive techniques. Data were 
collected for all first cycles of assisted reproductive treatment at the Radboud university 
medical center (Radboudumc) between 1 January 2001 and 1 June 2013. Data were 
obtained with respect to: the age of men and women at the time of oocyte retrieval; type 
of assisted reproductive technique (IVF or ICSI); type of spermatozoa used for the treatment 
(ejaculated or non-ejaculated: percutaneous epididymal sperm aspiration [PESA]; micro -
surgical epididymal sperm aspiration [MESA] or testicular sperm extraction [TESE]); condition 
of spermatozoa (fresh or cryopreserved); FSH dose; number of follicles and oocytes; 
fertilization rate; embryo quality of transferred embryos; single embryo transfer (SET) or 
double embryo transfer (DET); number of good quality embryos for cryopreservation; 
and pregnancy results (biochemical and ongoing pregnancies). 
Of all first cycles (n = 7246), the study excluded couples who underwent assisted 
reproductive treatment in a modified natural cycle (n = 51); women who did not have ET 
for risk of ovarian hyperstimulation syndrome (OHSS); or assisted reproductive treatment 
in oncology patients because of fertility preservation (n = 74) or for oocyte vitrification 
(n = 70). As a result, 7051 first assisted reproductive technique cycles were included in this 
study. Ethical committee approval was not required for this retrospective study according 
to the Medical Treatment Agreements Act (Medical Treatment Agreements Act, 1994), 
Procedures
Patients underwent assisted reproductive treatment in a long agonist protocol as 
described previously by Dam et al. (Dam, et al., 2012). Briefly, stimulation was initiated by 
injections with FSH with doses depending on anti-Müllerian hormone concentrations 
and/or antral follicle count. Oocyte retrieval was planned when ≥3 follicles with a diameter 
of ≥17 mm were observed by ultrasound examination, and was performed 36 h after 
human chorionic gonadotrophin (HCG) injection. ICSI was performed as described 
previously by Palermo et al. (Palermo, et al., 1992).  
Luteal phase support was started on the day of oocyte retrieval by vaginal administration of 
200 mg progesterone (Utrogestan) three times daily, continued until pregnancy test.
Three days after oocyte retrieval, one or two embryos were transferred. SET or DET was 
performed depending on national policy, the woman’s age, the woman’s medical history and 
the couple’s preference. Transfer policy has changed over time, the last 3 years into SET in 
women <38 years in the first two IVF/ICSI cycles including cryotransfers. No embryo transfer was 
performed in cases of absence of fertilization, abnormal embryos or in cases of (risk for) OHSS. 
Embryo scoring and evaluation was based on fragmentation and the number of 
blastomeres using an inverted light microscope by a qualified embryologist or laboratory 
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technician. All embryos were examined to determine fragmentation and the number of 
blastomeres on day 3 (ESHRE, 2000). The quality of embryos selected for transfer was 
classified from best to lowest as follows: A-quality embryos with 0–20% fragmentation 
and containing seven, eight or nine blastomeres (top quality); B-quality embryos with 
20–50% fragmentation containing seven or eight blastomeres, or embryos with 0–20% 
fragmentation containing four, five or six, or ten, eleven or twelve blastomeres (mean 
quality); C-quality embryos (poor quality). After scoring, one or two of the best embryo(s) 
available were selected for embryo transfer. Fifteen days after ET, patients performed a 
urine pregnancy test at home and informed the hospital about whether or not a 
biochemical pregnancy had occurred. A miscarriage was defined as a pregnancy 
diagnosed only by the detection of HCG in serum or urine and that did not develop into a 
clinical pregnancy or the spontaneous loss of a clinical pregnancy that occurred before 20 
completed weeks of gestational age (Zegers-Hochschild, et al., 2009). A clinical pregnancy 
was defined as a pregnancy diagnosed by ultrasonographic visualization of one or more 
gestational sacs or definitive clinical signs of pregnancy. It includes ectopic pregnancy 
(Zegers-Hochschild, et al., 2009). An ongoing pregnancy was defined as the appearance 
of a foetal heartbeat examined by ultrasound at 8 weeks’ gestational age.
Statistical analysis
Descriptive statistics are used to present the characteristics by paternal age group. Three 
(different) age classes were used for men and women based on literature (de La 
Rochebrochard, et al., 2006, de La Rochebrochard and Thonneau, 2003, Wiener-Megnazi, 
et al., 2012). Multivariable logistic regression was used to study the influence of paternal 
and maternal age on the probability after the first cycle of an ongoing pregnancy, of a 
biochemical pregnancy and of an A-quality embryo and a miscarriage separately. The 
dependant variable was an ongoing pregnancy (a biochemical pregnancy, an A-quality 
embryo, a miscarriage, respectively). The independent class variables were paternal age (3 
levels: < 35, 35 − 44, ≥ 45 years) and maternal age (3 levels: < 35, 35 − 39, ≥ 40 years). The 
type of assisted reproductive techniques and embryos transferred (none, SET, DET) were 
treated as confounder variables. Initially, the interaction between paternal age and 
maternal age was also included in the model to evaluate whether or not this contributed 
to the fit of the model. Finally, a confirmative analysis was performed using the initial 
model and the data related to SET or DET only. The adjusted odds ratios (OR) with the 
appropriate 95% confidence interval (CI) of the final models are presented. 
In an analogous manner to the methods described above, logistic regression analysis was 
used to study the influence of paternal age using the data of IVF, ICSI and ICSI with 
non-ejaculated spermatozoa only and of paternal age groups ≥50 and ≥60 years. Statistical 
analysis was performed using IBM SPSS Statistics 20 for Windows (IBM Inc., USA) and SAS 
version 9.2 for Windows (SAS Institute, Cary, NC, USA). A P-value of <0.05 was considered 
statistically significant.
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Results
In total, 16,343 assisted reproductive techniques cycles were performed between 1 
January 2001 and 1 June 2013 in Radboudumc. Of these, 7246 were related to a first 
assisted reproductive treatment cycle of unique couples. Cycles with oocyte vitrification, 
no ET because of OHSS or fertility preservation and modified natural cycles, were excluded. 
As a result, 7051 assisted reproductive techniques cycles were included in this study 
(Figure 1). 
In 776 cycles, assisted reproductive treatment was performed with cryopreserved 
sperma tozoa: 17 cycles in the IVF group, 111 cycles in the group of ICSI with ejaculated 
spermatozoa and 648 in the group of ICSI with non-ejaculated spermatozoa. The group 
with ICSI with non-ejaculated spermatozoa consisted of: 570 PESA-ICSI, 19 MESA-ICSI and 
Table 1   Baseline characteristics and ongoing pregnancy rate by paternal age group
Paternal age (year)
<35 35-44 ≥45
n median (range)/ 
n (%)
n median (range)/ 
n (%)
n median (range)/ 
n (%)
Maternal age (year) 3076 30.7 (20-42) 3339 35.3 (21-44) 636 36.8 (22-43)
Paternal age (year) 3076 32.0 (17-34) 3339 38.3 (35-44) 636 48.6 (45-73)
First ART cycles 3076 3339 636
IVF 1548 (50.3) 1971 (59.0) 233 (36.6)
ICSI 1528 (49.7) 1368 (41.0) 403 (63.4)
ejaculated sperm 1202 (39.1) 956 (28.6) 163 (25.6)
non-ejaculated sperm 326 (10.6) 412 (12.3) 240(37.7)
Fertilisation 66.7 (0-100) 66.7 (0-100) 66.7 (0-100)
No. of embryos transferred 3076 2 (0-2) 3339 2 (0-2) 636 2 (0-2)
No ET 270 (8.8) 313 (9.4) 66 (10.4)
SET 1253 (40.7) 1252 (37.5) 236 (37.1)
DET 1553 (50.5) 1774 (53.1) 334 (52.5)
 ≥1 A-quality embryo 1642 (53.4) 1678 (50.3) 305 (48.0)
Ongoing pregnancy rate 853 (27.7) 792 (23.7) 150 (23.6)
ART: assisted reproductive techniques IVF: in vitro fertilization; ICSI: intracytoplasmic sperm injection; Fertilisation: 
percentage of inseminated (or injected) oocytes fertilised in IVF (or ICSI); ET: embryo transfer; SET: single embryo 
transfer; DET: double embryo transfer; A-quality embryo: embryos with 0-20% fragmentation and containing 7, 8 
or 9 blastomeres on the 3th day after ovum pick up.
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389 TESE-ICSI cycles. For those cycles with cryopreserved spermatozoa, men’s age was 
considered as that at the time of cryopreservation.
In Table 1 the baseline characteristics and ongoing pregnancy rate are presented 
according to paternal age group. IVF was the most frequent treatment in the two youngest 
paternal age groups, whereas in the eldest group ICSI with non-ejaculated spermatozoa 
was as frequently applied as IVF. This study contained 636 men of ≥45 years; the eldest 
man in this study had an age of 73 years. The ongoing pregnancy rate was 27.7% (853/3076), 
23.7% (792/3339) and 23.6% (150/636) in the youngest, intermediate and eldest paternal 
age group, respectively. 
The interaction term between paternal age and maternal age never statistically 
significantly improved the fit to the data (likelihood-ratio test) and is therefore omitted 
from the models presented. In addition, a significant relationship between number of 
embryos transferred and paternal age group was not found. Therefore, the variable 
number of embryos transferred was omitted from the final model. In Table 2 the adjusted 
OR of paternal and maternal age for the probability of ongoing pregnancy and for the 
probability biochemical pregnancy and of the availability of at least one A-quality embryo, 
respectively, are presented. The OR’s are adjusted for the type of treatment and the other 
Figure 1   Flow diagram of all patients included in this study
7246 first IVF/ICSI 
cycles
Exclusion
- oocyte vitrification: 70
- modifed natural cycle: 51
- no embryo transfer¹: 74
Inclusion 7051 
IVF/ICSI cycles
 3752 IVF cycles
978 ICSI cycles
non ejaculated sperm
 2321 ICSI cycles
ejaculated sperm
3725 oocyte retrieval 2308 oocyte retrieval  971 oocyte retrieval
1379 SET
1909 DET 
957 SET
1250 DET
405 SET
502 DET
Cycles with no oocyte retrieval
IVF: 27
ICSI ejaculated sperm: 13
ICSI non ejaculated sperm: 7
Cycles with no embryo transfer
IVF: 437
ICSI ejaculated sperm: 101
ICSI non ejaculated sperm: 64
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variable in the model. No statistically significant differences between the paternal age 
groups were found with respect to the probability of an ongoing pregnancy after the first 
cycle (35–44 years: OR = 0.97 [95% CI: 0.86 to 1.10] and ≥45 years: OR = 1.01 [95% CI: 0.82 
to 1.26], respectively, compared with <35 years of age). Similar results were found with 
respect to paternal age and the probability of the availability of at least one A-quality 
embryo. 
In addition, the probability of an ongoing pregnancy after the first cycle in the (middle) 
maternal age group of 35 to 39 years was significantly lower compared with the younger 
group <35 years, OR = 0.70 (95% CI: 0.61 to 0.80) and significantly higher compared with 
the oldest group ≥40 years, OR = 1.63 (95% CI: 1.22 to 2.17). These differences were not 
significantly different between the paternal age groups. The study did not find a 
statistically significant paternal age effect in subgroups with a paternal age, respectively 
≥50 (n = 244) and ≥60 (n = 29) years (data not shown). Similar results were found with 
respect to maternal age and the availability of at least one A-quality embryo after the first 
cycle, except that the probability in the two older maternal age groups were similar but 
significantly lower compared with the youngest age group: 35–39 years OR 0.77 (95% CI: 
0.69–087) and ≥40 years OR 0.70 (95% CI: 0.57–0.86). The study then looked at the influence 
of the paternal and maternal age in the subgroup of first cycles related to IVF, ICSI and ICSI 
with non-ejaculated spermatozoa specifically and found nearly identical results as 
presented above (Supplementary Tables 1-3). 
Table 2   Adjusted OR with 95% confidence interval (CI) of paternal age and  
of maternal age for the probability of an A-quality embryo, biochemical  
and ongoing pregnancy after a first ART cycle
A-quality  
embryo
Biochemical  
pregnancy
Ongoing  
pregnancy
n OR (95% CI) OR (95% CI) OR (95% CI)
Maternal age (year)
        <35 4526 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-39 2081 0.77 (0.69-0.87) 0.70 (0.62-0.80) 0.70 (0.61-0.80)
        ≥40 444 0.70 (0.57-0.86) 0.47 (0.37-0.60) 0.43 (0.32-0.57)
Paternal age (year)
        <35 3076 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-44 3339 1.00 (0.90-1.11) 0.98 (0.87-1.10) 0.97 (0.86-1.10)
        ≥45 636 0.90 (0.75-1.09) 1.02 (0.83-1.24) 1.01 (0.82-1.26)
OR: odds ratio, ART: assisted reproductive technique, A-quality embryo: embryos with 0-20% fragmentation and 
containing 7, 8 or 9 blastomeres on the 3th day after ovum pick up. 
Note that the adjusted OR’s are adjusted for type of treatment and the other variable in model by using multivari-
able logistic regression analysis.
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In Table 3 the adjusted OR of paternal age and of maternal age for the probability of a 
miscarriage after detecting a biochemical pregnancy are presented. No statistically 
significant differences between the paternal age groups were found. However, the 
probability of a miscarriage after the first cycle in the maternal age group of ≥40 years was 
significantly higher compared with the youngest group <35 years, OR 1.65 (95% CI: 
1.04–2.59).
Discussion
The results from this study show a significant negative influence of maternal age on 
ongoing pregnancy using assisted reproductive techniques, as expected (Templeton, et 
al., 1996), and moreover a higher chance of miscarriage. However, no paternal age effect 
was evident in these two outcomes. In addition, no paternal ageing effect on best embryo 
quality available for transfer and biochemical pregnancy was found in this study. In 
subgroup analyses based on IVF, ICSI and ICSI with non-ejaculated spermatozoa, nearly 
identical results were found.
Table 3   Adjusted OR with 95% confidence interval (CI) of paternal age and  
of maternal age for the probability of a miscarriage after detecting  
a biochemical pregnancy after a first ART cycle
IVF ICSI ejaculated 
sperm
ICSI non- 
ejaculated 
sperm
Total group
n OR (95% CI) n OR (95% CI) n OR (95% CI) n OR (95% CI)
Maternal age (year)
    <35 742 1.00 
(reference)
702 1.00 
(reference)
255 1.00 
(reference)
1699 1.00 
(reference)
    35-39 363 1.40 (1.02-1.94) 164 1.05 (0.69-1.60) 82 0.76 (0.40-1.45) 609 1.17 (0.93-1.48)
    ≥40 73 1.69 (0.98-2.91) 14 1.70 (0.54-5.36) 9 2.13 (0.54-8.45) 96 1.65 (1.04-2.59)
Paternal age (year)
    <35 524 1.00 
(reference)
472 1.00 
(reference)
130 1.00 
(reference)
1126 1.00 
(reference)
    35-44 586 0.95 (0.69-1.29) 349 1.09 (0.77-1.53) 138 1.10 (0.61-1.97) 1073 1.02 (0.83-1.27)
    ≥45 68 0.98 (0.54-1.77) 59 0.97 (0.50-1.90) 78 1.18 (0.59-2.36) 205 1.01 (0.70-1.45)
OR: odds ratio; ART: assisted reproductive technique.
Note that the adjusted OR’s are adjusted for type of treatment and the other variable in model by using multivari-
able logistic regression analysis.
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A French retrospective cohort study found evidence for a paternal age effect on failure to 
conceive linked to male ageing (de La Rochebrochard, et al., 2006). However, they only 
included IVF cycles in which the female partners were sterile due to bilateral tubal 
obstruction or absence of both tubes. If there is a paternal age effect, it will be found most 
clearly in the group of couples with young women and older men (i.e. men ≥40 years). 
They found no significant paternal ageing effect on failure to conceive in this group (OR 
1.25, 95% CI 0.43–3.62), but mentioned that the group in the study was very small (n = 22) 
so their results should be treated with caution (de La Rochebrochard, et al., 2006).
For the present study the total group of men aged ≥40 years is much larger (n = 1676 
versus n = 480) compared with that of de La Rochebrochard et al., so a more reliable 
interpretation is possible. It should be noted that in the eldest paternal age group ICSI 
treatment was used in 63.4% of the cases, while in the younger group this was 49.7%. 
Besides, it has to be noticed that de la Rochebrochard et al. did not give a definition of an 
ongoing pregnancy and their outcome measure was failure to conceive instead of 
ongoing pregnancy rate as in this study.
A systematic review of 10 studies with assisted reproductive treatment outcomes found 
an age-dependent decrease in semen volume, but other parameters of semen analysis 
were not affected (Dain, et al., 2011). Furthermore, nine of them concluded no significant 
paternal age effect on assisted reproductive treatment outcome. An important limitation 
mentioned was the poorly described and small group of advanced paternal age (>50 
years) in a number of studies (Dain, et al., 2011). The present study included 636 males ≥45 
years and 244 men equal or above ≥50 years. At this moment, as far as we are aware, no 
large studies concerning the influence of paternal age in assisted reproductive treatment 
with non-ejaculated spermatozoa have been published. Although the data were limited 
for this subgroup, the results of this subgroup analysis were comparable with the results 
of the IVF and ICSI groups with ejaculated spermatozoa. 
The strength of this study is the large number of first assisted reproductive treatment 
cycles available for data analysis, especially in the eldest category. This enabled us to 
analyse subgroups, especially ICSI with non-ejaculated spermatozoa. A larger share of ICSI 
with non-ejaculated spermatozoa in the eldest male group could probably be explained 
by restarting new families after failed vasovasostomy. Those couples have an indication 
for ICSI with epididymal or testicular spermatozoa.
This study has some limitations. It lacks information on live births. Therefore, ongoing 
pregnancy at a gestational age of 8 weeks was chosen as the major outcome measure. 
Information on live births would be useful for analysis of the effect of paternal age on this 
outcome measure. The influence of men’s lifestyle factors and congenital abnormalities in 
relation to their fertility were also not taken into account. However, the effects of paternal 
age on miscarriage were analysed. During the 13-year study period, changes and 
improvements have taken place in assisted reproductive techniques which might 
influence the study outcome. However, despite the long study period, the ongoing 
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pregnancy rate had some fluctuations but did not suggest an increase in ongoing 
pregnancy rate over time (data not shown). 
Spermatozoa quality seems to decrease with age (Sharma, et al., 2015), resulting in decline 
in semen volume, percentage motility, progressive motility, normal morphology and 
unfragmented cells (Johnson, et al., 2015). This makes the need to use ICSI to achieve 
fertilization in the older group more evident. Moreover, poor sperm chromatin 
condensation resulting in increased DNA damage might have long-term effects not 
observed at the time of fertilization, biochemical pregnancy or ongoing pregnancy at 8 
week ultrasound. These paternal effects may affect the development of live born children, 
as discussed below. 
A study performed on DNA damage in sperm cells in mouse zygotes found that DNA 
repair is mediated by factors stored in the oocyte (Derijck, et al., 2008). DNA damage in 
spermatozoa is related to male ageing (Belloc, et al., 2014, Cocuzza, et al., 2008). In the 
literature, it is postulated that when oocyte quality is affected by age, repair mediating 
factors in the oocyte might be insufficient (Ben-Meir, et al., 2015, Derijck, et al., 2008). 
However, our results do not support this hypothesis in that spermatozoa of older men will 
lead to negative influence on embryo quality, BPR, OPR and miscarriage. 
Although no paternal ageing effect on ongoing pregnancy rate at 8 weeks of gestational 
age was found in this study, other late genetic effects might be transferred to the offspring. 
The number of de-novo mutations in children of older fathers may be increased due to a 
combination of different mechanisms, such as DNA damage in spermatozoa, the 
increasing number of cell divisions during life combined with incorrect meiosis I, 
insufficient repair mechanisms because of lower testosterone concentrations in older 
men and environmental influences and life style (Bakshi, et al., 2001, Cocuzza, et al., 2008, 
Sakkas, et al., 1999).
De-novo mutations are known to largely originate during male gametogenesis, and their 
number increases with paternal age (Kong, et al., 2012, Veltman and Brunner, 2012). Most 
de-novo mutations occur outside of the gene and do not affect gene functioning. 
However, as more mutations occur at random in the genome this increases the chance 
that a mutation will affect a gene’s functioning and thereby causes disorders such as 
intellectual disability. Genome sequencing recently indicated that de-novo mutations are 
the major cause of severe intellectual disability (Gilissen, et al., 2014). Others found 
associations between paternal age and DNA fragmentation in spermatozoa and fibroblast 
growth factor receptor 3 gene mutations associated with achondroplasia (Wyrobek, et al., 
2006). In addition, epidemiological studies have clearly demonstrated an association 
between paternal age and the prevalence of autism spectrum disorders, schizophrenia 
and low educational attainment (D’Onofrio, et al., 2014, Humm and Sakkas, 2013). Others 
recently studied the relationship of paternal sperm DNA methylation and autism risk in 
offspring, in fathers of autistic children. They suggest based on their results that epigenetic 
differences in paternal spermatozoa may contribute to autism risk in offspring (Feinberg, 
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et al., 2015). Therefore, it may be that advanced paternal age does not have an impact on 
the probability of an ongoing pregnancy, but does have an impact on the risk of congenital 
abnormalities and neurodevelopment (Kovac, et al., 2013). 
In conclusion, we found no significant influence of paternal age on OPR in assisted 
reproductive treatment at 8 weeks of gestational age. Further research should focus on 
paternal ageing influences on neonatal health and genetic disorders related to male 
infertility.
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Supplementary tables 
Supplemental table 1  Sub analysis of the IVF group - OR with 95% confidence interval 
(CI) of paternal age and of maternal age 
A-quality 
embryo
Biochemical 
pregnancy
Ongoing 
pregnancy
n OR (95% CI) OR (95% CI) OR (95% CI)
Maternal age (year)
        <35 2117 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-39 1315 0.79 (0.67-0.92) 0.70 (0.60-0.83) 0.65 (0.54-0.79)
        ≥40 320 0.76 (0.59-0.97) 0.54 (0.40-0.72) 0.48 (0.34-0.67)
Paternal age (year)
        <35 1548 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-44 1971 1.08 (0.93-1.25) 1.00 (0.85-1.17) 1.01 (0.85-1.21)
        ≥45 233 0.91 (0.68-1.23) 1.08 (0.78-1.49) 1.09 (0.76-1.55)
OR: odds ratio, IVF: in vitro fertilization, A-quality embryo: embryos with 0-20% fragmentation and containing 7, 8 
or 9 blastomeres on the 3th day after ovum pick up.
Supplemental table 2  Sub analysis of the ICSI group - Adjusted OR with 95% 
confidence interval (CI) of paternal age and of maternal age  
A-quality  
embryo
Biochemical 
pregnancy
Ongoing 
pregnancy
n OR (95% CI) OR (95% CI) OR (95% CI)
Maternal age (year)
        <35 2409 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-39 766 0.78 (0.65-0.93) 0.72 (0.60-0.87) 0.77 (0.62-0.94)
        ≥40 124 0.60 (0.41-0.88) 0.35 (0.22-0.55) 0.30 (0.17-0.54)
Paternal age (year)
        <35 1528 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-44 1368 0.94 (0.80-1.11) 0.98 (0.83-1.15) 0.95 (0.80-1.13)
        ≥45 403 0.97 (0.76-1.24) 1.04 (0.81-1.35) 1.01 (0.76-1.33)
OR: odds ratio, ICSI: intracytoplasmic sperm injection, A-quality embryo: embryos with 0-20% fragmentation and 
containing 7, 8 or 9 blastomeres on the 3th day after ovum pick up. 
Note that the adjusted OR’s are adjusted for ICSI with ejaculated and non-ejaculated sperm and the other variable in 
model by using multivariable logistic regression analysis.
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Supplemental table 3  Sub analysis of the ICSI group with non-ejaculated sperm -  OR 
with 95% confidence interval (CI) of paternal age and of maternal age 
A-quality  
embryo
Biochemical  
pregnancy
Ongoing  
pregnancy
n OR (95% CI) OR (95% CI) OR (95% CI)
Maternal age (year)
        <35 668 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-39 264 0.61 (0.44-0.83) 0.78 (0.56-1.08) 0.88 (0.61-1.25)
        ≥40 46 0.49 (0.26-0.91) 0.42 (0.20-0.90) 0.34 (0.13-0.88)
Paternal age (year)
        <35 326 1.00 (reference) 1.00 (reference) 1.00 (reference)
        35-44 412 1.23 (0.90-1.67) 0.85 (0.62-1.17) 0.84 (0.60-1.19)
        ≥45 240 1.27 (0.88-1.83) 0.85 (0.58-1.25) 0.82 (0.54-1.23)
OR: odds ratio, ICSI: intra cytoplasmic sperm injection, A-quality embryo: embryos with 0-20% fragmentation and 
containing 7, 8 or 9 blastomeres on the 3th day after ovum pick up
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In this thesis various aspects of safety and efficacy of assisted reproductive techniques 
(ART), especially regarding non-obstructive azoospermia (NOA) and testicular sperm 
extraction with intracytoplasmic sperm injection (TESE-ICSI) treatment are explored. This 
thesis addresses questions from both the couples who are considering treatment, as well 
as the physicians treating male infertility. In this chapter the main findings are summarized 
and discussed, including their implications for daily practice. Finally, suggestions on which 
future research should focus are pointed out.
 
Basically, this thesis is written, to help patients and their physicians in their journey in ART. 
So, let’s start from that point of view. Imagine, Couple X and Doctor Y.
TESE & TESE-ICSI
When Couple X is referred to the fertility clinic, they meet Doctor Y (Box 1). After complete 
andrologic evaluation including medical history, physical examination and blood tests, 
Doctor Y tells the couple that Mr. X will need a TESE procedure in order to obtain 
spermatozoa for ICSI. From the literature it’s known that the chance of successful sperm 
retrieval is about 50% (Chan and Schlegel, 2000, Colpi, et al., 2005, Tournaye, 2010). 
A number of prediction models for successful sperm retrieval in TESE have been developed 
but none of them has been externally validated (Boitrelle, et al., 2011, Ramasamy, et al., 
2013, Samli and Dogan, 2004, Tsujimura, et al., 2004).
In order to counsel the couple appropriately, we developed and externally validated a 
prediction model for obtaining spermatozoa with TESE in men with NOA, as described in 
Chapter 2. Our model demonstrated that a higher male age, higher values for testosterone 
and lower values for follicular stimulating hormone (FSH) and luteinizing hormone (LH) 
are predictive for successful sperm retrieval. Diagnosis of idiopathic NOA and an AZF-c 
deletion were predictive for unsuccessful sperm retrieval. 
As mentioned, male age is one of the parameters included in our prediction model. 
One should realize that including male age into the model did improve the fitness of our 
model. Although there is a positive correlation between higher male age and successful 
sperm retrieval, we later on discuss potential negative effect of male age on the child 
health. However, one should take into account that in our development data set male age 
had a range between 22 and 72 years but only 4% (37/918) of them were above 45 years 
old. Moreover it is possible that there is a selection bias based on severity of testicular 
dysfunction. In other words, it is imaginable that in younger men with severe testicular 
dysfunction it is still more likely to find just enough ejaculated spermatozoa to perform 
ICSI and will not yet present azoospermia. While when getting older more often these 
males have developed azoospermia. With other words, when a young man presents with 
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azoospermia he might probably suffer from a more severe form of a spermatogenesis 
disorder. The fact that older men still can produce sperm does not reflect the superior 
quality of them.  
The predictive parameters found in our model confirmed that hormones are involved 
in the disturbed spermatogenesis.
After knowing the chance of obtaining spermatozoa (Box 2) it is also important to know 
the chance to conceive. Therefore, as described in Chapter 3, we developed and externally 
validated a prediction model for live birth after TESE-ICSI. Our model demonstrated that  a 
lower female age, a first (versus subsequent) TESE-ICSI cycle, lower male LH, higher male 
testosterone, availability of motile spermatozoa for ICSI and having obstructive 
azoospermia as an initial diagnosis were predictive for a live birth.
Box 1  Couple X
- Together for 6 years
- Married for 2 years
- Trying to conceive for 1.5 year
- Mr. X is recently diagnosed with (idiopathic) NOA
Male LH  
9 IU/L 
Male  
Testosteron 
  11 nmol/L 
Male FSH  
18 IU/L  
karyotype:
46XY   
no AZF  
deletions  
31yr   36yr
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At this point, Doctor Y is able to involve Couple X in the process of making decisions about 
their personal chances for conception (Box 3) so that Couple X can decide for their own 
whether they want to join the ‘ART’ journey. This is called “shared decision making” (Legare, 
et al., 2010). Using shared decision Doctor Y and Couple X can assess the burden of the 
TESE and ICSI treatment and on the other hand the chance of obtaining spermatozoa 
and finally achieving a live birth. Several studies demonstrate that patients who are 
involved in decision making are less prone to experience decisional conflict and regret 
(Bastings, et al., 2014, Legare, et al., 2010). Using our model Doctor Y is able to inform 
Couple X about their actual chances.
Unfortunately, our developed prediction models have also some limitations. Both models 
have a retrospective study design and lack complete data on potentially contributing factors 
such as male BMI. The negative influence of male obesity on reproductive outcome has 
been reported in terms of impaired blastocyst development and reduced clinical 
pregnancy rate and live birth rate as well as an increased risk of miscarriage (Bakos, et al., 
2011). Others describe that sperm retrieval rates were similar in normal weight and obese 
man, but a lower male BMI predicted a higher chance of clinical pregnancy after micro 
dissection TESE-ICSI (Ramasamy, et al., 2013). Obesity may alter the microenvironment 
inducing epigenetic changes (Milagro, et al., 2013), which in turn impairs embryo development 
in couples with male partners suffering from azoospermia.
It is assumed that obesity deregulates the hypothalamic pituitary gonadal axis, resulting in 
aberrant reproductive hormones such as reduced testosterone and elevated oestrogen 
levels which are in turn associated with impaired spermatogenesis (Fejes, et al., 2006, 
Box 2  Couple X
Probability of obtaining spermatozoa in TESE = 1/ (1+ exp (−(β))) where  
β= -1.009 + (male age * 0.058) + (LH x -0.115) + (LH2 * 0.001) + (FSH * -0.019) + 
(testosterone * 0.034) + (AZF-c deletion * -1.480) + (idiopathic NOA * -0.855). 
Mister X 
Male age: 36
LH: 9 IU/L
FSH: 18 IU/L
Testosterone: 11 nmol/L
AZF-c deletion: no (0)
Ideopathic NOA: yes (1)
Following our predictive model above the chance to find sperm for Mr. X is 33%
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Strain, et al., 1982). In males with NOA the hypothalamic pituitary axis is generally already 
deregulated but obesity might also contribute to low testosterone levels. An inverse 
relationship between male BMI and motility of sperm as well as sperm chromatin integrity 
has been found in normal healthy men (Kort, et al., 2006).  Male obesity may not only 
influence hormones and reproductive outcome but also affect the offspring according to 
a study which found that paternal obesity is associated with insulin-like Growth Factor 2 
hypomethylation in newborns (Soubry, et al., 2013). 
Both our models have limitations in their predictive value, with an area under the curve 
(AUC) of 0.69 in the prediction model for obtaining spermatozoa and an AUC of 0.62 for 
the prediction model for live birth. Moreover, the predicting model for live birth includes 
the parameter motility of the spermatozoa used for ICSI, information that is not available 
before the start of the TESE procedure. In the counselling of couples one should discuss 
both options i.e. with or without motile spermatozoa used for ICSI. For the future it would 
be valuable to develop and validate one integrated prediction model for predicting the 
chance of a live birth before undergoing a TESE procedure.
Box 3  Couple X
Probability of live birth after TESE-ICSI = exp(-β)/(1+exp(-β)) where β=7.659 +  
(female age * 0,442) + (female age² * -0,008) + (cycle number * -0,278) + 
(motility*0,608) + (testosterone*0,026) + (LH*-0,06) +  (OA/NOA*0,269)) 
Couple X 
Female age: 31
Cycle number: 1
Testosterone: 11 nmol/L
LH: 9 IU/L
OA/NOA: NOA (0)
In case sperm is found in TESE, the chance of a live birth for Couple X, following our 
prediction model above, is: 17% in their first TESE-ICSI cycle if there are motile 
spermatozoa available for injection of the oocyte and 10% if viable but immotile 
spermatozoa are used.
Processed on: 21-9-2016
505365-L-bw-Meijerink
133
General discussion
7
Health of offspring
Using immature spermatozoa for fertilization of oocytes in TESE-ICSI might have 
consequences for the children born after TESE-ICSI. Mr. and Mrs. X heard about the 
moratorium which was set on ICSI with surgical retrieved sperm due to concerns about 
the possible short and long term effects on the health of children. Couple X would like to 
be informed about these possible effects on child’s health.
In Chapter 4 these issues were addressed. We found no significant difference in the 
prevalence of major birth defects between the TESE group (5.9%) and the PESA group 
(6.9%). We also studied whether or not several maternal and treatment related factors – 
maternal age, maternal smoking behaviour, fresh or frozen-thawed sperm, fresh or 
frozen-thawed embryos and embryo quality –had a significant effect on the prevalence 
of birth defects. This was not the case. In addition to the results described in chapter 4, we 
studied the birth defects in relation to paternal age. The paternal age of children with or 
without a major birth defect did not differ significantly in the PESA group, in the TESE 
group the paternal age of children with a major birth defect was significantly lower. This 
might reflect a more severe spermatogenesis disorder in younger NOA men compared 
with older NOA men as discussed previously.  Moreover, we performed an observational 
prospective cohort study to behavioural, cognitive and motor performance and growth 
parameters of five-year-old children born after TESE-ICSI as described in Chapter 5. Four 
children (3.8%) of the ‘five-years-old cohort’ presented with developmental problems. 
Two of them were already diagnosed with a form of autism (Pervasive Developmental 
Disorder-Not Otherwise Specified). Two children had developmental problems based on 
two or more of our behavioural, cognitive and motor assessments. In addition to the 
results described in chapter 5, we found no significant difference in paternal age of the 
children with or without a developmental problem. 
Our ‘five-years-old cohort’ assessed significantly better on behavioural and cognitive 
performance than general population. The ‘five-years-old cohort’ assessed significantly 
worse on motor performance compared with general Dutch population. Although there 
is a significant difference compared with general Dutch population, the mean total test 
score of our cohort is still within the normal range and is therefore less clinically relevant. 
Our results concerning the safety of TESE-ICSI regarding long term effects on development 
and health in children born after these procedures, seems therefore reassuring. Doctor Y 
is now able to tell Couple X about the prevalence of birth defects and the development 
of the children born after TESE-ICSI.
In the meantime the Minister of Health, Welfare and Sport lifted the moratorium on 
TESE-ICSI in June 2014 after the presentation of a preliminary report about the safety of 
treatment (NVOG, 2013, Staatscourant, 2014). After this decision, beside the fertility centres 
of Radboud university medical center and Academic Medical Center other fertility centres 
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can to offer TESE-ICSI treatment as long as they adhere to the professional Quality 
Standard. To collaborate in TESE care, Radboud university medical center and Academic 
Center initiated biannual TESE-NL meetings for all Dutch fertility centres which are 
(planning to) provide TESE (-ICSI). During these meetings all fertility centres agreed to 
register all TESE procedures and whether or not there were complications during or after 
treatment.
Paternal ageing
In this given example of Couple X, Mrs. X is 31 and Mr. X is 36 years old. What if Mr. X would 
have been a lot older, e.g. 68 years? Doctor Y knows that women older than 35 years have 
a higher risk of spontaneous abortion, pregnancy complications and chromosomal 
abnormalities (de la Rochebrochard and Thonneau, 2002), and also the chance of getting 
pregnant decreases with women’s age. In the Netherlands the participation in reproductive 
programs for women is available till 45 years, however only reimbursed for women aged 
up to 42. But what about ageing men, what are their chances in ART?
In Chapter 6, we studied the paternal age effect on reproductive outcome after different 
ART treatments in terms of embryo quality, biochemical pregnancy and ongoing 
pregnancy. We did not find a paternal age effect for these criteria. Subgroup analyses 
based on IVF, ICSI and ICSI with non-ejaculated spermatozoa, nearly identical results were 
found. Although the results of this study do not support our hypothesis of a negative 
effect on ART outcome due to paternal ageing, this subject should be studied more 
extensively. As stated in the introduction of this thesis, male age for parenthood has 
increased in the last decade. In the Netherlands in 2000, 11.1% (n=22981) of the children 
born had a father over 40 years old; in 2012 this percentage was 16.4% (n=28 888) (CBS, 
2011). No paternal ageing effect on ongoing pregnancy was found in this study. This 
doesn’t mean that paternal age has no effect. It would be of great interest to link paternal 
age at conception to data on live births including data on the presence or absence of 
congenital abnormalities or developmental delay. As stated in the introduction, epidemi-
ological literature demonstrates an association between paternal age and the prevalence 
of autism spectrum disorders, schizophrenia and low educational attainment in offspring 
(D’Onofrio, et al., 2014, Humm and Sakkas, 2013).
We suspect that several biological processes are influenced by paternal ageing. De novo 
mutations are known to largely originate during male gametogenesis and their number 
increases with paternal age (Crow, 2000, Kong, et al., 2012). Recent studies using exome 
and whole genome sequencing described that many de novo mutations in children with 
intellectual disability had a paternal origin (Crow, 2000, Glaser, et al., 2000, Hehir-Kwa, et al., 
2011, Moloney, et al., 1996, Vissers, et al., 2010). About 80% of the copy number variations 
originated from the fathers (Hehir-Kwa, et al., 2011). Results of next generation DNA 
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sequencing techniques confirm that humans have an exceptionally high mutation 
induction rate per generation (Vissers, et al., 2010).  Most de novo mutations do not lead to 
a congenital abnormality, as most mutations occur outside of gene and do not affect 
gene functioning. However, as more mutations occur random in the genome this 
increases the chance of mutation affecting gene functioning and thereby causing 
disorders such as intellectual disability. 
Although the association between the number of de novo mutations and increased 
paternal age has been reported, so far no data are available on the number of de novo 
mutations in offspring from fathers over 45 (Hehir-Kwa, et al., 2011, Kong, et al., 2012). It is 
therefore currently unknown whether paternal age effects remains linear or become 
exponential after a certain age (Figure 1), as is the case for de novo chromosomal 
abnormalities in women over 35 (Schmidt, et al., 2012). Besides, it is still unknown whether 
the use of IVF or ICSI (with ejaculated or non-ejaculated sperm) influences the number of 
de novo mutations in offspring. Further research should focus on these two aspects.
Figure 1   Relation between paternal age, number of de novo mutations and genetic 
disease in offspring, based on pilot data (Gilissen, et al., 2014)
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Conclusion 
In this thesis various aspects of safety and efficacy in severe male infertility were studied. 
Two prediction models for couples undergoing TESE-ICSI were developed and validated. 
Moreover, the safety of ICSI with testicular spermatozoa was studied and seems to be a 
safe treatment regarding the offspring up to the age of five. No increased numbers of 
birth defects or developmental problems were found. Finally, no paternal ageing effect 
on reproductive outcome in terms of embryo quality, biochemical pregnancy and 
ongoing pregnancy after ART could be demonstrated. 
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Summary
In this thesis, we describe the research we have performed in order to improve the 
counselling of couples with severe male infertility. We focus primarily on the safety and 
efficacy of fertility treatments for couples facing azoospermia and need testicular sperm 
extraction with intracytoplasmic sperm injection (TESE-ICSI) treatment. The introduction 
(Chapter 1) addresses the medical background of azoospermia, the introduction of 
assisted reproduction techniques in a historical perspective and the available knowledge 
on the safety of the TESE-ICSI. In addition, the potential risks of an increased paternal age 
are discussed. Finally, we formulated a number of research questions.
In Chapter 2, we examine what factors are predictive for obtaining spermatozoa with 
TESE in men with non-obstructive azoospermia. We studied the results of 918 men with a 
non-obstructive azoospermia (NOA) who underwent a first TESE procedure. After analysis 
we found that the probability of obtaining spermatozoa with TESE was associated with a 
higher male age, a higher testosterone and a lower follicular stimulating hormone and 
luteinizing hormone. In addition, an idiopathic NOA or having an AZF-c deletion on the Y 
chromosome had a negative effect on the probability of obtaining spermatozoa with 
TESE. The developed prediction model had an area under the curve (AUC) of 0.69 and was 
tested on an external patient population in which 453 TESE procedures were performed. 
The model was externally validated and had an AUC of 0.65. If sperm retrieval was 
successful, the couple can continue treatment with TESE-ICSI in order to try to conceive. 
Therefore, we investigated in Chapter 3 what factors are predictive of the likelihood of a 
live birth after TESE-ICSI treatment. We studied 526 couples with fertility problems based 
azoospermia who underwent a total of 1006 TESE-ICSI treatment cycles. After analysis we 
found that the probability of a live birth was associated with a lower female age, a first 
treatment cycle, a low male luteinizing hormone, a high level of male testosterone, the 
availability of motile spermatozoa for injection of the oocytes, and having an obstructive 
azoospermia as an initial diagnosis. The prediction model we developed this had an AUC 
of 0.62 and was tested on an external patient population with 289 couples who underwent 
553 cycles. The model was externally validated and had an AUC of 0.67.
Chapter 4 describes the results of our study regarding the prevalence of birth defects in 
children born after ICSI treatment with percutaneous epididymal sperm aspiration (PESA) 
and TESE-ICSI. We studied the birth defects in 406 children who were born after PESA-ICSI 
in 237 children who were born after TESE-ICSI. The prevalence of ‘major’ birth defects was 
6.9% in the PESA group and 5.9% in the TESE group, this was not significantly different. In 
addition, we investigated whether maternal or treatment factors (including maternal age, 
maternal smoking, using fresh or frozen spermatozoa, transferring fresh or frozen embryos 
and embryo quality) influenced the risk of a birth defect. This could not be demonstrated.
Chapter 5 describes the study in which we investigated whether children born after 
TESE-ICSI have behavioural, cognitive, motor and / or physical problems at age five. We 
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evaluated the development in 404 children born after TESE-ICSI at birth, one year and four 
years of age, and evaluated the development of 103 five-year-olds with behavioural, 
cognitive and motor performance tests and growth parameters. Four children (3.8%) of 
the ‘five-years-old cohort’ had developmental problems. Two of them were previously 
diagnosed with a form of autism (Pervasive Developmental Disorder-Not Otherwise 
Specified). Two children had developmental problems based on our behavioural, cognitive 
and motor assessments. Our ‘five-years-old cohort’ assessed significantly better on 
behavioural and cognitive performance and significantly worse on motor performance 
than general population. Our results concerning the safety of TESE-ICSI regarding long 
term effects on development and health in children born after these procedures, seems 
therefore reassuring.
Chapter 6 describes the results of a study on the influence of paternal age on the 
availability of top quality embryo for transfer, biochemical pregnancy rate, ongoing 
pregnancy rate and miscarriage after the application of assisted reproduction techniques. 
We studied the results of 7051 first in vitro fertilization (IVF) and ICSI treatments. After 
analysis, we found no significant effect of paternal age on the availability of top quality 
embryos for transfer, biochemical pregnancy rate, ongoing pregnancy rate and / or 
miscarriage after use of assisted reproduction techniques. In subgroup analyses based on 
IVF, ICSI and ICSI with non-ejaculated sperm, nearly identical results were found.
In Chapter 7 of this thesis, we discuss the main conclusions of our studies. With the use of 
an example case, we described the applicability of the prediction models developed by 
us and the implications for the practice for both the doctor and the patient. ICSI with 
testicular sperm obtained by TESE seem to be a safe treatment according to study 
regarding the development of five-year-olds born after TESE-ICSI. We could not 
demonstrate a paternal age effect on the outcome of assisted reproduction techniques.
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Samenvatting
In dit proefschrift beschrijven we het onderzoek dat we hebben verricht om paren met 
ernstige mannelijke subfertiliteit beter te kunnen counselen. Onze focus ligt voornamelijk 
op de veiligheid en de effectiviteit van vruchtbaarheidsbehandelingen bij paren met 
azoöspermie waarbij een testiculaire sperma extractie met intracytoplasmatische sperma 
injectie (TESE-ICSI) behandeling wordt verricht. In de introductie (Hoofdstuk 1), wordt de 
medische achtergrond van azoöspermie, de introductie van geassisteerde voortplan-
tingstechnieken in een historisch perspectief en de beschikbare kennis over de veiligheid 
van de TESE-ICSI behandeld. Daarnaast worden de potentiële risico’s van een toegenomen 
leeftijd van de man besproken. Aan de hand hiervan formuleerden we een aantal onder-
zoeksvragen.
In Hoofdstuk 2 onderzoeken we welke factoren voorspellend zijn voor de kans op het 
vinden van zaad bij TESE bij mannen met een niet obstructieve azoöspermie (NOA). We 
bestudeerden de resultaten van 918 mannen met een NOA die een eerste TESE ingreep 
ondergingen. Na analyse bleek dat de kans op het verkrijgen van zaad bij TESE was 
geassocieerd met een hogere leeftijd, een hoger testosteron, een lager folliculair 
stimulerend hormoon en luteïniserend hormoon. Daarnaast hadden een ideopathische 
NOA en het hebben van een AZF-c deletie op het Y chromosoom een negatief effect op 
de kans op het verkrijgen van zaad bij TESE. Het predictie model wat we hiermee 
ontwikkelden had een ‘area under the curve’ (AUC) van 0.69 en werd getest op een 
externe patiënten populatie waarin 453 TESE’s werden verricht. Het model werd hierdoor 
extern gevalideerd en had een AUC van 0.65. Als er bij deze paren zaad werd gevonden, 
dan konden zij behandeld worden met TESE-ICSI in de hoop dat hun kinderwens in 
vervulling kon gaan. Daarom hebben we in Hoofdstuk 3 onderzocht welke factoren 
vervolgens voorspellend zijn voor de kans op een levend geboren kind na TESE-ICSI 
behandeling. We bestudeerden 526 paren met een vruchtbaarheidsprobleem op basis 
van azoöspermie die in totaal 1006 TESE-ICSI behandelcycli ondergingen. Na analyse 
bleek dat de kans op een levend geborene was geassocieerd met een lagere leeftijd van 
de vrouw, een eerste behandel cyclus, een laag mannelijk luteïniserend hormoon, een 
hoog mannelijk testosteron, de beschikbaarheid van bewegende zaadcellen voor ICSI en 
de verdenking op een obstructieve azoöspermie bij het eerste onderzoek. Het predictie 
model wat we hiermee ontwikkelden had een AUC van 0.62 en werd getest op een 
externe patiënten populatie met 289 paren die 553 behandelcycli ondergingen. Het 
model werd hierdoor extern gevalideerd en had een AUC van 0.67.
Hoofdstuk 4 beschrijft de resultaten van onze studie naar de prevalentie van aangeboren 
afwijkingen bij kinderen die geboren zijn na behandeling met percutane epipidymale 
sperma aspiratie (PESA)-ICSI en TESE-ICSI. We bestudeerden de aangeboren afwijkingen 
in 406 kinderen die geboren waren naar PESA-ICSI en in 237 kinderen die geboren waren 
na TESE-ICSI. De prevalentie van ‘major’ aangeboren afwijkingen was 6.9% in de PESA 
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groep en 5.9% in de TESE groep, dit was niet significant verschillend. Daarnaast 
onderzochten we of maternale of behandelingsfactoren (o.a. leeftijd van de moeder; 
rookgedrag van de moeder; het gebruik van vers of ingevroren zaad; het terugplaatsen 
van verse of ingevroren embryo’s; de embryokwaliteit) invloed hadden op de kans op een 
aangeboren afwijking. Dit werd niet aangetoond.
Hoofdstuk 5 beschrijft de studie waarin we hebben onderzocht of kinderen die geboren 
zijn na behandeling met TESE-ICSI gedrags, cognitieve, motorische en/of lichamelijke 
problemen hebben op vijfjarige leeftijd. We bestudeerden de ontwikkeling van 404 
kinderen geboren na TESE-ICSI bij de geboorte, op 1-jarige en 4-jarige leeftijd. Daarnaast 
onderzochten we het gedrag, de intelligentie, de motorische en de lichamelijke 
ontwikkeling van 103 vijfjarige kinderen uit deze groep. Vier kinderen (4%) van de 
onderzochte vijfjarigen hadden problemen in de ontwikkeling. Twee van hen waren al 
gediagnosticeerd met een vorm van autisme (PDD-NOS). De twee andere kinderen 
hadden problemen in de ontwikkeling gebaseerd op onze testen. Onze groep 
onderzochte 5-jarige scoorden significant beter op gedrag en intelligentie en significant 
slechter op motoriek in vergelijking met een algemene groep kinderen. Onze resultaten 
met betrekking tot de ontwikkeling van kinderen geboren na TESE-ICSI en de veiligheid 
van de behandeling zijn daarom geruststellend.
In Hoofdstuk 6 worden de resultaten beschreven van een studie naar de invloed van de 
leeftijd van de man op de beschikbaarheid van een topkwaliteit embryo voor 
terugplaatsing, het optreden van een biochemische zwangerschap, doorgaande 
zwangerschap en/of miskraam na de toepassing van geassisteerde voortplantingstech-
nieken. We bestudeerden de resultaten van 7051 eerste in vitro fertilisatie (IVF) / ICSI 
behandelingen. Na analyse vonden we geen significant effect van paternale leeftijd op de 
beschikbaarheid van een topkwaliteit embryo voor terugplaatsing, het optreden van een 
biochemische zwangerschap, doorgaande zwangerschap en/of miskraam na toepassing 
van geassisteerde voortplantingstechnieken. Ook in subgroep analyses waarbij we 
hebben gekeken naar IVF, ICSI of ICSI met chirurgisch verkregen zaad vonden we vrijwel 
dezelfde resultaten, met andere woorden geen invloed van paternale leeftijd op de be-
handeluitkomsten.
In Hoofdstuk 7 van dit proefschrift gaan we in op de belangrijkste conclusies die we 
hebben kunnen trekken uit dit onderzoek. We hebben de toepasbaarheid van de door 
ons ontwikkelde predictiemodellen beschreven en de implicaties voor de praktijk voor 
zowel de dokter als de patiënt aan de hand van een voorbeeld. ICSI behandeling met 
testiculair verkregen zaad door middel van TESE lijkt een veilige behandeling als we naar 
de resultaten van onze studie naar de ontwikkeling van vijfjarige kinderen kijken. We 
hebben geen paternaal leeftijdseffect kunnen aantonen op de uitkomsten van 
geassisteerde voortplantingstechnieken. 
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Abbreviations
Abbreviations
ART assisted reproductive techniques
AZF azoospermia factor
BPR biochemical pregnancy rate
CBCL child behaviour checklist
CI confidence interval
DET double embryo transfer
DNA desoxyribo nucleic acid
ET embryo transfer
FSH follicular stimulating hormone
HCG human chorionic gonadotrophin
ICSI intracytoplasmic sperm injection
IQ intelligence quotient
IVF in vitro fertilization
LH luteinizing hormone
M-ABC movement assessment battery for children
MESA microsurgical epididymal sperm aspiration
OHSS ovarian hyperstimulating syndrome
OPR ongoing pregnancy rate
OPU ovum pick up
OR odds ratio
PESA percutaneous epididymal sperm aspiration
SET single embryo transfer
TESE testicular sperm extraction
TRF teacher report form
WPPSI wechsler preschool and primary scale of intelligence
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Allereerst, een woord van dank aan alle patiënten voor de deelname aan mijn studies, in het 
bijzonder de vijfjarige kinderen geboren na TESE-ICSI en hun ouders. Er werden puzzeltjes 
opgelost, kraaltjes geregen, met pitten zakken gegooid, op de weegschaal en onder de meetlat 
gestaan en vaak werd er speciaal een vrije dag genomen. Jullie bereidwilligheid om deel te 
nemen aan mijn studie heeft ervoor gezorgd dat ik een mooi onderzoek heb kunnen doen.
Prof. dr. D.D.M. Braat, beste Didi, je hebt je rol als promotor met verve vervuld. Je bewaakte 
de onderzoekslijn, gaf me goede aanwijzingen voor het schrijven van mijn artikelen en als 
er wat geregeld moest worden dan sprong je voor me op de bres ondanks al je andere 
drukke bezigheden. Ik bewonder hoe je altijd alle ballen hoog houdt en daarnaast oog 
blijft houden voor de mens achter de medewerker. 
Prof. dr. ir. J.A. Veltman, beste Joris, ik kan me onze eerste kennismaking nog goed heugen. 
Ik had een hele powerpoint presentatie gemaakt met het idee dat ik je zou moeten 
overtuigen om samen dit onderzoek op te gaan zetten. Ik was blij verrast, want nog 
voordat ik goed en wel kon beginnen had je al allemaal plannen voor ogen. Je inspiratie, 
en je straight forward aanpak kan ik zeer waarderen, ik was dan ook niet verbaasd dat je 
met al je ambitie zelfs een VICI grant hebt binnengesleept. Ik hoop dat hieruit nog veel 
mooie projecten mogen volgen.
Dr. K. Fleischer, beste Kathrin, bedankt voor je vertrouwen en begeleiding. Ik kan me nog 
goed herinneren dat ik een jaar bezig was met mijn promotie, naar mijn idee al heel lang, 
en ik onzeker werd omdat ik nog steeds niks had gepubliceerd. Het is dan heel fijn als 
iemand je het vertrouwen geeft dat er echt wel een proefschrift uit komt rollen en dat 
publicaties soms even op zich laten wachten. Ook bij frustraties kwam je met een mooie 
oneliner… “De Beatles hebben daar een liedje over ….Let it be”. En uiteraard had je gelijk.
Dr. L. Ramos, beste Liliana, sinds jij in mijn team zat, of eigenlijk sinds ik was toegetreden 
tot team Liliana, voelde dat ook echt zo. Je komt echt voor je promovendi op en praat over 
ons met veel trots en respect. Ik kon altijd even bij je binnenlopen en je dacht met me 
mee. Versies van artikelen kreeg ik altijd met ruime feedback terug, vaak op donderdag 
omdat je dan op je vrije dag woensdag thuis in Arnhem in de tuin had gezeten om er eens 
rustig naar te kijken. Dankjewel voor de fijne tijd!
Leden van de manuscript commissie, geachte prof. C. Noordam, prof. dr. M.J.C.  Eijkemans 
en prof. dr. P. de Sutter, hartelijk dank voor het beoordelen van het manuscript. Alle leden 
van de corona wil ik graag bedanken voor het vervullen van hun taak als opponent bij 
de verdediging.
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Appendix
Een wetenschappelijk artikel schrijf je niet zomaar en zeker niet alleen. Graag zou ik alle 
mede onderzoekers en auteurs willen bedanken: van de kinderfysiotherapie (Anjo, Carina 
en Dionne) van de kinderpsychologie (Birgit,  Ilse, Jolanda, Manon, Monique en Nienke), 
van de urologie (Kathleen), en van de health science (Jan en Joanna). Collega’s uit het AMC 
(Andreas, Annemieke, Madelon, Monique, Niels en Sjoerd), bedankt voor al jullie input, 
ik denk dat de presentaties bij de ESHRE en de publicaties van onze gezamenlijke stukken 
een mooie kroon zijn op ons werk. Gwendolyn, het was een eer om het ‘kinder-follow-up’ 
stokje van je over te nemen, bedankt voor je hulp bij hoofdstuk 4 en je goede tips en 
suggesties.
Lieve Maartje, sinds dat jij bent aangehaakt bij de TESE stukken kwam er schot in de zaak. 
We hebben samen onze tanden erin gezet, en met een mooi resultaat. Bedankt voor al je 
inzet, ik wens je heel veel succes met je eigen verdediging, maar dat gaat zeker goed 
komen!
En dan een hele tuin vol met gezellige collega’s. Amper in de tuin aangekomen werd ik al 
gestrikt voor de organisatie van de het onderzoekersweekend. Sophieke en Suzan ik vond 
het tof om het met jullie te organiseren en vind het super dat we nog regelmatig met 
elkaar borrelen als er (n)iets te vieren is. Veel succes gewenst met jullie laatste loodjes! 
Lieve tuinbewoners, ik heb genoten van onze onderzoekersweekendjes in thema met 
o.a. GPS tochten die eindigen bij een oud oma’tje op het erf bij een champignonkwekerij, 
de vrimibo’s bij Anneke op het terras, de publicatietaarten, het waterskiën, de vierdaagse 
met de onderzoekers compleet met takken zwembanden en kunstkerstbomen, sushi 
etentjes (a.k.a. all you can not eat) en natuurlijk de skiweekenden met de varkenshouders. 
Keep up the good work!
Wat moet een promovendus zonder een paar goede studenten? Reinoud en Ilse wat had 
ik het met jullie getroffen, bedankt voor jullie inzet en fanatisme. 
Lieve (oud) IVF artsen Bea, Ellen Marie, Fleur, Lobke, Marloes, Martje, Myra, Ouijdane, 
telkens in een wisselende samenstelling maar altijd een gezellig club. Samen op de 
wielrenfiets een tochtje maken, uiteten of even lekker lunchen in het restaurant om bij 
te kletsen. Ik heb altijd fijn en gezellig met jullie gewerkt.
Team VPG: gynaecologen, IVF artsen, verpleegkundig specialisten, arts-assistenten, 
 verpleeg kundigen, analisten, embryologen, secretaresses, bedankt voor het mij wegwijs 
maken in de wondere wereld die Voortplantingsgeneeskunde heet. Ik heb ontzettend 
veel geleerd van jullie en af en toe hartelijk met jullie gelachen, het was een vruchtbare 
samenwerking. Een speciaal woord van dank aan Lisette die jarenlang zeer zorgvuldig 
voor mij alle ouders van kinderen geboren na ICSI-TESE vragenlijsten heeft toegestuurd.
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Oud-collega’s van het JBZ, wat heb ik een fijne tijd bij jullie gehad. De warmte en de 
hechtheid van jullie team is een uitstekende plek om als jonge ANIOS de eerste stappen 
op het dokterspad te zetten. Jan-Willem, Mieke en Sanne wat fijn dat jullie destijds met 
me mee wilden denken om mijn carrière uit te stippelen. Ik heb dat zeer gewaardeerd, 
mede daardoor ligt hier nu een mooi proefschrift.
Lieve vriendinnen, Floor, Judith, Willemijn, Shanna, Esther, Linda, Joosje, Maartje en Mieke 
ook al ken ik jullie allemaal op een andere manier, via geneeskunde, als huisgenoot, al 
sinds de peuterspeelzaal in ons dorp, de middelbare school of van mijn eerste grote reis 
naar Thailand, jullie waren altijd geïnteresseerd. Misschien snapten jullie niet altijd helemaal 
waarom iemand die graag de gynaecologie in wil zich bezig houdt met (afwezige) 
zaadcellen… het leverde zeker interessant gesprekmateriaal op….Het is fijn om zulke fijne 
vriendinnen te hebben. 
Lieve Marloes, wat ben ik blij dat je naast mij wilt staan op deze grote dag. Het was heel 
fijn om jou als voorganger te hebben en in je voetsporen te mogen treden, eerst als 
ANIOS in Den Bosch, later als fertiliteitsarts en onderzoeker in het Radboud. En nu straks 
als AIOS in cluster Nijmegen. Ik was vereerd dat ik bij jou paranimf mocht zijn, en je hebt je 
verdediging ook echt ‘gerockt’. In mijn ogen ben jij de meest relaxte collega die iedereen 
graag zou willen hebben. 
Lieve Fleur, wat fijn dat je speciaal voor mijn verdediging vanuit Frankrijk naar Nederland 
bent gekomen om me bij te staan en je taak als paranimf op je te nemen. Je bent voor mij 
altijd een zeer gewaardeerde collega geweest zowel als onderzoeker en als fertiliteitsarts. 
Natuurlijk is het jammer dat je nu niet meer in Nederland woont, maar ik vind het super 
stoer van je dat je je liefde achterna bent gegaan. Daar kan ik alleen maar bewondering 
voor hebben. Ik wens je heel veel succes met de laatste loodjes van je eigen promotie 
maar dat gaat zeker goed komen.
Lieve pap, mam, Rick en Joost, volgens mij kijken jullie je ogen uit vandaag…..het is ‘net 
echt’ hé! Ikzelf had niet gedacht, en volgens mij jullie ook niet, dat ik ooit zou gaan 
promoveren, en toch is het zo. Nena en Sophie, wat leuk dat jullie er ook bij zijn vandaag.
Ons gezin, door mij getekend als vijfjarige kleuter voor het geboorte kaartje van Joost, 
staat op de kaft staat van mijn proefschrift. Het staat symbool voor de essentie van het 
proefschrift maar ook waar ik jullie voor wil bedanken, een warm liefdevol gezin waarin je 
wordt gesteund en aangemoedigd om jezelf te ontwikkelen, en eruit te halen wat erin zit. 
Dankjewel!
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Aukje Meijerink werd op 25 april 1987, als oudste van drie 
kinderen, geboren te Deventer en groeide op in het 
Overijsselse Lettele. De middelbare school doorliep zij aan 
het Geert Groote College (later: Etty Hillesum Lyceum) te 
Deventer waaraan zij in 2005 haar VWO diploma behaalde. 
Na te zijn ingeloot voor de studie geneeskunde verhuisde 
zij naar het hoge noorden om aan de Rijks universiteit 
Groningen te gaan studeren. Tijdens haar studie maakte 
Aukje twee buitenlandse uitstapjes, eenmaal naar Bangkok 
(Thailand) voor een IFMSA stage kindergeneeskunde en eenmaal naar Kondoa (Tanzania) 
voor een coschap sociale/tropen geneeskunde. Echter Aukje raakte in het bijzonder 
geïnteresseerd in de gynaecologie. Na twee reguliere coschappen gynaecologie in het 
UMCG (Groningen) en in de Isala Klinieken (Zwolle) besloot zij ook een semi arts stage 
en een wetenschappelijke stage binnen de gynaecologie te volgen in het Deventer 
Ziekenhuis onder leiding van dr. P.J.Q. van der Linden. Tijdens deze wetenschappelijke 
stage kwam zij voor het eerst in aanraking met pathologie, immuunhistochemie en het 
doen van onderzoek, dit resulteerde in een eerste publicatie. In 2012 nam zij haar artsenbul 
in ontvangst, waarna zij als ANIOS gynaecologie in het Jeroen Bosch Ziekenhuis 
(Den Bosch) aan de slag ging. Na een leuke, leerzame en tijd in Den Bosch was zij helemaal 
overtuigd, ze wilde gynaecoloog worden. Aukje startte in 2013 als fertiliteitsarts en 
arts-onderzoeker in het Radboudumc (Nijmegen). Aanvankelijk betrof het onderzoek de 
follow up van de ontwikkeling van kinderen geboren na ICSI-TESE echter als snel groeide dit 
uit tot een promotietraject onder leiding van prof. dr. D.D. M. Braat, prof. dr. ir. J.A. Veltman, 
dr. K. Fleischer en dr. L. Ramos. Het proefschrift dat nu voor u ligt is hiervan het resultaat. 
Per 1 februari 2017 zal Aukje starten met de opleiding tot gynaecoloog in cluster Nijmegen, 
in ziekenhuis Gelderse Vallei te Ede.
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